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Abstract 
Lung surfactant is a complex mixture of lipids and proteins that enables normal 
breathing by reducing the surface tension at the alveolar air-water interface, and additionally 
provides the first line of defense against inhaled microbes in the lungs. Surfactant protein B 
(SP-B) is an indispensable component of lung surfactant system and absolutely essential for 
the survival of mammals. SP-B is thought to function by facilitating large-scale 
rearrangements of lipid structures at various stages of the breathing cycle. However, neither 
the structural mechanisms for this ability nor the physiological ramifications of the lipid 
rearrangements are yet understood, in part because a high-resolution structure of SP-B has 
not been determined. As is generally the case for membrane and other lipid-associated 
hydrophobic proteins, the production of an SP-B sample for structural studies has been very 
challenging and unsuccessful to date. Interestingly , synthetic fragments of SP-B retain 
substantial biological activity when compared to the full -length protein . This Ph.D. research 
has applied solution nuclear magnetic resonance (NMR) methods to three SP-B-based 
peptides to reveal at least some of the critical structural features and lipid/protein interactions 
that presumably underlie the functional mechanisms of SP-B in physiological conditions. 
The high-resolution structure of Mini-B, an N-terminal - C-terminal construct of 
SP-B that exhibits even better performance than the full-length protein in rat models, is 
determined in the presence of surfactant lipid-mimetic sodiumdodecylsulfate (SDS) micelles. 
Mini-B consists of two a-helices with a projecting tryptophan anchor and displays a 
strikingly amphipathic surface. The structure of Mini-B appears very well-suited for making 
strong interactions with surfactant phospholipid analogues. Indeed, Mini-B binds both 
anionic and zwitterionic micelles composed of SDS, dodecylphosphocholine (DPC), 
lysomyristoylphosphatidylcholine (LMPC), lysomyristoylphosphatidylglycerol (LMPG) and 
mixed LMPC/LMPG, and induces substantial rearrangements of the micelle structures. To 
prepare a foundation for directly probing the interaction between Mini-B and surfactant 
protein A (SP-A), the conformation and lipid interactions of SP-A are investigated separately 
in the presence of micelles composed from the same model surfactant lipids. SP-A also binds 
11 
both zwitterionic and anionic micelles. Surprisingly, in the presence of micelles, SP-A exists 
predominantly as smaller oligomers, in sharp contrast to the octadecamers observed when in 
an aqueous environment, and the form in which SP-A has long been presumed to function. 
Mini-B appears to interact with SP-A in all micelle systems, although the interaction is 
indirect and the degree of the interaction is dependent on the type of detergent/lipid 
headgroup. Next investigated are the changes to SP-B's structure and lipid interactions 
brought about by tryptophan oxidation, a modification which is thought to be a major 
contributor to acute respiratory distress syndrome (ARDS). Replacement of tryptophan by 
one of its oxidized forms, kynurenine, substantially disrupts the helical structure of SP-Bs-25, 
anN-terminal fragment of SP-B, and also affects its interactions with the micelles. Lastly, as 
a step towards the determination of the structure of full-length SP-B, the overall 
conformation of Maxi-BeT, the C-terminal half of SP-B, has been investigated in the organic 
solvent hexafluoroisopropanol (HFIP) and SDS micelles. 
SP-B is indispensable for life, but the molecular basis for its activity is not yet 
understood. The findings of this Ph.D. research contribute to the ongoing endeavor in 
characterizing SP-B 's structure-function relationships and its mechanisms of lipid/protein 
interactions that are crucial for lung surfactant function. This work also provides a strong 
foundation for future studies on the conformation and interactions of full-length SP-B. 
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Chapter 1 
Intro uction 
1.1 Respiratory System and Lung Surfactant 
It is essential for almost all multicellular living organisms to inhale oxygen from the 
external environment in order to perform various physiological functions and to exhale 
carbon dioxide produced in the internal metabolic reactions from the body. For humans and 
all air-breathing vertebrates, the blood transports both of these gases and the exchange takes 
place in the lungs. This lung function is accomplished through airways ending in tiny air sacs 
known as alveoli (Figure 1.1). Adult human lungs contain approximately 2400 km of airways 
and 300 to 500 million alveoli, covering a total surface area of about 70m2 [1]. In the lungs, 
the air-filled alveoli are surrounded by blood-filled capillaries and the barrier in between is 
extremely thin. Molecules of oxygen and carbon dioxide are passively exchanged by 
diffusion between the air and the blood. Because of an incessant direct exposure to the 
external gaseous environment, the inner surface of the alveoli is coated by an approximately 
0.2 f.tm thick water layer to prevent it from dehydration [2]. As a result, a surface tension is 
created at the air-water interface since the forces of attraction between water molecules are 
stronger than the forces between water and air. 
The water-coated alveoli are roughly spherical in shape. The alveoli, and thereby the 
lung as a whole, inflate and deflate cyclically with inhalation and exhalation. Maintaining the 
alveolar structure throughout the cyclical changes in the lung volume is critical for normal 
respiration. The surface tension created at the air-water interface is largely governed by 
LaPlace's equation that relates the fluid pressure P inside a spherical vessel of radius R with 
the surface tension T, 
T = RP/2. 1.1 
Pure water has a surface tension of about 70 mN/m. Such a surface tension, unless countered, 
would promote lung collapse and increase the work required to re-inflate the lung at the end 
of an expiration [3]. However, the surface tension is indeed countered by a material called 
lung surfactant (also known as pulmonary surfactant) which enables normal breathing. Lung 
surfactant is a mixture of lipids and proteins that lines the air-water interface in alveoli. When 
lung surfactant is at thermodynamic equilibrium between the outer or water surface covering 
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monolayer and a bulk phase inside water, it decreases the surface tension to about 25 mN/m 
[4]. However, when the monolayer is compressed laterally, as at the end of expiration, it 
reduces the surface tension to near 0 mN/m [4]. This function of lung surfactant, termed 
"surface activity", successfully prevents alveolar collapse during exhalation and also eases 
the work of breathing during subsequent inhalation. 
In addition to reducing the surface tension and thereby enabling normal breathing, 
lung surfactant also provides the first line of defense and the innate immune response against 
inhaled pathogens, toxins and allergens [5]. This function of lung surfactant is also crucial 
since the respiratory system is continually exposed to toxic substances and infectious agents 
due to its direct contact with the external environment. 
Alveolar cell 
Alveoli Alveolus 
Figure 1.1 : A schematic representation of the human respiratory system. The lungs are 
composed of millions of alveoli where the 0 2/C02 exchange takes place. The inner surface of 
the alveoli is coated by a water layer. Lung surfactant, a lipid-protein lining at the air-water 
interface, reduces the surface tension and enables normal breathing. 
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The initial discovery of lung surfactant was made by von Neergaard in the late 1920s 
[6]. However, the significance of his discovery was not understood at that time. In the mid 
1950s, the observation of surfactant's ability to reduce the surface tension led to its 
rediscovery by Pattie [7] and Clements [8]. Since then, extensive research has been 
performed to unveil the molecular mechanisms that underlie its essential physiological 
functions. Although important advancements have been made over past decades, a complete 
structural description of the components and their interactions during the respiratory 
dynamics are still unavailable. 
1.2 Synthesis and Composition of Lung Surfactant 
Lung surfactant is synthesized and secreted into the alveolar fluid by one of the two 
boundary-forming cells of the alveoli, known as Type II pneumocytes (Figure 1.2) [9]. These 
cells are cuboidal in shape and contain specialized secretory intermediaries known as the 
lamellar bodies (LB) [ 1 0]. LB is actually a storage form of the surfactant. It consists of a core 
composed of multilamellar membranes surrounded by another membrane [11]. Its secretion 
occurs in response to local biochemical factors [12], signals from the autonomic nervous 
system [13] and deep breathing [14] or stret~h [15]. After reaching the extracellular aqueous 
environment, the LB contents become hydrated and can unravel into a highly ordered array 
of tubules with nearly rectangular cross section known as the tubular myelin (TM) [ 16]. The 
sidewalls of the TM are thought to be constructed from bilayers of surfactant phospholipids 
and their characteristic crosshatched structures are probably maintained through interactions 
with surfactant proteins [I 7]. Some models for surfactant formation suggest TM as the 
immediate precursor from which the surfactant components are released and finally form a 
surface active film at the alveolar air-water interface that is responsible for surface tension 
reduction [18, 19]. Electron microscopic images and surface activity studies suggest that the 
surface active film consists of multiple layers of phospholipids closely packed by the proteins 
[20, 21]. These multilayered structures act as a surface-associated reservoir of surfactant 
material and remain attached to the interface although the constituents are probably 
interchanged and recycled [22]. The final coating at the edge of the surface film, however, is 
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likely in the form of a lipid monolayer with the headgroups in contact with water and other 
polar molecules and the hydrocarbon acyl chains exposed into the air [22]. 
The composition of lung surfactant vanes among different vertebrates and also 
throughout the physiological development of a particular species [23]. For adult humans, and 
most mammals, phospholipids make up the bulk of surfactant materials (- 80% by weight), 
with the remaining being neutral lipids (- 10% by weight) and proteins (- 10%, by weight) 
[24]. Table 1.1 lists the components of adult human lung surfactant with percentages by 
weight [23-25]. 
Air 
Alveolar 
Type II cell 
Compression 
Figure 1.2 : A model for the life cycle of lung surfactant [19, 22]. After being synthesized in 
the endoplasmic reticulum (ER), surfactant materials are transported to the golgi apparatus 
(GA) and then packed into the lamellar bodies (LB). The LB, being secreted then into the 
water layer, swells and unravels to form the tubular myelin (TM). From the TM, lipids and 
proteins are released to form the surface active film at the air-water interface. 
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Table 1.1 : The composition of adult human lung surfactant [23-25]. 
Category Components with Percentages by Weight 
1. Phosphatidylcholine (PC) ~ 70% 
~ 35% dipalmitoylphosphatidylcholine (DPPC), 
~ 15% other disaturated species, and 
~ 20% unsaturated forms 
Phospholipids(~ 80%) 2. Phosphatidylglycerol (PG) ~ 9% 
3. Minor amount ofPhosphatidylinositol (PI) 
4. Minor amount of Phosphatidylethanolamine (PE) 
5. Minor amount ofPhosphatidylserine (PS) 
6. Minor amount of Sphingomyelin (SM) 
1. Mostly Cholesterol ~ 10% 
Neutral lipids(~ 10%) 2. Minor amounts of mono, di and triglycerides 
3. Minor amount of free fatty acids 
1. Surfactant Protein A (SP-A)~ 6% 
Proteins ( ~ 1 0%) 2. Surfactant Protein B (SP-B) ~ 1.5% 
3. Surfactant Protein C (SP-C) ~ 1.5% 
4. Surfactant Protein D (SP-D) ~ l% 
1.3 Lung Surfactant Activity, Disorder and Treatment 
An effective surfactant exhibits at least three critical properties. Firstly, it adsorbs 
quickly (within a few seconds) to the alveolar air-water interface [21]. This ensures that the 
materials reach the respiratory interface before a newborn completes the first inspiration. 
Secondly, attaining a thermal equilibrium after lining the interface, the surfactant brings 
down the surface tension close to 25 mN/m [26], which is further reduced to almost 0 mN/m 
during lung compression following an expiration [25]. This ensures that the alveolar collapse 
is avoided at the end of the expiration and that the subsequent lung expansion, following the 
next inspiration, can be performed with ease. Thirdly, during the re-expansion of the lung, 
the surfactant respreads back and covers the whole respiratory interface again [ 12]. This 
ensures that the surface film is protected from any rupture and is ready to repeat the cycle. 
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Since its rediscovery in the mid 1950s, lung surfactant has been subjected to various 
analytical and experimental techniques, but the molecular mechanisms underpinning its 
functions are not yet known in detail. There are a lot of unanswered questions regarding the 
structures, roles and mechanistic behaviors of the components at different stages of the 
breathing cycle. However, based on various biophysical studies, a few models have been 
proposed [12, 25, 27]. These models suggest that the phospholipids, due to their ability to 
form oriented interfacial monolayers, act as the principal surface active agents in the 
surfactant [27]. The proteins are primarily considered as modulating agents, evolved to 
optimize the surface activity of the phospholipids during the respiratory cycle and provide 
the innate immune response to microbes in the lungs [28, 29]. However, one of the proteins, 
namely surfactant protein B (SP-B), plays such crucial roles that lung surfactant loses its 
surface activity in the absence of SP-B and fails to function [30]. Thus SP-B is absolutely 
essential for the survival of mammals [31]. 
Deficiency or inactivation of lung surfactant leads to potentially fatal respiratory 
disorders such as neonatal respiratory distress syndrome (NRDS) in premature newborns [32] 
and acute respiratory distress syndrome (ARDS) in adults with acute injury or illness [33]. 
Development of lung surfactant replacement treatments in the early 1990s greatly improved 
the outlook for NRDS [34], but successful treatment of ARDS with endogenous surfactant has 
proved more challenging, probably because the conditions that lead to ARDS in the first place 
also lead to a rapid deactivation of the replacement surfactant [35]. Clinical trials have shown 
artificial surfactants to be much more effective if they include the proteins, SP-B in particular, 
as compared to protein-free preparations [36]. The requirement for SP-B's presence in 
effective surfactant replacement therapy is in keeping with the lethality of hereditary SP-B 
deficiency in humans [3 7] and knockout mice [3 8]. Improvement of surfactant replacement 
preparations, for example to avoid the use of animal derived surfactant and to improve its 
activity in the context of ARDS, is hampered by the lack of understanding of the structural 
features of surfactant proteins in detail that lead to their activities in the lungs. 
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1.4 Roles of Surfactant Lipids 
Lung surfactant consists of a distinct set of phospholipids that is largely dissimilar to 
other membranous systems in most organisms. The importance of these phospholipids for the 
physiological function of lung surfactant has been recognized for many years [24]. The roles 
of the major phospholipid species belonging to the PC and PG categories (Figure 1.3) have 
been well-identified but those of the minor phospholipid species, such as PI, PE, PS and SM, 
are still far less characterized. For the most part, experimental focus has been on the surface 
activity properties of the surfactant lipids, i.e., the surface tension reduction, rapid adsorption 
and respreading characteristics. In addition to these essential functions, however, the lipid 
components may also play other important roles, such as controlling lung fluid balance and 
thereby preventing alveolar edema [39]. 
During expiration, the surfactant film at the air-water interface is compressed and the 
surface tension must be reduced to almost 0 mN/m in order to prevent alveolar collapse [8]. 
This means that the surfactant film sustains a surface pressure of about 70 mN/m at the 
interface. Previous biophysical studies on monolayers composed of the major surfactant 
phospholipids led to a general consensus that only a pure dipalmitoylphosphatidylcholine 
(DPPC) film is capable of withstanding such high pressures [40]. This is because the 
disaturated hydrocarbon acyl chains of DPPC can be packed tightly enough to sustain the 
highest pressure. However, this idea has undergone some revision recently following 
observations such as (1) the monolayers which include unsaturated lipids, such as 
palmitoyloleoylphosphatidylcholine (POPC), can also reduce the surface tension to very low 
values if they are compressed quickly enough [ 41, 42], (2) the collapse pressures of mixed 
mono layers, such as a monolayer of DPPC/DPPG (at a ratio of 80 : 20), are similar to that of 
pure DPPC [43], and (3) the liquid-expanded and tilted condensed monolayer phases coexist 
even at surface tensions approaching zero [44-47]. Thus a new school of thought, aimed at 
explaining how lung surfactant reaches near-zero surface tension without necessitating a pure 
DPPC monolayer formed by squeezing out other phospholipids, suggests that the mixture of 
DPPC and other phospholipids may take on a metastable super-compressed structure when 
they are compressed sufficiently rapidly at the alveolar air-water interface [ 41, 48]. 
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Molecular dynamics (MD) simulations of several different phospholipid compositions, 
performed at the Booth lab, have found results consistent with this newer view [ 49]. 
Nevertheless, since DPPC is the most abundant surfactant phospholipid in most organisms 
(in humans, - 35% of the total weight), all working models consider at least a DPPC-
enriched film as the critical surface tension reducing structure at the alveolar air-water 
interface [19, 22, 25, 27, 50]. Other phospholipid components are mainly attributed with 
modulating roles to facilitate DPPC's adsorption to the interface as well as its respreading in 
the successive respiratory cycles [24]. It has been shown that DPPC, by itself, adsorbs very 
slowly into the air-water interface, especially at temperatures below its gel-to-liquid 
crystalline phase transition temperature of 41 oc [51]. However, mixing with more fluid 
phospholipids, such as unsaturated PCs, PG and/or PI, improves the adsorption of DPPC by a 
large extent [24]. 
DPPC 0 
POPG 0 
H, C, ~CH, 
. c . \ 
CH) CH, 
HO 
Cholesterol 
Figure 1.3 : Chemical structures of major lung surfactant lipids. DPPC is the most abundant 
phospholipid with PC headgroup, POPG is the most abundant phospholipid with PG 
headgroup and Cholesterol is the main neutral lipid in human lung surfactant. 
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Other than the phospholipids, a considerable amount ( ~ 1 0% of the total weight) of 
cholesterol is also present in lung surfactant. The ability of cholesterol to alter many essential 
physical properties of membranous systems is well-established. Its involvement in lateral 
phase separation of native lung surfactant membrane at physiological temperatures has been 
reported [52]. However, no clear data are available to date to evaluate its actual roles in lung 
surfactant function. 
It is to be noted that the lipids alone do not make a fully functional endogenous lung 
surfactant. The protein SP-B is indispensable for an effective lung surfactant. The other 
proteins are also important for its optimum performance, in terms of the surface activity as 
well as the host defense. However, the detailed mechanistic descriptions of the proteins' roles 
are not available till to date. 
1.5 Roles of Surfactant Proteins 
Lung surfactant consists of four proteins which are named as surfactant protein A 
(SP-A), surfactant protein B (SP-B), surfactant protein C (SP-C) and surfactant protein D 
(SP-D) according to their chronological order of discovery. In the native condition, SP-A is 
octadecameric consisting of six trimers [53], SP-B is dimeric [54], SP-C is monomeric [55], 
and SP-D is dodecameric consisting of four trimers [56]. SP-A is the most abundant protein 
of lung surfactant by weight (~ 6% of the total weight). Its main role is thought to be in 
defending the lungs against pathogens [5, 57]. Experiments showed that mice born without 
SP-A could breathe normally but were extremely prone to developing infections [58]. In vitro 
and in vivo studies suggest that SP-A also promotes the formation of tubular myelin, but this 
requires the protein SP-B and calcium too [59-61]. In addition, it has been observed that 
SP-A enhances adsorption of phospholipids along the air-water interface in a concerted 
action with SP-B [62, 63]. The protein SP-B is indispensable for life. It performs such crucial 
roles in surfactant function that its hereditary deficiency is lethal in humans [3 7] and in 
knockout mice [38]. Deactivation of SP-B by antibodies also causes respiratory distress 
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syndrome (RDS) in rabbit models [64]. Deficiency of the protein SP-C is not lethal at birth in 
knockout mice but they develop mild respiratory dysfunction later in life [65, 66]. Also, 
several cases have been described in which mutations of the SP-C gene are related to the 
occurrence of chronic familial respiratory diseases [67, 68]. The exact roles played by SP-B 
and SP-C in surfactant function and the mechanisms by which they act are not yet known. 
However, experiments showed that the presence of SP-B and SP-C provide necessary 
enhancement in adsorption of phospholipids at the alveolar air-water interface [69]. These 
proteins also appear to be important in preventing detachment of the folded structures from 
the water layer [70]. The other protein SP-D is not associated with the surface active lipid-
protein complexes and is not considered to play any significant role in the biophysical 
mechanisms of lung surfactant at the air-water interface in alveoli [71]. Although it is evident 
that SP-D affects the lipid homeostasis in vivo, perhaps, like SP-A, its main role is to provide 
an immune response against microbes in the lungs [72]. 
Understanding the molecular basis of surfactant proteins' functions and obtaining the 
mechanistic descriptions of their interactions are hindered, in part, by the lack of knowledge 
of their high-resolution structures. To date, the only known full-length structure of a 
surfactant protein is that of SP-C determined using solution-state nuclear magnetic resonance 
(NMR) spectroscopy (PDB ID 1 SPF) [55]. However, X-ray crystallographic structures of the 
carbohydrate recognition and neck domains, in both native and ligand-bound forms, of rat 
SP-A (PDB IDs 1R13 and 1R14) and human SP-D (PDB IDs 1B08 and lPWB) have been 
determined [73-75]. Additionally, the structures of SP-B fragments containing the terminal 
regions have been determined in organic solvent and/or detergent micelles by NMR (PDB 
IDs lKMR, 1RG3, 1RG4 and 2JOU) [76, 77]. Figure 1.4 shows the structural models for the 
native multimeric forms of SP-A, SP-B and SP-D constructed based on preliminary 
assumptions [56, 70] and the high-resolution structure of SP-C determined by NMR [55]. 
The high-resolution crystallographic structures of the trimeric carbohydrate recognition and 
neck domains of SP-A and SP-D [73, 74] are also shown. 
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Monome1 
Trimer 
SP-A (Model) 
Based on Ref. [56] 
SP-A CRD and 
Neck Trimer 
(Experimental) 
PDB ID 1Rl3, [73] 
SP-D (Model) 
Based on Ref. [56] 
SP-B (Model) 
Based on Ref. [70] 
SP-C (Experimental) 
PDB ID 1 SPF, [55] 
Figure 1.4 : Structural models for lung surfactant proteins, based on Refs. [55, 56, 70]. 
Native SP-A, SP-B and SP-D are multimers while SP-C is a monomer. High-resolution 
X-ray crystallographic structures of the carbohydrate recognition and neck domains of SP-A 
and SP-D are shown enlarged [73, 74]. For SP-C, an ensemble of the 20 lowest energy 
structures, determined by solution NMR, is shown [55]. 
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1.6 Properties and Function of SP-B 
SP-B is considered the most important protein component of lung surfactant as it is 
essential for survival [37, 38, 78]. In mammals, native SP-B is composed of two covalently 
linked identical proteins (homodimer) [54]. Human SP-B monomer consists of 79 amino 
acids and weighs about 8.7 kDa [70]. However, the SP-B gene is first transcribed and 
translated into a significantly larger precursor consisting of 3 81 residues [79]. The mature 
form of SP-B consists of residues 201-279 .of the precursor [80]. The flanking regions of the 
precursor are cleaved in at least two steps within type II alveolar cell compartments that lie 
between the trans-golgi and the lamellar body [81] . The amino acid sequence of mature 
human SP-B is shown in Table 1.2 [70]. 
Table 1.2 : Amino acid sequence of human surfactant protein B [70]. 
1-20 Phe-Pro-lle-Pro-Leu-Pro-Tyr-Cys-Trp-Leu-Cys-Arg-Ala-Leu-Ile-Lys-Arg-Ile-Gln-Ala-
21-40 Met-Ile-Pro-Lys-Gly-Ala-Leu-Ala-Val-Ala-Val-Ala-Gin-Val-Cys-Arg-Val-Val-Pro-Leu-
41-60 Val-Ala-Gly-Gly-Ile-Cys-Gln-Cys-Leu-Ala-Glu-Arg-Tyr-Ser-Val-Ile-Leu-Leu-Asp-Thr-
61-79 Leu-Leu-Gly-Arg-Met-Leu-Pro-Gln-Leu-Val-Cys-Arg-Leu-V al-Leu-Arg-Cys-Ser-Met 
Compared to water soluble proteins, SP-B consists of a high proportion (- 52%) of 
nonpolar and hydrophobic amino acids, such as alanine, valine, leucine, isoleucine, 
methionine, phenyalanine and tryptophan. SP-B also exhibits a strong cationic profile as it 
contains nine positively charged (arginine & lysine) and two negatively charged (aspartic 
acid & glutamic acid) amino acids yielding a net charge of +7 at neutral pH. There are seven 
cysteines, six of which form three intra-molecular disulfide bridges and the remaining one 
forms an inter-molecular bond responsible for the dimerization. 
Biophysical studies have presented a long list of SP-B activities including membrane 
binding, membrane lysis, membrane fusion, promotion of lipid adsorption to air-water 
surfaces, stabilization of monomolecular surface films and respreading of films from 
collapsed phases [82]. However, it is not clear which of these activities, if any, underlies 
SP-B's crucial contributions to surfactant function in the lungs. As SP-B is positively 
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charged at neutral pH, it seems likely that electrostatic interactions between SP-B and 
surfactant lipids with negatively charged headgroups contribute to its physiological function. 
Indeed, there are studies which have found that SP-B preferentially binds negatively charged 
phospholipids such as phosphatidylglycerol (PG) in surface monolayers of surfactant films 
[83, 84], as well as in multilamellar vesicles [85]. Some models aiming to explain the 
functional mechanism of SP-B suggest that upon compression, as would happen in lungs 
during the expiration, films composed of positively charged SP-B and negatively charged 
lipids may form buckled structures that remain attached to the monolayer [86]. During 
subsequent expansion of the film at a lower surface pressure, the buckled structures may 
rapidly be reincorporated into the film to re-form a flat monolayer [87, 88]. The most 
dramatic acceleration of the interfacial adsorption of phospholipids is also caused by SP-B 
[25] . Furthermore, SP-B, in addition to SP-A, is required for the formation of tubular myelin, 
an ordered array of phospholipid aggregates that is thought to be involved in transporting 
lipids from aqueous subphase to the surface-associated phase [59, 60]. All these observations 
suggest that SP-B's critical contributions to lung surfactant function are made via facilitating 
large-scale rearrangements of lipids and stabilizing complex structures required at various 
stages of the breathing cycle. Unfortunately, the molecular basis of SP-B's function in the 
lung is still far from being understood, in part because the three-dimensional structure of 
SP-B has not yet been determined. 
SP-B belongs to the Saposin protein superfamily [Table 1.3], a unique family of small 
lipid-binding and membrane-perturbing proteins [54, 89, 90]. High-resolution structures are 
known for quite a few Saposin proteins such as Saposin A (PDB ID 2DOB) [91] , Saposin B 
(PDB ID 1N69) [92], Saposin C (PDB ID 1SN6) [93], NK-Lysin (PDB ID 1NKL) [94] , 
Amoebapore A (PDB ID 10F9) [95] and the saposin-like Granulysin (PDB ID 1L9L) [96]. 
All these proteins display a predominantly a-helical conformation, although the extent of the 
helices and the way the helices pack together vary from protein to protein. However, in all 
Saposins, three intra-protein disulfide bonds are formed by six conserved cysteines which 
define a characteristic fold that has been conserved for an estimated 300 million years [97]. 
Thus, SP-B is expected to possess four (or five) a-helical regions connected by loops and 
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bundled by three disulfide bonds (Figure 1.5). The helical structure of native SP-B has been 
verified by circular dichroism (CD) and Fourier transform infrared (FTIR) spectroscopy m 
both lipid and organic solvent environments [98-1 00]. 
Table 1.3 : Amino acid sequence of Saposin family proteins [70]. Mini-S and Maxi-B, 
shown at the bottom, are peptide fragments of SP-B. 
Protein Amino acid sequence 
Sap A SLP-CDICKDVVTAAGDMLKDNAT-EEEILVYLEKTCDWLPKPNMSASCKEIVDSYLPVILDIIKGEMSRPGEVCSALNLCESLQ 
SapB GDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLG-PGHADICKNYISQYSEIAIQMMMH--MQPKEICALVGFCD--E 
SapC SDVYCEVCEFLVKEVTKLIDNNKT-EKEILDAFDKMCSKLPKS-LSEECQEVVDTYGSSILSILLEEVS-PELVCSMLBLCSGT 
SapD DGGFCEVCKKLVGYLDRNLEKNST-KQEILAALEKGCSFLPDP-YQKQCDQFVAEYEPVLIEILVEVMD-PSFVCLKIGACPSAB 
NKL G-YFCESCRKIIQKLEDMVGPQPN-EDTVTQAASQVCDKL-K-ILRGLCKKIMRSFLRRISWDILTGK-KPQAICVDIKICK-E 
PFP GEILCNLCTGLINTLENLLTTK-G-ADKVKDYISSLCNKA-SGFIATLCTKVLDFGIDKLI-QLIEDKVDANALCAKIBAC 
SP-B FPIPLPYCWLCRALIKRIQAMIPKGA-----LAVAVAQVCRVVPLVA-GGICQCLAERYSVILLDTLLGRML-PQLVCRLVLRCS-M 
Mini-B -------CWLCRALIKRIQAMIPKG-------------------------------------------GRML-PQLVCRLVLRCS--
Maxi-B -------CWLCRALIKRIQAMIPKGA-----LAVAVAQVCRVVPLVA-GGICQSLAARYSVILLDTLLGRML-PQLVfRLVLRCS--I I I I I 
I I 
..__ S-S __J I I Bonds 
SP-8 Maxi-8 
c 
N N 
N~c SP-8cTERM c 
Mini-8 
N ~ c SP-8NTERN N 
Figure 1.5 : Topology of SP-B predicted based on the known structures of Saposin family 
proteins. a-Helical regions are portrayed by cylinders and disulfide bonds connecting the 
helices are shown by dashed lines. Fragments covering the terminal helical regions that are 
known to exhibit some biological activity and a near-full proposed peptide are also shown. 
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1. 7 Activities and Structures of SP-B Fragments 
Fragments of SP-B containing individual helices or pairs of helices have been shown 
to retain significant biological activity when compared to the full-length protein (Figure 1.6). 
Surfactant preparations that include synthetic peptides representing either N- or C-terminal 
helical segments of SP-B enhance oxygenation and lung compliance in surfactant-deficient 
animal models [IOI, I02]. A 25-residue N-terminal segment of SP-B (SP-B 1_25) facilitates 
dynamic respreading [I 03] and improves lung function in premature rabbits and lavaged rats 
[104]. Peptides based on the C-terminal domain also induce in vitro and in vivo surfactant 
activities that, at least partially, simulate those of the native protein [10I, I05, I06]. The 
N-terminal half of SP-B consisting of residues I-37 promotes rapid liposome fusion, while a 
shorter peptide containing residues 7-22 is sufficient for liposome lysis [I07]. KL4 (a 
component of Surfaxin), a 21-residue peptide designed by use of the hydrophobic and 
hydrophilic repeats of SP-B57_63 as a molecular template, has shown some promise as a 
bronchoalveolar lavage for improving lung function in meconium aspiration syndrome [I 08]. 
Mini-B is another synthetic construct that includes both N- and C-terminal predicted 
helical regions of SP-B. This 34-residue peptide consists of SP-Bs-25 and SP-B63-78 covalently 
connected through the backbone [I 09]. Like the full-length protein, Mini-B possesses a net 
charge of +7. The proportion of hydrophobic amino acids is also similar, 44% in Mini-B as 
compared to 52% in SP-B. In addition, Mini-B possesses four of the six conserved cysteines 
that define the Saposin fold and thus, in its oxidized form, has two disulfide bridges linking 
the two helices. Surfactant deficient rats treated with synthetic surfactant preparations 
containing Mini-B attain oxygenation and lung compliance values as good as, or better than, 
those achieved in the presence of native SP-B [I 09] (Figure I.6). 
To date, structures of three peptide fragments representing SP-B's terminal regions 
have been determined at atomic resolution by solution NMR. The structure of anN-terminal 
peptide (SP-B 11_25) was determined in methanol (PDB ID 1KMR) [76]. The structure of a 
C-terminal peptide (SP-B63-?s) was determined in aqueous solution containing 40% 
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fluorinated alcohol hexafluoroisopropanol (HFIP) (PDB ID I RG4) and in lipid-mimicking 
sodiumdodecylsulfate (SDS) micelles (PDB ID IRG3) [77]. The structure of a reduced 
version of Mini-B, that lacks the two disulfide bonds between the helices, was determined in 
aqueous solution containing 40% HFIP (PDB ID 2JOU) during my M.Sc. work (Booth lab, 
Memorial University of Newfoundland) [110]. Figure 1.7 shows the high-resolution 
structures ofthese three SP-B-based peptides. 
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Figure 1.6 : Respiratory function related responses from rats subjected to removal of lung 
surfactant by in vivo lavage and then exogenously administered with synthetic surfactants 
prepared from lipids only and lipids plus native SP-B or Mini-B [I 09]. The lipid-based 
surfactant contained 35 mg of phospholipids (16 mg of DPPC, 10 mg of DOPC, 3 mg of 
POPG, 1 mg of POPE and 3 mg of POPS) and 2 mg of cholesterol in I mL of phosphate-
buffered saline. The lipid-protein mixed surfactants contained an additional O.I !J.mol of 
protein or peptide. Arterial partial pressure of oxygen (Pa0 2) and dynamic lung compliance 
(calculated by dividing tidal volume/kg body weight by changes in airway pressure) are 
shown as a function of time after surfactant instillation. The plots are prepared using the 
published data of Ref. [I 09]. 
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SP-BNTERM (SP-811-25) in 
Methanol (PDB ID lKMR, [76]) 
SP-BcTERM (SP-863-78) in 
HFIP (PDB ID 1RG4, [77]) 
SP-BcTERM (SP-863-78) in SDS 
micelles (PDB ID 1 RG3, [77]) 
Mini-BREo (SP-88-25+63-78) in 
HFIP (PDB ID 2JOU, [11 0]) 
Figure 1.7 : Ensembles of the high-resolution structures (lowest energy 10 to 17) of the 
terminal fragments of SP-B determined by solution NMR. The fragments are SP-BNTERM 
(SP-8 11_25) in methanol (17 structures, PDB ID lKMR) [76] , SP-BcTERM (SP-863-78) in HFIP 
(10 structures, PDB ID 1RG4) [77], SP-BcTERM (SP-863-78) in SDS micelles (10 structures, 
PDB ID 1RG3) [77] and reduced Mini-B (SP-88_25 +63-78) in HFIP (15 structures, PDB ID 
2JOU) [ 11 0]. 
1.8 Outline and Objectives of Present Work 
A protein's biological function comes about due to the organization of its amino acid 
chain into a specific well-folded three-dimensional structure. Knowledge of the high-
resolution structure of SP-B is thus essential for understanding its function at the molecular 
and submolecular levels. However, the production of an SP-B sample to pursue the structural 
studies, either in the form of a crystal to perform X-ray crystallography or appropriately 
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labeled with 13C/15N isotopes to perform solution NMR, has been very challenging and 
unsuccessful to date. For SP-B, solution NMR would be a suitable choice since using this 
method the protein can be studied in a physiologically relevant lipid-mimetic environment and 
its dynamics and interactions can also be probed. Unfortunately, attempts at recombinant 
expression of the full-length protein or chemical synthesis of a near-full protein have not 
succeeded yet, mainly due to its high degree of hydrophobicity and the presence of three 
intrachain disulfide bonds. Interestingly on the other hand, some of the successfully produced 
synthetic fragments of SP-B have shown substantial biological activity when compared to the 
full-length protein. Oxidized Mini-B tops this list and it likely encompasses the key functional 
regions of the full-length protein. The structure of reduced Mini-B was determined in 40% 
HFIP during my M.Sc. but the lack of disulfide bonds and the fluorinated organic solvent 
environment limit this structure's ability to explain SP-B's function in native lung conditions. 
Nevertheless, it was an important first step that aided in the structural studies of 
physiologically relevant oxidized Mini-B in a lipid-mimetic detergent micelle environment. 
This Ph.D. research was conducted with Mini-B and two other SP-B-based peptides 
to reveal the key structural features that underlie the functional mechanisms of SP-B in 
physiological conditions. The research was performed using solution NMR spectroscopy. 
The entire work was divided into six specific projects and thereby the findings are reported in 
six separate chapters of this Thesis. The research objectives were to : 
1. determine the high-resolution structure of oxidized Mini-B in SDS micelles, 
2. investigate the conformation of Mini-B in the presence of lung phospholipid analogues and 
probe its interactions with the model surfactant lipids, 
3. investigate the conformation of SP-A in the presence of lung phospholipid analogues and 
probe its interactions with the model surfactant lipids, 
4. probe the interaction between Mini-B and SP-A, if any, m the presence of lung 
phospholipid analogues, 
5. investigate the modifications to SP-B 's structure and lipid interactions brought about by 
tryptophan oxidation, that is common in ARDS, using theN-terminal fragment SP-88_25, and 
6. investigate the conformation of the C-terminal half of SP-B. 
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Chapter 2 
Protein N R Met ods 
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2.1 Protein Structure 
Proteins are molecular machines that perform numerous indispensable functions for 
life; enzymatic catalysis, immunity against pathogens, regulation of cellular conditions, 
information processing, transportation of cellular cargo, formation of body tissues and 
muscle movement are a few to name. Proteins are polymeric macromolecules composed of a 
long chain of chemical units called amino acids (also known as residues). While there are 
literally hundreds of amino acids known, only 20 are directly encoded by the universal 
genetic code and all of them are in the L isomeric form [Ill]. The backbone chemical 
structure, - N - Ca(H)- C(O) -, is the same for all 20 amino acids (Figure 2.1 (A)). The third 
substituent of Ca, an H, is also the same. However, the fourth substituent is represented by 20 
different side chains (or R groups) and this is what distingushies one amino acid from 
another. Individual atoms in an amino acid are referred to as HN, Ca, Ha, C~, Hp, etc. (Figure 
2.1 (B)). In a full-length protein, the constituent amino acids are linked into a linear sequence 
through peptide bonds between the carboxyl C of one residue and the amino N of the next 
residue [Ill]. The first and the last residues in the chain are termed as the N- and C-terminal 
residues, respectively [111]. 
Residue1 Residuel+1 Residuel+2 
Backbone 
0 
] Backbone 
Side-chain 
Figure 2.1 : Chemical structure of a protein. (A) A single amino acid. All 20 amino acids 
have the same backbone chemical structure(- N- Ca- C - ) but different side-chains (Rs). 
(B) Amino acids are connected by peptide bonds between Ci and Ni+J to form a full-length 
protein. A residue is shown with the names of the side-chain nuclei as an example. 
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Proteins do not have a uniform, standard structure, in part, because the 20 different 
amino acids from which they are made have widely varied chemical and physical properties. 
However, the function of any protein depends on how its linear chain of amino acids folds to 
assume a defined, three-dimensional (3D) structure. Like other polymeric biomolecules, 
proteins can be described in terms of levels of organization, in this case, their primary, 
secondary, tertiary and quaternary structures [112] (Figure 2.2). A protein's primary structure 
is the amino acid sequence of its polypeptide chain(s). Individual segments or regions of the 
chain may form local regular configurations, such as a-helices and/or ~-strands, that 
represent the protein's secondary structure. The tertiary structure refers to the overall 3D 
conformation of the entire chain formed by packing such regular structural elements. Many 
proteins are composed of two or more polypeptide chains, loosely referred to as subunits. 
The quaternary structure of a multi-chain protein represents the spatial arrangement of all 
folded subunits. 
AminoAcidi 
HN Ha 0 
I I I 
···· N- C..- C ···· 
I 
R1 
AI A2 A3 Ai 
DD-0-····000·····DD-D 
t t 
N-Ter-minus C -Terminus 
Primary Structure 
Quaternary Structure 
Alpha 
HelL~ 
Beta 
tr-and 
Secondary Structure 
j 
Tertiary Structure 
Figure 2.2 : Four levels of protein structure, from primary to quaternary. The figures used to 
demonstrate the tertiary and quaternary structures are taken from the Protein Data Bank 
(PDB) (PDB IDs 2X25 and 2X2C, respectively). 
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2.2 Methods for Protein Structure Determination 
A key to deciphering the function of a given protein is to understand its structure, 
since it is the distinct structure that leads to the chemical and physical properties of the 
protein and, ultimately, its mechanism of action in a living organism [113). To date, only two 
techniques are available for determining the structure of a protein at atomic resolution; X-ray 
crystallography and solution NMR spectroscopy [114). 
X-ray crystallography requires the protein to be grown as a well-ordered crystal [115). 
When the protein crystal is exposed to a collimated (parallel) beam of X-rays, the atoms 
scatter the X-rays and the resulting diffraction pattern is recorded. An electron density map is 
then generated from which the 3D image of the crystal structure is constructed by fitting the 
known sequence of the protein. This technique can calculate the atomic coordinates precisely. 
However, it only provides information about one of the low-energy conformations that the 
protein may adopt but nothing regarding the dynamics. Therefore, the crystal structure of a 
protein may sometime be misleading and may lack physiological relevance. Furthermore, for 
membrane and other lipid-associated hydrophobic proteins, it is very challenging to grow 
diffraction-quality crystals due to the problems caused by aggregation. 
Solution NMR spectroscopy has only been developed as a technique for protein 
structure determination in the last three decades [116). The first complete 3D structure solved 
using NMR was presented in 1986 [ 117]. The unique advantage of NMR spectroscopy over 
X-ray crystallography is that the protein structural studies can be performed in a 
physiologically relevant solution environment. The technique exploits the quantum 
mechanical property of any nuclei with nonzero spin, but predominantly works with spin 1/2 
nuclei eH, 13C, 15N, etc.). The NMR phenomenon derives from the fact that the energy levels 
of nuclei with nonzero spin become unequal when the nuclei are placed in a magnetic field. 
The energy of the nuclei are then perturbed (i.e., moved between levels) by the application of 
radiofrequency (RF) pulses whose wavelength corresponds to the gap between the energy 
levels. High-resolution structural data are generated by manipulating the magnetization of the 
nuclei using scalar (through bond) and dipolar (through space) couplings by application of 
23 
appropriate pulse trains, delays and phase cyclings. The data contain information on inter-
nuclear distances and backbone dihedral angles which are used to compute the structural 
model of the protein. However, the inherent properties of solution NMR impose a limitation 
on the protein size that is amenable to NMR studies. The classical high-resolution NMR 
methods are limited to a molecular size (mass) typically up to about 20 kDa (i.e., - 175 
amino acids), provided the protein is appropriately 13C/15N-labeled and soluble in water [118]. 
In addition to obtaining high-resolution structural data, solution NMR can be used to 
study the flexibility of the proteins and their dynamics over a wide range of time scales [ 119]. 
The interactions between a protein and its ligand can also be probed using solution NMR 
methods. For a membrane or lipid-associated protein, such as SP-B, NMR is a suitable 
method since the protein can be studied in detergent/lipid micelles which mimic its 
physiological environment. However, this is very challenging because the large size of 
protein/micelle complex substantially reduces the spectral intensity. Only relatively small 
proteins or protein fragments (up to - 150 amino acids) are thus acquiescent to study in 
micelles using solution NMR. Although recently developed solid-state NMR methods 
provide useful information about the struc~ur~ and orientation of a membrane protein in lipid 
bilayers [120], the micelle-route using solution NMR is still the principal NMR technique to 
determine the high-resolution structure of a lipid-associated hydrophobic protein. 
2.3 Basic Principles of NMR 
All nuclei with an odd mass number (e.g., 1H, 15N) or an even mass number and an 
odd atomic number (e.g., 2H, 14N) possess spin angular momentum characterized by the spin 
quantum number I [121]. Nuclear magnetic resonance is a phenomenon which occurs when a 
group of nuclei with nonzero spin angular momentum is immersed in a static magnetic field 
inside the NMR spectrometer and exposed to RF pulses with appropriate energy [122]. 
Nuclei with zero spin (i.e., I = 0), such as 12C and 160, are thus not observable by NMR. 
Nuclei with spin 1 or more (i.e., I~ 1), such as 2H and 14N, are also not generally useful for 
structural studies in solution [123]. They possess electric quadrupole moments and the 
24 
lifetimes of their magnetic states are very short resulting in broad resonance lines which are 
difficult to observe. Nuclei with spin 112 (i.e., I = 112), such as 1H, 13C and 15N, are the most 
useful nuclei for solution NMR [123]. For protein structural studies, 12C and/or 14N nuclei of 
the molecule are often replaced by their isotopes 13C and/or 15N, respectively. 
In the absence of any external magnetic field, the spin 1/2 nuclei of a sample, which 
can be considered as tiny bar magnets, do not have any preferred orientation. However, when 
the sample is placed in the large static magnetic field of an NMR spectrometer, all spin 112 
nuclei assume one of the two orientations, either in the same direction as, or opposed to, the 
external field. This is characterized by the two allowed quantum mechanical states given by 
the magnetic quantum number m = ± 112. The two states have different energy levels known 
as Zeeman levels (Figure 2.3). In thermal equilibrium, these states are unequally populated, 
having some more nuclei in the lower energy state (ground state, m = I /2) than the higher 
energy state (excited state, m = - 112), as determined by the Boltzmann distribution. The 
small nuclear magnets may spontaneously flip from one orientation (energy state) to the 
other but the rate is extremely slow. However, when energy equal to the difference between 
the two states is applied, much more flipping is induced. This exemplifies a resonance 
phenomenon and is hence referred to as Nuclear Magnetic Resonance (NMR). 
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Figure 2.3 : Energy levels of a spin 112 nucleus in an external magnetic field. (A) The 
applied field Bo (the spectrometer field) causes the energy state of the nucleus to be split into 
two levels known as Zeeman levels. The energy difference between the levels is proportional 
to the external field strength. (B) The nucleus assumes one of the two quantum mechanically 
allowed energy states and a transition occurs by the absorption or emission of energy equal to 
the difference of the two states. 
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A nucleus with spin angular momentum I also possesses nuclear magnetic moment f.A. 
(both are vector quantities as indicated by the boldface), and the relation between the two is 
,.... = yl, (2.1) 
where y is the proportionality constant known as the gyromagnetic ratio of the nucleus. The 
magnitude of y, in part, determines the receptivity of a nucleus in NMR spectroscopy since 
nuclei with larger gyromagnetic ratios (e.g., 1H and 19F) generate stronger NMR signals. 
However, the magnitude ofthe z-component of I is specified by 
lz = mh, (2.2) 
where h = h!2:rt and h is Planck's constant. Therefore, the z-component of the nuclear 
magnetic moment is 
!-lz = ymh. (2.3) 
Now, in an external magnetic field B along the z-axis, the energy of a spin state is 
E = - f.A. • B =- ~-tzB. (2.4) 
The energy of a particular spin state m is then 
· Em=- mhyB. (2.5) 
Thus the energy difference between the two Zeeman levels of a spin 1/2 nucleus placed in an 
external static magnetic field B0 applied along the z-axis is 
~E = E-112 - E+112 = - [(- 1/2)hyBo - (1/2)hyBo], 
or ~E = yhBo. (2.6) 
This is also the irradiation energy required to cause transition between the two Zeeman states. 
Now, the Bohr condition, 
~E = hv, (2.7) 
enables the frequency of nuclear transition, known as the Larmor frequency, to be written as 
vo = (1/2:rt)yBo, (2.8) 
or wo = yBo. (2.9) 
in units of Hz or rad/s, respectively. Hence, the irradiation energy depends on both y and Bo. 
In practice, it is in the radiofrequency range and is typically applied as a short pulse. 
Table 2.1 lists the gyromagnetic ratios and the Larmor frequencies of selected NMR-
active bio-nuclei in an 11.74 T field [119, 123]. 
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Table 2.1 : Properties of nuclei commonly used in bio-NMR [119, 123]. 
Nucleus Natural abundance(%) I y (Ts) - I Wo at Bo = 11.74 T (MHz) 
IH 99.98 1/2 2.68 X 108 500 
2H 0.02 1 4.11 X 107 77 
13c 1.11 1/2 6.73 X 107 125.7 
tsN 0.36 112 -2.72 X 107 50.7 
19F 100 1/2 2.52X108 488.4 
3lp 100 112 1.08 X 107 201.5 
In an external magnetic field, the Zeeman splitting of the magnetic states of a group 
of spin 1/2 nuclei at thermal equilibrium also leads to a net bulk magnetization M 0 since the 
two states are unequally populated. It is the bulk magnetization from the whole ensemble that 
determines the NMR signal, not the magnetic moment of any individual nucleus. 
Conventionally, the direction of the external field Bo is taken as the z-axis of the coordinate 
system. So, M 0 is also aligned along the z-axis. 
During NMR experiments, the bulk magnetization M0 is manipulated by an RF pulse, 
which is a time varying magnetic field, B1, oscillating at the same Larmor frequency w0 
(Figure 2.4). The pulse applies a torque on the longitudinal bulk magnetization and tips it 
from the z-axis. If B1 is a 90° pulse applied along the y-axis, the longitudinal magnetization 
converts to a transverse magnetization along the x-axis following a rotation in the ZX-plane. 
However, immediately after the pulse, the transverse magnetization starts precessing about 
the z-axis in the XY -plane with frequency w0 under the influence of the external field Bo. The 
precession induces an electric current in the detection coil of the spectrometer. In the absence 
of any further perturbing RF pulses, relaxation processes bring the spin system to thermal 
equilibrium over time with the magnetization oriented back along the z-axis. During this 
period, the transverse magnetization decays with time and consequently the induced current 
also decays. The free induction decay (FID) of the induced current is recorded as a function 
of time over a certain acquisition period. The FID is thus a time-domain signal with 
contributions typically from different nuclei with slightly different frequency caused by the 
variations of the local chemical environment surrounding each nucleus. The usual frequency 
-domain NMR spectrum is obtained by computing the Fourier transformation of the FID. 
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Figure 2.4 : Steps of a simple one-pulse 1 D NMR experiment. In a static external field Bo, 
the net bulk magnetization Mo lies along the z-axis at thermal equilibrium (A). A 90° RF 
pulse, applied along the y-axis, rotates M0 to the x-axis where it is renamed as M(n/2) (B). 
Immediately after the pulse, M(n/2) starts precessing in the XY-plane under the influence of 
Bo and relaxations also start. The time-varying magnetic field M(t) induces a current in the 
spectrometer coil (C). The induced current is measured as a function of time during the 
acquisition period following the pulse in the form of free induction decay (FlO) (D). The 
subsequent Fourier transformation of the FID gives the normal NMR spectrum with 
absorption peaks at frequencies corresponding to the energy differences between the ground 
and excited states of the nuclei at different chemical environments (E). 
2.4 Basic NMR Parameters 
2.4.1 Relaxation Times (T 1 and T 2) 
Relaxation is the process by which a nuclear spin system, perturbed by absorbing an 
RF energy, returns back to thermal equilibrium. There are two relaxation processes; spin-
lattice or longitudinal relaxation, characterized by the time T1 and spin-spin or transverse 
relaxation, characterized by the time T2 [119, 123]. At equilibrium, the net magnetization 
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vector Mo lies along the z-axis, so there are no transverse components present and the 
longitudinal component represents the total magnetization, i.e., Mz = Mo and Mx = Mv = 0. 
A 90° RF pulse (of the order of 10 f.A.S) with appropriate energy and phase rotates the 
magnetization from the z-axis and diminishes Mz to zero. After the pulse, the spin system 
gradually (of the order of 1 s for a typical protein) returns back to the thermal equilibrium 
and Mz regains its original magnitude. The time constant which describes how Mz returns to 
its equilibrium value is called the spin-lattice relaxation time T 1• The equation governing this 
behavior as a function of time t after the displacement is 
Mz(t) = Mo (1 - e-trr1). (2.1 0) 
Also, when the longitudinal bulk magnetization is rotated from the z-axis by the application 
of a 90° RF pulse, it evolves as transverse magnetization and starts precessing in the XY-
plane under the influence of the static external field. However, the magnetizations of 
individual nuclei belonging to a particular ensemble immediately start to dephase (fan out) 
causing the net magnetization to gradually shrink. Fluctuating local fields which perturb the 
energy levels of the spin states cause the dephasing. The longer the elapsed time the greater 
the dephasing, till the transverse magnetization diminishes to zero upon saturation of the 
whole plane. The time constant that describes how the net transverse magnetization, Mxv, 
decays from its initial value Mxvo to zero over time is called the spin-spin relaxation time T2. 
This is governed by 
(2.11) 
There are actually two factors that contribute to the decay of transverse magnetization; 
mutual exchange of spin energies (leading to a pure T2 molecular effect) and variations in the 
static external field B0 (leading to an inhomogeneous T2 effect). The combination of these 
two factors is what actually results in the decay of the transverse magnetization. The 
combined time constant is called T2* and is expressed as 
(2. 12) 
In reality, both T 1 and T2 processes occur simultaneously, the only restriction being 
that T2 is always less than or equal to T 1• Following a pulse sequence that perturbs the spin 
system from the thermal equilibrium, T2 governs the length oftime during which the FID can 
be observed and T1 governs the minimum time required for equilibrium to be restored. 
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T2 plays a crucial role in protein NMR studies. It is inversely proportional to the overall 
rotational correlation time (tc) of the particle and thus depends on the mass and shape of the 
protein (or protein complex). Typical values of T 1, T2 and 'tc for proteins in solution are of 
the order of 1, 0.1 and 1 o-s s, respectively. 
2.4.2 Chemical Shift (~) 
In NMR spectroscopy, nuclei of different elements (e.g., 1H, 13C or 15N), because of 
their different gyromagnetic ratios, yield signals at completely different frequencies when 
placed in the same external magnetic field (Table 2.1 ). However, the observed resonance 
frequencies also depend on the local chemical environments of individual nuclei and hence, 
even for a single element, differ slightly from the frequencies predicted by Eq. 2.9. The 
difference between the predicted and observed resonance frequencies is referred to as a 
chemical shift. It provides the opportunity of distinguishing between nuclei that are identical, 
but for their location in different chemical environments. The phenomenon of chemical shift 
arises because the motions of electrons around nuclei, induced by the external magnetic field, 
generate secondary magnetic fields. The net local magnetic field experienced by a specific 
nucleus results from the combination of the external and the secondary fields. The effect of 
the secondary field, called nuclear shielding, can enhance or diminish the effect of the main 
field. Depending on the surrounding chemical environments, each nucleus experiences a 
slightly different degree of shielding causing a variation in the local magnetic fields [119, 
123]. Consequently, the resonance condition is modified to 
Wetr= yBlocal = yBo(l- a), (2.13) 
where Weer is the effective resonance frequency due to the actual local field, B1ocaJ, 
experienced by the nucleus and a is a 'dimensionless screening or shielding constant. 
However, it is difficult to determine the exact resonance frequency of a nucleus with absolute 
accuracy. It is rather much easier to determine the difference between the resonance 
frequencies of a nucleus of interest and a reference. Since the induced secondary field that 
causes the chemical shift is about a million times weaker than the applied main static field, 
the chemical shift is expressed in terms of parts per million (ppm) [119, 123]. This also 
30 
removes the dependence of the chemical shift on the applied field strength and makes it a 
dimensionless number {) (Figure 2.5) given by 
(2.14) 
where Wint and Wref are the frequencies of the nucleus of interest and the reference nucleus, 
respectively, and w0 is the operating frequency of the spectrometer. For 1H, the reference 
frequency is usually set to 0 ppm so that Wref = wo. The most commonly used reference 
compounds are tetramethylsilane (TMS) and sodium 2,2-dimethyl-2-silapentane-5-sulfonate 
(DSS). TMS is often used as an external reference while DSS is used as an internal reference. 
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Figure 2.5 : Basic NMR spectral parameters. The reference signal is assigned a chemical 
shift of 0 ppm. The chemical shifts of other signals are measured from the reference and 
referred to as &a, &b and so on. The height of a signal represents its amplitude and the area 
under the curve represents its intensity which is proportional to the number of nuclei 
contributing to the signal. The coupling constant represents the difference between two 
adjacent multiplets which results from scalar coupling. 
2.4.3 Linewidth (A v112) 
In an NMR spectrum, a series of absorption peaks or resonance signals representing 
resonance frequencies of various ensembles of nuclei belonging to different chemical 
environments are observed. Under ideal experimental conditions, the area of a signal (not the 
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height) is directly proportional to the number of nuclei contributing to the signal. The 
linewidth (~v 1 12) is defined as the full-width at half-height of a signal with Lorentzian 
lineshape (Figure 2.5) [119, 123]. The linewidth is a key factor affecting both resolution and 
signal to noise (SIN) ratio of the spectrum. It is exclusively dependent on the spin-spin or 
transverse relaxation time T 2 and represented by 
~v 112 = lhtT2. (2.15) 
The relaxation time T2, however, is inversely proportional to the overall rotational correlation 
time 'tc of the molecule in solution. Again, 'tc depends on mass (and shape) of the molecule. 
Thus, the lines are inevitably broader for larger proteins. The line broadening, caused by a 
fast T2 relaxation, is the main factor that limits the size of a protein amenable to NMR studies. 
For smaller proteins, observed linewidths substantially larger than expected primarily 
indicate an increase in the rotational correlation time, likely caused by a molecular 
aggregation. If aggregates are large enough, the lines become too broad to observe. 
2.4.4 Scalar Coupling (J) 
Scalar couplings between nuclei linked via a small number of covalent bonds in a 
chemical structure result in mutual splitting of the NMR signal from each nucleus into 
multiplets (Figure 2.5) [119, 123]. Scalar couplings arise from spin-spin interactions 
mediated by the electrons forming the chemical bonds between the nuclei. The coupling is 
ordinarily not important beyond three bonds. The two-bond coupling is termed geminal (e.g., 
H-C-H) while the three-bond coupling vicinal (e.g., H-C-C-H). To a first approximation, the 
relative intensities of the multiplets are given by binomial coefficients; 1:1 for a doublet (i.e., 
for a nucleus interacting with another nucleus), 1:2:1 for a triplet (i.e. , for a nucleus 
interacting with two other equivalent nuclei), 1 :3:3 :1 for a quartet (i.e. , for a nucleus 
interacting with three other equivalent nuclei), and so on. The difference between any two 
adjacent components of a multiplet is the same and yields the magnitude of the scalar 
coupling constant (J) in Hz. This is independent of the magnetic field strength. To simplify a 
protein spectrum and to improve the SIN ratio, selective decoupling is often employed by 
irradiating the coupled nuclei with a weak RF field. 
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2.4.5 Nuclear Overhauser Effect (NOE) 
The nuclear Overhauser effect (or enhancement) (NOE) is the fractional change in 
intensity of one NMR line when another resonance is irradiated in a double irradiation 
experiment [124]. It is customarily quoted in percent of the unperturbed resonance intensity. 
The NOEs are observed because of the dipolar cross-relaxation (through-space) between 
pairs of nuclei (proton-proton or proton-other spin 1/2) with sufficiently close spatial 
proximity (usually < 5 A). The intensity of an NOE is proportional to the inverse sixth power 
of the distance between the two nuclei and also depends on the dynamics of the molecule, 
NOE = f(dynamics) x llr6. (2.16) 
Thus the NOEs observed between pairs of protons in a protein characterize inter-proton 
distances that are invaluable for the high-resolution structure determination. Another 
application of this effect is the information on a protein' s internal dynamics since the NOE 
intensity is a function of the dynamics too. The dynamics arise since proteins are not rigid 
molecules and have a certain degree of conformational freedom which is often essential to 
their biological functions. From an NOE experiment performed for individual amino acids of 
a protein in physiologically relevant conditions, the rigidity or flexibility of its local 
backbone conformation can be determined in a quantitative manner [125]. 
2.5 Protein NMR Experiments 
A suite of complex multi-dimensional NMR experiments, starting with a simple 1 D 
experiment, are performed to determine the high-resolution structure of a protein as well as 
to probe its dynamics and interactions. Proton (1H) is the most useful nucleus in protein 
NMR studies because of its high natural abundance and large gyro magnetic ratio (Table 2.1 ). 
However, spin 1/2 carbon and/or nitrogen nuclei (i.e., 13C and 15N) are also regularly used in 
NMR studies by replacement of their natural isotopes ( 12C and 14N). The structure 
determination process begins with identifying which resonance frequency belongs to which 
magnetic nucleus in the chemical structure of the protein. Afterwards, NOEs are used to 
identify pairs of protons that are close in space. The NOE data is combined with a restrained 
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molecular dynamics simulation to provide the 30 atomic coordinates of the protein. 
Protocols for many protein NMR experiments have been developed over the years with new 
pulse sequences being developed all the time. Only the experiments used for this Ph.D. work 
are briefly described here. 
In the simple ID 1H experiment, the sample magnetization that lies along the z-axis at 
thermal equilibrium is rotated into the XY -plane by a 90° RF pulse, applied for - 10 f.!S at the 
powers typical of solution NMR probes. After the pulse, the transverse magnetization 
precesses about the z-axis and decays over time. The time-domain data are acquired by 
recording the FID during the acquisition period. The FID is then Fourier-transformed to yield 
the final frequency-domain spectrum. Because the resonance frequency is modulated by the 
chemical environment that an ensemble of protons finds itself in, the 1 D spectrum shows a 
dispersion of signals resulted from protons at different sites in different amino acids. 
However, the protons in similar chemical groups (e.g., amide protons or a-protons) have 
characteristic ranges of frequencies and hence chemical shifts (Figure 2.6) [ 119, 123]. 
backbone HN Ha. 
aromatic 
side-chain HN 
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0 
Figure 2.6 : Schematic 
representation of the 
1 D 1 H NMR spectrum 
of a protein. Chemical 
shift ranges usually 
observed for the 
protons from different 
chemical groups are 
marked. 
The second basic experiment, the proton-detected 2D Heteronuclear Single Quantum 
Correlation (HSQC), uses a magnetization transfer mechanism. For this experiment, at least 
some of the 12C and/or 14N nuclei must have been replaced by their spin 112 isotopes 13C 
and/or 15N during the protein production. 13C will not be mentioned any further as only 15N 
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labels were used in this work. The magnetization is transferred from covalently linked 1H to 
15N during a part of the pulse sequence called the mixing time. The peaks in the Fourier-
transformed 20 spectra are usually shown as contour plots correlating the resonance 
frequencies of 15N- 1H pairs (Figure 2.7) [119,123]. 
1H Chemical Shift (ppm)' 
Figure 2. 7 : Schematic 
representation of the 
20 15N-1H HSQC 
spectra of a protein 
with four 15N-labeled 
amino acids Ra, Rb, Rc 
and RJ. The peaks, 
represented as contour 
plots, correlate the 
resonance frequencies 
of the four covalently 
linked 15N-1H pairs. 
The 1D 1H and 20 HSQC experiments are routinely done to optimize the sample 
conditions (concentration, pH, temperature, etc.) and to check the status of the sample before 
and after any long multi-dimensional experiments. These spectra also provide indications of 
the protein' s structural homogeneity, molecular aggregation, dynamics and interactions. 
Furthermore, preliminary hints on the secondary structure (a-helix/P-sheet) may be obtained 
since nuclei belonging to such structures exhibit characteristic frequency shifts with respect 
to the random coil configuration [ 126-128]. 
To determine the structure of a protein, the resonance frequencies of its magnetic 
nuclei must be determined first. Thus, a number of multi-dimensional homonuclear and 
heteronuclear experiments are performed leading to the complete resonance assignments. 
The 2D Total Correlation Spectroscopy (TOCSY) and Nuclear Overhauser Effect 
I 
Spectroscopy (NOESY) are the standard homonuclear experiments for identifying spin-spin 
coupling connectivities between pairs of protons. These experiments rely on magnetization 
transfer along the proton networks, which take place during the mixing period of the pulse 
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sequence [129]. In TOCSY, the magnetization is transferred from one proton to another 
through covalent bonds (up to 3 bonds) via scalar coupling. In NOESY, on the other hand, 
the magnetization transfer is achieved through space (up to - 5 A) via dipolar coupling. The 
diagonal peaks of these 2D spectra reproduce the complete 1 D 1 H spectrum. The off-diagonal 
or cross-peaks, however, correlate pairs of protons between which the magnetization transfer 
takes place (Figure 2.8, only a few selected peaks are shown and two are labeled for clarity). 
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Figure 2.8 : Schematic representations of the 2D homonuclear NMR spectra of a protein. In 
TOCSY, the cross-peaks result from the magnetization transfer between protons through 
covalent bonds (up to 3 bonds) (A). In NOESY, the cross-peaks result from the 
magnetization transfer between protons through space (up to - 5 A) (B). The NOESY spectra 
consist of peaks from both intra-residue and sufficiently close inter-residue proton pairs. The 
diagonal peaks reproduce the complete lD 1H spectrum in both. The spectra are symmetrical 
with respect to the diagonal. 
The NOEs (observed as the cross-peaks in the NOESY spectra) act as the primary 
source of structural information in protein NMR because they indicate the spatial proximity 
of protons within the molecule. The intensities of the NOEs vary approximately as the 
inverse sixth power of the inter-proton distances. However, there are difficulties in using the 
NOE intensity quantitatively since the intensity is also affected by spin diffusion, intra-
protein motions and artifacts. Therefore, the intensities of all NOEs are classified into strong, 
medium and weak categories and, rather than being converted into discrete distances, are 
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given distance ranges large enough to allow for the effects of motion, etc. on NOE intensity. 
These distance restraints act as the most crucial inputs in the protein structure calculation. In 
addition to distance restraints, dihedral angle and hydrogen bond restraints are also generated 
for amino acids that can be clearly identified as having a particular secondary structure 
conformation by indicators such as selected NOEs (e.g., strong HNi-HNi+I indicates a-helix, 
strong Hai-HNi+I indicates B-sheet, etc.) and chemical shift perturbations of specific nuclei 
(e.g., Ha, Ca, etc.) based on the random coil chemical shifts [126]. 
As the 2D homonuclear spectra are crowded with cross-peaks (especially the 
NOESY), overlapping of peaks, that inevitably occurs in larger proteins, substantially hinders 
the resonance assignments. The 3D and 4D heteronuclear-edited NMR experiments resolve 
overlapped peaks according to the chemical shifts of the heteronuclei (e.g., 15N) bonded 
directly to the protons [130, 131]. In 3D experiments, the spectra are separated along a third 
dimension (' 5N or 13C), so that the 1H- 1H peaks are distributed throughout a cube instead of a 
plane. This spreading-out is achieved by combining an HSQC at the end of a TOCSY or 
NOESY in a single experiment. The FID data are collected after the HSQC instead of at the 
end of the TOCSY/NOESY [132]. The 4D experiments consist of the concatenation of a 
NOESY pulse sequence followed by two HSQC building blocks. The peaks in the 4D spectra 
are separated with respect to one heteronuclei first to generate 3D cubes which are then 
sliced further with respect to the other heteronuclei attached to the protons [133]. 
Diffusion-Ordered Spectroscopy (DOSY) provide a measure of the sizes of particles, 
such as micelles or protein-micelle complexes, undergoing free diffusion in solution by 
determining the translational diffusion coefficients (also known as diffusion constants) [134]. 
This method can be used to probe the proteip-lipid or protein-protein interactions as the size 
would change upon binding. The DOSY data are acquired by attenuating the final 1H signals 
to about 5% of the initial amplitudes using gradient pulses. The signals are attenuated 
gradually by increasing the gradient strength from ~ 2% to ~ 95% of maximum amplitude in 
16 or 32 steps. The conventional 2D DOSY spectra show approximate measures of the 
translational diffusion coefficients of various species present in the sample with respect to 
their 1H chemical shifts (Figure 2.9 A). The exact value of a diffusion coefficient is 
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determined from slope of the signal attenuation curve obtained from the underlying 1 D 1 H 
experiments (Figure 2.9 B). The equation for attenuation of the signal [135] is 
S = S(O)exp[ -Dy2g2&\~ - &/3)], (2.17) 
or ln[S(k)/S(O)] = -Dk, (2.18) 
(2.19) 
Here S [or S(k)] is the observed signal intensity, S(O) is the unattenuated signal intensity, D is 
the diffusion coefficient, y is the gyromagnetic ratio of the observed nucleus CH), g is the 
gradient strength, & is the gradient pulse length and ~ is the diffusion time. The size of the 
particles can then be calculated using the Stokes-Einstein equation for spherical particles 
undergoing free diffusion in solution, 
(2.20) 
where k8 is the Boltzmann constant, T is the absolute temperature, 11 is the viscosity of the 
solution and dH is the hydrodynamic diameter of the particle. The hydrodynamic diameter 
corresponds to the diameter of a sphere that would be diffusing at the same rate. 
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Figure 2.9 : Translational diffusion coefficients of the particles obtained from the DOSY 
data. (A) Schematic representation of the 2D DOSY spectra of a sample consisting of three 
species. Approximate measures of the diffusion coefficients Da, Db and De are obtained from 
the horizontal positions of the 1H peaks. (B) Exact values of the diffusion coefficients are 
obtained from the slopes of the signal attenuation curves plotted using Eq. 2.18. The peaks at 
chemical shifts H1, H3 and H4 each yield a single linear fit (i.e., a single diffusion coefficient), 
but the peak at chemical shift H2 yield two linear fits (i .e., two diffusion coefficients). The 
hydrodynamic diameters are calculated using the Stokes-Einstein equation (Eq. 2.20). 
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2.6 Protein Structure Calculation 
The high-resolution structure of a protein is calculated using computer programs that 
translate the NMR-derived proton-proton distances and the dihedral angle data into 3D 
molecular coordinates. The calculated structure reflects both the experimental data, as well as 
the restrictions on bond lengths, angles, etc. that are known from the chemical structure of 
the protein. Both the NMR data and the chemical structure data are implemented as empirical 
energy functions in a restrained molecular dynamics simulation. In practice, first an extended 
initial structure with ideal covalent geometry is generated using the known amino acid 
sequence. The computer program then refolds the initial structure in a way so that the 
experimentally determined distance and angle restraints are satisfied. To achieve this, each 
known parameter is assigned an energy potential. The program calculates a structure by 
minimizing the overall energy [136, 137]. 
Without the spatial restrictions imposed by the experimentally determined distance 
and dihedral angle restraints, the protein can adopt a huge number of conformations that are 
still consistent with the covalent geometry derived from its chemistry. It is therefore 
important to identify as many restraints from the NMR spectra as possible to restrict the 
conformational space to the subset of space actually sampled by the properly folded protein. 
Simulated annealing, combined with the molecular dynamics simulation, is the most 
commonly used method for calculating the NMR-based structure of a protein in solution. In 
this method, the initial extended structure is heated to a high temperature in a simulation 
giving the atoms a high thermal mobility. buring the subsequent cooling steps, the initial 
extended structure evolves towards the energetically favorable and properly folded final 
structure under the influence of a force field derived from the experimentally determined 
spatial restraints [136, 137]. In the calculation, the total energy is classified into two 
categories and given by, 
ETotal = EEmpirical + EExperimentaJ, 
where EEmpirical = Esond + EAngle + Evan-der-Waals + EEiectrostatic, 
and EExperimental = ENOE + Eoihedral + EH-bond· 
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(2.21) 
(2.22) 
(2.23) 
The folded final structure is calculated using these energy functions and the simulated 
annealing protocol which finds the set of atomic coordinates that represents the minimum 
total energy [136, 137]. ENoE, the pseudo energy term corresponding to the NOEs, plays the 
most crucial role in the protein structure calculation. However, the NOE-derived inter-proton 
distances are imprecise and expressed by a range rather than a specific value. Therefore, 
many closely related structural models are consistent with the observations. Hence, an NMR-
derived protein structure is usually reported as an ensemble of atomic coordinates. The 
conformational space sampled by the structural ensemble reflects the conformational space 
sampled by the protein in solution. It is thus beneficial if the experimental conditions match 
the native conditions. 
2. 7 Strategies for Studying SP-B Pep tides 
Despite the fact that approximately 30% of all proteins of currently sequenced 
genomes are associated with lipid membranes [138], structural information on these lipid-
associated hydrophobic proteins lags far behind when compared to the water-soluble proteins 
[139]. This is largely due to the difficulties involved in expression, purification and 
preparation of physiologically relevant protein samples in lipid-like environments. SP-B is 
one such lipid-associated and water-insoluble hydrophobic protein which presents unique 
challenges to structure determination by solution NMR. Attempts for recombinant expression 
and chemical synthesis of the full-length or near-full SP-B have not succeeded yet. However, 
some of the successfully produced synthetic fragments have exhibited substantial biological 
activity when compared to the wild-type protein [1 09]. I have studied three such SP-B-based 
peptides in this Ph.D. work. I have used a variety of detergent and lipid micelles to mimic the 
lipid environment in which SP-B functions in the lungs. 
Micelles are self-assembled aggregates of amphiphilic molecules, such as certain 
detergents and lipids, in water or other polar solvents (Figure 2.1 0). These amphiphiles 
contain a polar (hydrophilic) head group and one long or two short nonpolar (hydrophobic) 
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hydrocarbon tail(s) (acyl chain(s)). If the concentration of these molecules in aqueous 
solution is greater than a certain value, known as the critical micelle concentration (CMC), 
hydrophobic interactions force them to spontaneously form micelle structures [ 140, 141]. 
Under most circumstances, pure micelles are spherical or near-spherical in shape. However, 
depending on the headgroup area and acyl chain volume/length, other shapes, e.g., 
cylindrical, can also be adopted. The sizes of micelles vary substantially with composition. 
Even for a single detergent or lipid, the micelle-size varies considerably with changes in 
concentration, pH and/or temperature. However, in all types of micelles, the polar 
headgroups remain exposed to the water molecules and the nonpolar acyl chains get buried 
inside the core. Small lipid-associated proteins or polypeptides, such as the fragments of 
SP-B, likely interact with both headgroups and acyl chains of the micelles and fold into 
physiologically relevant 3D structures (Figure 2.1 0). 
Figure 2.10 : Schematic representation of a 
micelle-protein complex. When mixed in 
water in excess of CMC, amphiphiles with 
one long acyl chain or two short acyl chains 
form micelles. These micelles function as 
lipid environment mimetics for membrane 
or lipid-associated proteins. The proteins 
interact with the micelles and likely take on 
physiologically relevant 30 structures. 
In general, the size of a micelle-protein complex is significantly larger than the size of 
the protein by itself. In aqueous solution, the larger complex tumbles more slowly because of 
the higher rotational correlation time and thus undergoes a more efficient transverse 
relaxation. The faster transverse relaxation rate in turn leads to broader lines in the NMR 
spectra and produces consequent decreases in both resolution and SIN ratio, as well as 
increases in peak overlap. Therefore, analysis of the NMR data of a micelle-bound protein is 
much more challenging when compared to a water-soluble protein consisting of the same 
number of amino acids. 
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To gain insight into the mechanisms of SP-B's essential roles in lung surfactant 
function, the conformations of the SP-B-based peptides, their interactions and consequences 
of oxidation were studied in both zwitterionic and anionic micelles. These micelles mimic the 
lung lipid environments created by the most abundant surfactant phospholipids with PC and 
PG headgroups. The work began with the structural studies of Mini-B in micelles composed 
of anionic detergent SDS. Mini-B ' s conformation and interactions were then investigated in a 
variety of micelle systems composed of surfactant phospholipid analogues, namely 
dodecylphosphocholine (DPC), lysomyristoylphosphatidylcholine (LMPC), lysomyristoyl-
phosphatidylglycerol (LMPG) and an LMPCILMPG mixture. Interactions of the most 
abundant surfactant protein SP-A were also investigated in all these micelle systems to aid in 
the later studies of Mini-B/SP-A interactions in the presence of lipids. Next, the impacts of 
tryptophan oxidation on the structure of SP-Bs.25 were probed in water alone, organic solvent 
HFIP, and SDS and DPC micelles. Lastly, the conformation of Maxi-Bcr was investigated in 
HFIP and SDS micelles. Figure 2.11 shows the chemical structures of these lung lipid 
mimetics and the organic solvent. 
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Figure 2.11 : Chemical structures of the 
micelle-forming single acyl chain analogs of the 
most abundant lung surfactant phospholipids 
with the zwitterionic and anionic headgroups 
and the organic solvent HFIP. 
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Chapter 3 
Structure of Mini-B, an N-Terminal 
- C-Terminal Construct of SP-B, 
in Detergent M·ce les 
Note : Mini-B was synthesized and purified by Prof Alan J Waring and his group 
(Waring lab, Medicine, UCLA). The work presented in this chapter has been 
published as: Sarker, M, Waring, A. J, Walther, F. J, Keough, K. M W , and Booth, 
V (2007) Structure of Mini-B, a Functional Fragment of Surfactant Protein B, in 
Detergent Micelles. Biochemistry 46, 11047-11056. 
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3.1 Overview 
Fragments of SP-B containing predicted individual helices or pairs of helices have 
been shown to retain substantial activity when compared to the full-length protein [101-107]. 
Mini-B, a 34 residue construct based on the sequence of the N- and C-terminal predicted 
helices of SP-B (Figure 3.1), demonstrated the most significant biological function among 
these fragments [ 1 09]. Surfactant deficient rats treated with model surfactant preparations 
containing Mini-B attain oxygenation and lung compliance values as good as, or better than, 
those achieved in the presence of native SP-B [109]. However, for the study in Ref. [109], 
the surfactant material was added exogenously and so the findings cannot speak to any 
additional requirements that may be required for SP-B in naturally produced surfactant, 
which must somehow travel from the lamellar bodies secreted by type II alveolar cells to the 
air-water interface. Nevertheless, high resolution structural studies of Mini-B can be 
expected to unveil at least some of the critical structural features that underlie the activity of 
SP-B in native lung conditions. 
SP-B exhibits a strong cationic profile with nme positively charged and two 
negatively charged amino acids, yielding a net charge of + 7 at neutral pH. Seven of the nine 
positively charged amino acids are concentrated in the regions covered by Mini-B, giving the 
same net charge of +7 to this peptide at neutral pH. In addition, about half ( 44%) of Mini-B 
amino acids are hydrophobic, which compares well with the 52% hydrophobic amino acids 
of SP-B. Mini-B also includes the only tryptophan (Trp9) present in the SP-B sequence. 
Furthermore, Mini-B possesses four of the six conserved cysteines that define the Saposin 
fold and thus, in its oxidized form, has two disulfide bridges linking the two predicted helices. 
The function of SP-B is thought to relate to its positive charges, amphipathic helical structure 
and tryptophan anchor [83, 106, 142]. All these structural features are retained in Mini-Band 
presumably this is what makes the peptide so functional in model surfactants. 
For this part of my work, I have used solution NMR to determine the high resolution 
structure of Mini-B in the presence of micelles composed from anionic detergent SDS. These 
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micelles create an anionic, lipid-like environment that provides a reasonable mimetic for 
SP-B's physiological environment in the lungs. As expected, because of the large size of the 
peptide/micelle complex, the NMR spectra of Mini-B in SDS suffered from line broadening 
and signal overlap. However, with the help of NMR frequency assignments of a reduced 
version of Mini-B (i.e., without the disulfide bonds between the helices) in secondary 
structure promoting organic solvent HFIP (Sarker, M., M.Sc. Thesis, Booth lab [110]), it was 
possible to obtain the frequency assignments for this physiologically relevant oxidized 
version of Mini-B (i.e., including the native-like disulfide bonds between the helices) in SDS 
micelles. This allowed the definition of sufficient distance restraints, hydrogen bond 
restraints and dihedral angle restraints to determine the high resolution structure of the 
peptide in lipid-mimetic micelle-bound state. 
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Figure 3.1 : (A) Topology of SP-B predicted on the basis of the known structures of other 
Saposin proteins. The predicted helical regions are portrayed as cylinders and the disulfide 
bonds connecting the helices are shown by dashed lines. (B) Mini-B is constructed by 
connecting the helical segments at the termini of the full-length protein. The correspondence 
between Mini-B residue numbering and SP-B residue numbering is shown at the bottom. 
It should be noted that the correspondence between the Mini-B residue numbering 
and the full-length SP-B residue numbering is shown in Figure 3.1. In this chapter, residue 
numbers refer to Mini-B residue numbering. 
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3.2 Materials and Methods 
3.2.1 Peptide Synthesis and Purification 
Mini-B was synthesized and purified by the Waring lab (Medicine, UCLA). The 
peptide was produced by solid phase chemical synthesis using 0-fluorenylmethyloxycarbo-
nyl (Fmoc) chemistry with nine 15N-labels. 1 ~-leucine was incorporated at positions 3, 7, 22, 
25, 29 and 31; 15N-alanine at positions 6 and 13; and 15N-glycine at position 18. The primary 
structure of Mini-B is shown below with gray shading on the 15N-labeled amino acids : 
Cy~ Trp-Leu-Cy~Arg-Ala-Lru-ll<>Ly~Arg-llt>Gln-Ala-Met-ll<>Pro-Lys-Gly- (represents SP-B 8-2s) 
Gly-Arg-Met-LeU-Pro-Gln-Leu-V al-Cy~Arg-Leu-V al-LeU-Arg-Cy~ (represents SP-B63-78) 
The peptide was produced with disulfide bonds between C1-C33 and C4-C27. Fmoc 
ammo acids and coupling agents were purchased from AnaSpec (Fremont, CA). The 
15N-labeled amino acids were purchased from Cambridge Isotope Laboratories (Andover, MA) 
and converted to their Fmoc derivatives by AnaSpec. Organic solvents and other reagents used 
for the synthesis and purification were high performance liquid chromatography (HPLC) 
grade or better and purchased from Fisher Scientific (Ottawa, ON) and Aldrich Chemical (St. 
Louis, MO). The peptide was synthesized at a 0.25 mmol scale in an ABI 431A peptide 
synthesizer configured for FastMoc double-coupling cycles of all residues for optimum yield 
[143]. A prederivatized N-Fmoc-0-tert-butylserine HMP resin (AnaSpec) was used to 
assemble the peptide during synthesis. Deprotection and cleavage of the peptide from the resin 
were carried out using a TF A/thioanisole/EDT/phenol/water mixture (1 0/0.5/0.25/0.5/0.5 by 
volume) followed by cold precipitation with tert-butyl ether. The disulfide linkages were 
directed by selective deprotection of the Cys residues at amino acid positions 1 and 33 using 
trityl side chain protecting protocols and at positions 4 and 27 using acetamidomethyl groups 
[109]. The disulfide linkages were formed by air mediated oxidation of the peptide in 
structure-promoting solvents [I 09]. The crude product was purified by preparative reverse 
phase HPLC in a Vydac C-18 column using a water/acetonitrile linear gradient with 0.1% 
trifluoroacetic acid as the ion-pairing agent. The molecular weight of the peptide was 
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confirmed by fast atom bombardment or MALDI-TOF mass spectrometry. The purity (> 95%) 
of the final product was determined by analytical HPLC. The purified peptide was lyophilized 
and stored at 4 °C. 
3.2.2 Sample Preparation 
The sample of Mini-B in SDS micelles was prepared by dissolving 1.5 rnM peptide 
and 150 mM detergent (98% deuterated) in 90% H20 and 10% D20 with 0.4 mM DSS and 
0.2 mM NaN3. The deuterated SDS was purchased from Cambridge Isotope Laboratories. 
The pH of the sample was set at 5.0 using NaOH and HCl solutions, without taking the 
isotope effects into account. This pH was chosen in order to obtain the NMR spectra in a 
region where the amide proton/deuteron exchange rate is relatively slow. 
3.2.3 NMR Data Collection 
Solution NMR experiments were performed on Bruker A vance 500 MHz and 600 
MHz spectrometers (at Memorial University of Newfoundland) and a Varian !NOVA 800 
MHz spectrometer (at NANUC, AB). All the spectrometers were equipped with z-gradients. 
The 1D 1H experiments used presaturation [144], 2D 15N-1H HSQC experiments used water 
flip-back [145], and 2D/3D TOCSY and NOESY experiments used water-gate [146] water 
suppression techniques. Initial lD 1H and 2D 1 ~- 1H HSQC experiments were done at three 
different temperatures (25, 35 and 45 oc using Bruker 500 MHz) to evaluate the temperature 
dependence of the peptide conformation. It was observed that the peptide exhibited improved 
conformational homogeneity and less signal overlap at 45 °C. Therefore, all subsequent 
NMR experiments were conducted at this temperature. Scalar-coupled spin systems were 
identified using 2D 1H- 1H TOCSY (mixing time 80 ms, Bruker 500 MHz). NOE data for 
structure restraints were obtained from 2D 1H- 1H NOESY (mixing time 200 ms, Bruker 500 
MHz). Three-dimensional 15N-edited TOCSY (mixing time 80 ms, Bruker 500 MHz) and 
three-dimensional 15N-edited NOESY (mixing time 200 ms, Varian 800 MHz) were used to 
resolve overlapped peaks. 
47 
3.2.4 Data Processing and Structure Calculation 
The NMR spectra were processed using NMRPipe 2.2 [147] and the frequency 
assignments were made using Sparky 3.110 [ 148]. The NOESY spectra were used for 
generating the distance restraints for the structure calculation. The NOEs were classified into 
strong, medium and weak categories depending on the peak intensities (heights) and assigned 
distance ranges accordingly (1.8-2.8 A for strong, 1.8-3.4 A for medium and 1.8-5.0 A for 
weak). Dihedral angle and hydrogen bond restraints were added for residues that could 
clearly be identified as a-helical from local NOE patterns, which were residues 3-14 and 23-
32. Hydrogen bond restraints were set to 1.7-2.4 A for Oi · · · HNi+4 and 2.5-3.5 A for 
Oi · · · Ni+4, and dihedral angles were set to <1> = - 60° ± 30° and 1.jJ = - 40° ± 40° for these 
residues. Table 3.1 summarizes the experimental restraints used in the structure calculation. 
Structures of Mini-B were calculated using the simulated annealing algorithm within CNS 
1.1 [149]. Although over halfofthe NOEs (339 out of638) were intraresidue, those were not 
added into the CNS input as they contribute little structural information but their inclusion 
tends to over-constrain the structure calculation. Structures of Mini-B were viewed by 
MOLMOL 2k.2 [150]. Whenever possible, stereospecific assignments were made using 
distances derived from a preliminary structure calculation. A total of 500 structures were 
calculated for Mini-B. Ensembles of the lowest energy 15 structures were retained for further 
analysis and deposited to the Protein Data Bank (PDB) [ID 2DWF]. 
Restraints 
Total NOE distance restraints 
Unambiguous 
Intra-residue 
Sequential (li-jl = 1) 
Medium-range (li-jl s 5) 
Long-range (li-jl ~ 5) 
Ambiguous (inter-residue) 
Dihedral angle restraints 
Hydrogen bond restraints 
Disulfide bonds 
Number 
638 
613 
339 
158 
110 
6 
25 
44 
28 
2 
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Table 3.1: Mini-B Structural 
Restraints. All restraints 
except for the intra-residue 
restraints were input in the 
structure calculation. 
3.3 Results 
Mini-B is based on theN- and C-terminal predicted a-helices of human SP-B and is 
composed of the human sequence residues 8-25 joined to 63-78 [ 1 09] (Figure 3.1 ). In full 
length SP-B, these two predicted helical segments are linked by a pair of cysteine-cysteine 
disulfide bonds. The structure of Mini-B with the two native-like disulfide bonds was 
determined in SDS micelles, which provide an environment similar to the lipid-water 
interfacial environment in which SP-B functions in the lungs. The peptide was produced by 
chemical synthesis and hence it was feasible to use only limited isotope labeling. Nine of 
Mini-B ' s 34 amino acids (6 leucines, 2 alanines and 1 glycine) had 15N labels. 
The 2D 15N-1H HSQC spectra obtained at a variety of temperatures indicated that 
conformational inhomogeneity and spectral overlap were minimized at a temperature of 45 °C. 
Therefore, this temperature was chosen for the structural analysis. As expected, the HSQC 
peaks for Mini-B in SDS micelles are broad, given the large complex size, but at 45 oc they 
are well-dispersed and resolved (Figure 3.2 A). Eight of the peaks have comparable intensity 
but there are also some weaker peaks present. One of the weak peaks was later assigned to L3 
and the other weak peaks likely arise from minor conformations ofL7, G18 and L22. To probe 
the possibility that protein-protein interactions were responsible for the weak peaks, HSQC 
spectra were also acquired at lower peptide/micelle concentrations. There was no reduction in 
the intensity of the weak peaks as compared to the major peaks in either the 0.5 mM Mini-B/ 
50 mM SOS sample or the 0.1 mM Mini-B/10 mM SDS sample (Figures 3.2 Band C). Hence, 
it does not appear that these weak peaks are the result of protein-protein binding. Rather, these 
are consistent with a degree of flexibility in SOS-bound Mini-B. 
Frequency assignments for Mini-B were made primarily using 20 1H- 1H TOCSY and 
NOESY spectra (Figures 3.3 A and B) with the help from 15N-edited 30 experiments for the 
15N-Iabeled amino acids. Although there was significant overlap in the spectra of the micelle-
bound peptide, with the knowledge of side chain assignments of the reduced Mini-B in HFIP 
(Sarker, M., M.Sc. Thesis, Booth lab [110]), it was possible to identify the correlations to 
49 
confirm frequency assignments for all but Hy of L3, L 7 and L22 of the oxidized Mini-B in 
SDS. NOESY crosspeaks involving C1 , W2, L3, C4 and R5 were weak and displayed only a 
few inter-residue correlations. The relatively weak peak intensity for residues 1 through 5 is 
consistent with dynamics on an intermediate time scale involving the N-terminal region of 
the peptide. NOEs indicative of secondary structure and Ha chemical shift index (CSI) are 
shown in Figure 3.4. Hai-HNi+)!i+4 NOEs and generally negative CSI values indicate an 
a-helical conformation for residues 3-14 and 23-32 of Mini-B. 
The structures of Mini-B in SDS micelles (Figure 3.5) were calculated from 299 
inter-residue NOEs, plus 44 dihedral angle and 28 hydrogen bond restraints for the helical 
regions (Table 3.1). In the ensemble ofthe 15 lowest energy structures, 73% of the residues 
were found in the most favorable region of the Ramachandran plot, the overall backbone 
RMSD was 0.98 A and the backbone RMSD of the helical regions (residues 3-14 and 23-32) 
was 0.78 A. Unambiguous inter-helix NOEs were observed between residues R5 and R28, 
L7 and P23, 18 and C27, K9 and Q24 and W2 and S34. The two helices are packed close to 
each other and their relative positions are almost parallel. 
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Figure 3.2: 2D 15N-1H HSQC spectra ofMini-B in SDS at different concentrations (pH 5.0, 
temperature 45 °C). (A) 1.5 mM Mini-B in 150 mM SDS, acquired on a Bruker 500 MHz 
spectrometer with 16 scans. (B) 0.5 mM Mini-B in 50 mM SDS, acquired on a Bruker 600 
MHz spectrometer with 48 scans. (C) 0.1 mM Mini-B in 10 mM SDS, acquired on a Bruker 
600 MHz spectrometer with 240 scans. The base contour level shown in (A) is 3 and 4 times 
higher than that in (B) and (C), respectively. The number of increments acquired in the 15N 
dimension in (A) was half of that in (B) and (C) and hence the 15N lines are broader in (A). 
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Figure 3.3: Portions of2D 1H-1H NOESY spectra ofMini-B in SDS micelles, acquired on a 
Broker 500 MHz spectrometer with a mixing time of 200 ms and 128 scans. (A) Ha-HN 
region and (B) HN-HN region. Note, all of the peaks displayed were assigned, but for clarity, 
not all have been labeled in these figures. 
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Figure 3.4 : Secondary structure indicators for Mini-B in SDS micelles. Black bars represent 
unambiguously assigned NOEs and grey bars represent ambiguous NOEs. For sequential 
NOEs, the height of the bars corresponds to the intensity of the NOE. The chemical shift 
index (CSI) for the Ha. resonances are shown at the bottom. The CSI values were calculated 
using the random coil chemical shifts obtai~ed from Ref. [1511 . 
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Figure 3.5 : High resolution 
structure of Mini-B in SDS 
micelles. (A) Ensemble of 
the 15 lowest energy 
structures. The backbone 
(gray) and the side-chain 
heavy atoms (colored) are 
shown and the hydrogen 
atoms are omitted for clarity. 
(B) The representative 
structure (closest to the mean 
structure of the ensemble). 
(C) The molecular surface 
formed by the structure. 
Figures (A) and (B) were 
prepared using MolMol 
[ 150] and Figure (C) was 
prepared using PPG [152]. 
3.4 Discussion 
Although SP-B's contributions to lung function are clearly essential for life, the 
mechanism by which SP-B acts are still far from being understood. The current evidence 
points to SP-B-induced lipid restructuring, especially through interactions with anionic lipids, 
as being a key part of SP-B function [83, 86]. In order to help reveal the structural 
mechanisms that underlie SP-B's function, I have performed NMR structural studies of 
Mini-B, a SP-B based peptide that appears to retain much of the essential activities of native 
SP-B [1 09]. Mini-B is constructed from theN- and C-terminal helical regions of human SP-
B (Figure 3.1).1t contains 34 ofSP-B's 79 amino acids and possesses the same net charge of 
+7 at neutral pH as full-length SP-B. Mini-Band native SP-B both contain a high proportion 
of hydrophobic residues (Ala, Val, Leu, Ile, Phe, and Trp ), 41% in Mini-B and 52% in SP-B. 
The distribution of the positively charged and hydrophobic residues is of high interest since 
this distribution defines how Mini-B and SP-B interact with lipids. One major finding of this 
structural study is that Mini-B possesses a strikingly amphipathic surface with most of the 
positively charged residues localized to one face of the peptide and a large hydrophobic patch 
on the opposite face (Figure 3.6 A). 
SP-B is a member of the Saposin superfamily of proteins whose common structural 
features are four to five helices and three internal disulfide bonds; two disulfide bonds 
between the terminal helices and the third one between the two middle helices [91-95]. 
Mini-B contains theN- and C-terminal predicted helical regions of SP-B and also four of the 
six cysteine residues that form two intrachain disulfide bonds as in native SP-B. The 
structure of Mini-B presented herein was determined in the presence of SDS micelles, which 
provide an anionic, lipid-like environment with a hydrophobic/hydrophilic interface. NMR 
data was also acquired for the reduced Mini-B in aqueous solution containing 40% HFIP (as 
part of my M.Sc. work, Booth lab) and used to guide in the spectral assignment of this 
native-like oxidized Mini-Bin SDS micelles. 
The experimental structures indicated that, in SDS, Mini-B folds into the predicted 
two a-helical segments (Figure 3.5). The two helices are packed tightly together, with 
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interhelical interactions stabilized by the two disulfide bonds, as well as by several 
hydrophobic contacts. Ile 8, Ile 11, Ile 15, Leu 22, Pro 23, Leu 25 and Leu 31 are largely 
buried and make interleaved contacts across the interhelix interface that appear to stabilize 
the interaction between the helices. Given the extensive hydrophobic contacts, it does seem 
plausible that some helix-helix association could occur in a native-like lipid environment, 
even in the absence of disulfide bonds. This is consistent with the observation that reduced 
SP-B mimics the behavior of native SP-B in lipid-protein films subjected to dynamic 
compression-expansion cycling, but only in the presence of phosphatidylglyercol [153]. 
In water, at concentrations higher than the critical micelle concentration, the anionic 
detergent SDS forms micelles. These micelles are spherical structures of about 5 nm in 
diameter [154], with the hydrophobic chains on the inside and the negatively charged 
headgroups on the outside. Such micelles provide a mimic of the lipid environment in which 
SP-B is thought to function in the lungs. When in association with SDS micelles, Mini-B 
takes on a strikingly amphipathic structure (Figure 3.6 A). Five of the seven positively 
charged amino acids (Arg 5, Lys 9, Arg 10, Arg 28 and Arg 32) cluster into a positively 
charged patch on one face of the peptide. The remaining two cationic amino acids (Lys 17 
and Arg 20) extend outwards from the loop connecting the two helices. A large hydrophobic 
patch, formed mainly by amino acids Leu 3, Leu 7, Val 26, Leu 29 and Val 30, is located on 
the face opposite to the positively charged patch. This marked partitioning of hydrophobic 
amino acids to one face and positively charged amino acids to the opposite face is likely key 
in the mechanism by which Mini-B, and presumably SP-B, functions. 
Tryptophan is an amino acid that typically either contributes to the hydrophobic core 
of a protein or, in lipid-associated proteins, it may "anchor" the protein to the polar/apolar 
interface. In Mini-B, the tryptophan side chain does not appear to take part in any interhelix 
interactions (Figure 3.5 B) and therefore its role is most likely in interacting with lipids to 
help anchor Mini-B at the lipid-water interface. This role is consistent with tryptophan' s 
location between the hydrophobic face and the charged face of the 3D structure of Mini-B. A 
critical role for this tryptophan in positioning Mini-B and SP-B at the lipid interface is 
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supported by previous studies that have found that Trp9 of SP-B is critical for optimal 
interface affinity [107, 142]. It should be noted that although this tryptophan is at position 9 
of SP-B, it is at position 2 of Mini-B and so it is conceivable, although unlikely, that it may 
take on a different structure when the first seven residues of SP-B are present. 
Figure 3.6 : Electrostatic potential surface of Mini-B (A) and the corresponding segments of 
NK-lysin (B) and Saposin C (C). NK-lysin and Saposin C segments are constructed from 
their PDB coordinates (lNKL [94] and 1SN6 [93], respectively). Positively charged regions 
are blue and the negatively charged regions are red. The orientation of Mini-B shown in the 
upper panel of Figure (A) is the same as the orientation used in Figure 3.5. These figures 
were prepared using MolMol [150]. 
The middle loop region of Mini-B is composed of part of the loop that connects 
helices I and 2 in full-length SP-B, and part of the loop that connects helices 3 and 4 in full-
length SP-B. There are two positively charged amino acids in this loop of Mini-B (one from 
each of the parent loops of SP-B). The loop is unstructured in Mini-B, and it may be that 
these side chains are able to reconfigure in such a way as to interact optimally with lipid 
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molecules. Since the loop is unstructured in Mini-B, it is clear that the loop itself is not 
forcing any non-native contacts between the two helices. From the Mini-B structure it is not 
possible to draw any conclusions as to the characteristics of the corresponding loops in full-
length SP-B; they may also be unstructured, or they may take on a more defined 
conformation than the Mini-Bloop. 
The NMR spectra showed evidence that the structure of some regions of Mini-B were 
dynamic on intermediate (on the order of milliseconds) and slower timescales. There were 
several weaker peaks in the HSQC spectra, likely representing minor conformations of amino 
acids L 7, G 18 and L22. These peaks did not change relative intensity as the concentration of 
Mini-B was reduced, and thus it appears that protein-protein binding is not responsible for 
the minor conformations. Additionally, the intensity of the peaks originating from residues 1 
to 5 was relatively low in the NMR spectra, in comparison to the peaks from other parts of 
the peptide. These spectral features likely indicate a certain degree of plasticity in the regions 
of Mini-B covering theN-terminus, theN-terminal segment of the first helix, and the loop 
that connects the two helices. It is possible that this flexibility has a functional role, i.e., to 
allow Mini-B to form different types of associations with lipids. 
Several high resolution structures have been determined for Saposin proteins, the 
family to which SP-B belongs. These are Saposin A [91] , Saposin B [92], Saposin C [93], 
NK-lysin [94] and Arnoebapore A [95], as well as the Saposin related protein Granulysin 
[96]. All these Saposin proteins form structures consisting of four to five helices, with 
interactions between the N- and C-terminal helices stabilized by two disulfide bonds and 
interactions between the middle helices stabilized by a third disulfide bond [Figure 3.1]. 
However, the structures differ significantly in how the termini helix-pair (which corresponds 
to the region covered by Mini-B) interacts with the middle helix-pair. In some proteins, such 
as Saposin A, NK-lysin, Arnoebapore A and Granulysin, the two helix-pairs pack together 
tightly into a "closed" overall structure (Figure 3.7 A). On the other hand, in Saposin B and 
Saposin C, the pairs of helices do not pack closely together and the overall tertiary structure 
is relatively "open" (Figure 3.7 B). In Saposin B, the open type structure results in the 
formation of a large hydrophobic cavity that is likely responsible for its ability to extract 
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target lipids from membranes [92]. Saposin C, in complex with SDS micelles, also possesses 
an exposed hydrophobic pocket that is implicated in interactions with lipids [93]. Figure 3.6 
shows the electrostatic surfaces for Mini-B and, for comparison, the corresponding regions of 
NK-lysin, as a representative of the closed type Saposin structure, and Saposin C, as a 
representative of the open type Saposin structure. The surfaces on the bottom row of Figure 
3.6 represent the face of the termini helix-pair that is positioned to interact with the middle 
part of the protein. M ini-B more resembles the Saposin C helix-pair, which exhibits primarily 
hydrophi lic (although negatively charged in this case) and hydrophobic opposite faces, than 
it does the NK-Iysin structure which exhibits far a less amphiphilic surface. 
- Mini-Box - Mini-Box 
- NK-Lysin - SaposinB 
- SaposinA Saposin C 
- Amoebapore A 
- Granulysin 
Figure 3.7 : Overlay of the backbone structures of Mini-B and other Saposin family proteins . 
(A) Mini-B and "closed-type" Saposins; NK-lysin [94], Saposin A [91], Amoebapore A [95] 
and Granulysin [96]. (B) Mini-B and "open-type" Saposins; Saposin B [92] and Saposin C 
[93]. This figure was prepared using VMD [ 155]. 
SP-B has been observed to exhibit a number of in vitro behaviors relating to its 
interactions with lipids, such as promoting phospholipid vesicle aggregation, fusion and lysis, 
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promoting rapid adsorption of surfactant material to an air-water interface, and re-adsorption 
of surfactant material to the interface during compression-expansion cycling [82]. These in 
vitro activities relate to three important properties of lung surfactant activity in vivo: rapid 
interfacial absorption, surface tension reduction during compression and re-spreading of the 
surface film during subsequent expansion. A number of potential molecular mechanisms for 
SP-B's essential contributions to these critical lung surfactant properties have been proposed 
[27]. SP-B may act as a bridge between bilayers and/or between bilayers and monolayers to 
keep components that are squeezed out during compression in close association with the 
interface for rapid respreading. SP-B may stabilize high-energy intermediates required for 
phospholipids to pass into the interfacial monolayer. SP-B may induce lipid-packing 
perturbations leading to transfer of surfactant material to the interface. SP-B may act as a sort 
of carrier, taking associating molecules with it to the interface. The structure of Mini-B in 
SDS, with its strikingly amphipathic surface and projecting tryptophan anchor, appears very 
well suited for making strong interactions with lipids, especially anionic species, at an 
interface. The hydrophobic face provides a surface for interactions with several lipid acyl 
chains, the positively charged face provides a surface for interactions with negatively 
charged lipid headgroups, and the tryptophan side chain, which is itself amphipathic, extends 
out from the surface in a position to anchor Mini-B at the interface. The relatively large 
extent of the positively charged patch suggests that this surface may be able to interact with a 
second lipid layer through electrostatic interactions, or at least reduce the electrostatic 
repulsion between negatively charged lipid layers, allowing them to stay in closer association. 
Mini-B is considerably more effective in rat lung oxygenation and dynamic 
compliance assays than its unlinked N and C-terminal halves, even when they are added 
together [109]. This indicates that there is indeed extra functionality associated with Mini-
B's relatively large hydrophobic and cationic surfaces. Now that Mini-B's structure and 
resonance frequency assignments are known, it will be possible in future studies to directly 
observe Mini-B's interactions with phospholipids and other proteins. In particular, it will be 
of interest to study Mini-B's structure and lipid interactions in more physiologically relevant 
systems than SDS micelles, such as phospholipid monolayers and bilayers. 
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Chapter 4 
Mini-B in Model Surfactant Lip·ds: 
Conformations and nteract·ons 
Note : Mini-B was synthesized and purified by Prof Alan J Waring and his group 
(Waring lab, Medicine, UCLA). 
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4.1 Overview 
Biophysical studies have produced a long list of SP-B in vitro activities including 
membrane binding, membrane lysis, membrane fusion, promotion of lipid adsorption to air-
water surfaces, stabilization of monomolecular surface films and respreading of films from 
collapsed phases [82). Although it is not clear which of these activities, if any, underlies 
SP-B's essential roles in vivo, it is plausible that interactions between SP-B and 
phospholipids make crucial contributions to lung surfactant function. SP-B 's profile of 52% 
nonpolar amino acids, as well as nine positively charged and two negatively charged amino 
acids, enables the protein to engage in both electrostatic interactions with lipid headgroups 
and hydrophobic interactions with lipid hydrocarbon acyl chains. However, the lack of 
knowledge of the high-resolution structure of SP-B hinders direct probing of its interactions 
with lipids at molecular and submolecular levels. 
Mini-B, anN-terminal- C-terminal construct from SP-B, has been shown to provide 
excellent response in animal models (1 09]. Surfactant deficient rats treated exogenously with 
model surfactant preparations containing Mini-B attain oxygenation and dynamic lung 
compliance values as good as, or better than, those achieved in the presence of native SP-B 
(1 09). This indicates that Mini-B likely represents the most functionally active region of the 
full-length protein. Now that the high-resolution structure of Mini-B in SDS micelles and the 
resonance frequencies of its amino acid spin systems are determined (Chapter 3 and [ 156]), it 
is possible to directly probe Mini-B's interactions with surfactant phospholipids and other 
proteins. In particular, it is of interest to study Mini-B's conformation and lipid interactions 
in more physiologically relevant systems. Thus, in this part of my work, I have used solution 
NMR to investigate the conformation of Mini-B in dodecylphosphocholine (DPC), 
lysomyristoylphosphatidylcholine (LMPC) and lysomyristoylphosphatidylglycerol (LMPG) 
micelles and probe its interactions with these lipids, alongside the SDS micelles. DPC and 
LMPC are analogues of DPPC, an abundant zwitterionic surfactant phospholipid generally 
considered to be of paramount importance in attaining low surface tension at the alveolar air-
water interface [24]. LMPG, on the other harid, is an analogue for PGs, the anionic surfactant 
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phospholipids that SP-B is thought to preferentially bind in surface monolayers of surfactant 
films [83, 84]. Also studied were Mini-B's interactions with a mixed LMPCILMPG micelle 
system containing approximately the physiological ratio of PC to PG (85% : 15%). 
Furthermore, the reduced version of Mini-B that lacks the two native-like disulfide bonds 
between the helices was studied in SDS and DPC micelles. The structure of this version was 
determined previously in organic solvent HFIP (Sarker, M., M.Sc. Thesis, Booth lab [11 OJ). 
Since the reduced Mini-B also retains a considerable portion of the biological activity of 
full-length SP-B [1 09], it was worth looking at its conformation in micelle environments and 
learning about Mini-B's interactions with lipid mimetics, even in the absence of disulfide 
bonds. Figure 4.1 shows the chemical structures of the detergent mimetics and phospholipid 
analogues of PC and PG used in these studies. 
In addition to observing Mini-B ' s conformation in physiologically relevant lipid 
systems and probing its interactions with model surfactant lipids, this part of my work 
provided a foundation for studying Mini-B/SP-A interaction in the presence of these 
surfactant phospholipid analogues that was carried out later (Chapter 6). 
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Figure 4.1 :Chemical structures of the micelle-forming detergent mimetics and phospholipid 
analogues of the two most abundant zwitterionic and anionic lung surfactant phospholipids 
DPPC and POPG. The headgroups of DPPC and LMPC are identical while the neck region 
of DPC is slightly different. The headgroups of POPG and LMPG are also identical but that 
of SDS is different. 
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4.2 Materials and Methods 
4.2.1 Peptide Synthesis and Purification 
Mini-B was synthesized and purified by the Waring lab (Medicine, UCLA). The 
peptide was produced by solid phase chemical synthesis using 0-fluorenylmethyloxy-
carbonyl (Fmoc) chemistry and purified by preparative reverse phase HPLC in a Vydac C-18 
column as described previously (Chapter 3 and [ 156]). Two versions of Mini-B were 
synthesized. The oxidized version (termed as Mini-Box) contained two disulfide bonds as in 
the native protein [156]. The other version was in reduced form (termed as Mini-BRED) and 
thus lacked the disulfide bonds [110]. Both versions of Mini-B possessed nine backbone 
15N-labeled amino acids as shown with gray shading in Chapter 3 (Section 3.2.1, Page 46). 
4.2.2 Sample Preparation 
Mini-Box samples were prepared in DPC, LMPC, LMPG and mixed LMPC (85%)/ 
LMPG (15%) micelles, alongside SDS micelles. Mini-BRED samples were prepared in SDS 
and DPC micelles only. At least two Mini-B samples were prepared for each micelle system 
with varying peptide/lipid ratios. The exact composition of each sample is described in the 
results section. First, a stock buffer solution was prepared in H20 /D20 (90%11 0%) with 0.4 
mM DSS, 0.2 mM NaN3, and 4.5 mM Hepes (except for the Mini-BRED samples). The final 
NMR samples were then prepared by dissolving required quantities of Mini-B and 
detergent/lipid in the buffer. For each sample, the molar concentration of the detergent/lipid 
was kept at least 100 times higher than the peptide. Deuterated (98%) SDS and DPC were 
purchased from Cambridge Isotope Laboratories (Andover, MA). Non-deuterated LMPC and 
LMPG, purchased from Avanti Polar Lipids (Alabaster, AL) were used, as deuterated 
versions of these lipids were not available commercially to date. Hepes was also in the 
non-deuterated form. The pH of the samples was set to 7.0, 6.9 or 5.0 (the exact value for 
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each sample is reported in the results section) using NaOH and HCl solutions without taking 
the isotope effects into account. The pH values were chosen in order to either match the 
physiological condition(~ 6.9) or to match with the Mini-B structural studies (5.0). 
4.2.3 NMR Data Collection and Processing 
A set of ID 1H, 2D 15N- 1H HSQC and 2D DOSY experiments was performed for 
Mini-Bin each micelle system on a Bruker Avance II 14.1 Tesla (600 MHz) spectrometer 
(Billerica, MA) equipped with z-gradients and an inverse triple resonance TXJ probe. The 
NMR data were collected and processed using the Bruker Topspin 2.0 software. The pulse 
length (PI) and the transmitter offset (01) were optimized for each sample before running 
the full set of NMR experiments. The I D 1 H and 2D 15N- 1 H HSQC spectra were acquired at 
3 7 oc to match the physiological temperature. In 1 D 1 H experiments, data were collected 
with 64 to 320 scans (indicated in the figure captions) using the water-gate water suppression 
technique [ 146] and processed using an exponential apodization function with I Hz line 
broadening. The 2D 15N-1H HSQC spectra were acquired with 64 to 320 scans (indicated in 
the figure captions) using the flip-back water suppression technique [145] and processed 
using the Qsine apodization function with a sine bell shift of 2. The 2D DOSY experiments 
were performed using pulsed field gradient (PFG) NMR [157]. The pulse sequence used a 
stimulated echo with bipolar gradient pulses and one spoil gradient [158], followed by a 
3-9-19 pulse for water suppression [159]. The DOSY spectra of SDS and DPC samples were 
acquired at 37 °C. However, for LMPC and LMPG samples, the DOSY spectra were 
acquired at 25 oc to minimize the effect of thermal convection. The diffusion time was kept 
constant at 1 00 ms. The gradient pulse length was optimized for each sample and set between 
3 and 8 ms. The maximum amplitude of the gradient strength was 35 G/cm and the 1H 
signals were attenuated in 32 steps. The translational diffusion coefficient was determined 
from the slope of the signal attenuation curve plotted using Eq. 2.17. The hydrodynamic 
diameter was calculated using the Stokes-Einstein equation [Eq. 2.20]. The viscosity of pure 
water was used for the viscosity of solution in the calculation and the values were 8.91 x 10-4 
kg/m.s at 25 oc (298 K) and 6.92 x 10-4 kg/m.s at 37 oc (310 K). 
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4.3 Results 
4.3.1 Mini-Bin SDS Micelles 
The SDS micelles used in the structural studies of Mini-B (Chapter 3) provided a first 
approximation of the physiological lipid environment of SP-B in the lungs and thus this 
micelle system was included in the analysis of Mini-B/lipid interactions. However, the 
experimental conditions used in the structural studies were optimized for the structure 
determination rather than to best mimic the lung conditions. Therefore, to best probe the lipid 
interactions, these conditions were modified to better reflect the in vivo conditions, and thus 
most of the SDS spectra were re-acquired at lower protein concentrations and physiological 
pH and temperature. 
Figure 4.2 shows the 1 D 1H spectra of both oxidized and reduced versions of Mini-B 
in SDS micelles. The signals seen in the 6-9 ppm region, enlarged and shown in the bottom 
panel, correspond mostly to the backbone amide protons (HNs) of Mini-B. The spectral 
dispersion and intensity of these signals indicate that both versions of Mini-B are structured 
in SDS micelles even under conditions that are different from the structural studies (Chapter 
3 and [110]). 
The 2D 15N- 1H HSQC spectra, shown in Figure 4.3, also indicate a similar degree of 
structuring in more physiological conditions, as compared to the conditions used for the 
structural studies. The peaks seen in the HSQC spectra correspond to the backbone 15N-1H 
correlations. However, although Mini-B carries nine backbone 1 ~-labeled amino acids, there 
are eight strong peaks and about five additional weak peaks present for Mini-Box. As is 
known from the structural studies, the eight strong peaks and one weak peak correspond to 
the nine 15N-labeled amino acids and represent the major conformation of Mini-Box. The 
additional weak peaks likely represent minor conformations of some flexible regions of the 
peptide, as discussed in Chapter 3 (Section 3.4, Page 57). For Mini-BRED, nine strong peaks 
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are present only and there are no additional weak peaks seen. This suggests a homogeneous 
structuring of Mini-BRED in SDS micelles. Comparison of the HSQC spectra from the two 
Mini-B versions shows differences in chemical shift of at least two peaks (from Leu3 and 
Leu31) indicating a difference in the chemical environment for these amino acids between 
the oxidized and reduced versions. Thus, Mini-Box and Mini-BRED exhibit differences in the 
conformational homogeneity and structures. However, both versions of the peptide appear to 
take on similar a-helical secondary structures and the main difference is likely present in 
their tertiary structures. 
The effect of Mini-Box on the size or shape of SDS micelles is probed using the 
translational diffusion coefficients of pure SDS micelles and the Mini-B0 x/SDS complex 
obtained from the 2D DOSY spectra (Figure 4.4). The DOSY data are acquired using the 
same molar concentrations of SDS and Mini-Box as in the structural studies, i.e., 150 mM 
SDS and 1.5 mM Mini-Box. Two values of average diffusion coefficients are measured for 
SDS micelles alone and for the Mini-Box/SDS complex, from the attenuation of the two 
sharpest SDS peaks at 0.80 ppm (corresponding to CH3) and 1.22 ppm (corresponding to 
(CH2) 3_11). The excellent linear fits shown in the plots of Figure 4.4 indicate that each sample 
is dominated by a particle of one distinct size. The diffusion coefficients of pure SDS 
micelles are 1.388 x 10-10 and 1.385 x 10-10 rr/ls and those of the Mini-Box/SDS complex are 
0.900 X w-IO and 0.971 X w-IO m2/s, from the two peaks respectively. The corresponding 
hydrodynamic diameters, calculated using the Stokes-Einstein equation, are 4.73 and 4.74 
nm for the micelles alone and 7.29 and 6.76 nm for the peptide/micelle complex. 
The extraction of the hydrodynamic diameter of pure micelles from the translational 
diffusion coefficient is accurate only at low concentrations. Above CMC, the diffusion 
coefficients correspond to a weighted average of free and micelle-bound detergent/lipid 
molecules [218, 219]. Therefore, the measured hydrodynamic diameter corresponds to the 
lower size-limit for the micelles. In addition, at high concentrations, e.g., above ~ 100 mM 
for SDS, the micelles experience an obstructed diffusion as a result of crowding [218]. The 
crowding produces an opposite effect to the observed diffusion coefficients and the measured 
hydrodynamic diameters of the micelles tend to be larger. Thus, at 150 mM SDS 
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concentration, both effects will takes place simultaneously. A more complex behavior can be 
expected when Mini-Box is bound to the micelles. All the same, the apparent size of the 
micelles increases substantially upon the inclusion of the peptide. 
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Figure 4.2 : 1 D 1H spectra of (A) 0.20 mM Mini-Box in 40 mM SDS in the presence of 4.5 
mM Hepes at pH 6.9 (acquired using 256 scans) and (B) 0.75 mM Mini-BRED in 75 mM SDS 
at pH 5 (acquired using 64 scans). Both experiments were performed at temperature 37 oc 
and the spectra were processed with 1 Hz line broadening. The intense peaks seen in the 
spectra are from DSS and Hepes. The 6-9 ppm regions, exhibiting the protein HN signals, are 
enlarged and shown in the bottom panels (C and D). 
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Figure 4.3 : 2D 15N- 1H HSQC spectra of (A) 0.20 mM Mini-Box in 40 mM SDS in the 
presence of 4.5 mM Hepes at pH 6.9 (acquired using 160 scans) and (B) 0.75 mM Mini-BREo 
in 75 mM SDS at pH 5 (acquired using 64 scans). Both experiments were performed at 
temperature 37 °C. The base contour level shown in (A) is two times higher than (B). 
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Figure 4.4 : SDS micelles (ooo) and Mini-Box/SDS 
complex (•••) sizes as indicated by translational 
diffusion. Upper panels show 2D DOSY spectra of 
(A) 150 mM SDS and (B) 1.5 mM Mini-Box + 150 
mM SDS, at pH 7 and temperature 37 °C. Linear fits 
(C and D) show the attenuation of the peaks at 0.80 
and 1.22 ppm obtained from the DOSY data. The 
observed diffusion coefficients, represented by the 
slopes of the curves, and the corresponding 
hydrodynamic diameters, calculated using the 
Stokes-Einstein equation (Eq. 2.20), are shown in 
the table (E). 
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4.3.2 Mini-Bin DPC Micelles 
The DPC micelles mimic the native lung condition created by the most abundant 
surfactant phospholipids which have zwitterionic PC headgroups. The 1D 1H and 2D 15N-1H 
HSQC spectra (Figures 4.5 and 4.6) indicate an overall similar level of structure of Mini-Box 
in DPC micelles, compared to the structure in SDS micelles. However, there exists a 
noticeable change in the HSQC spectra of Mini-Box in DPC. Although the peptide contains 
nine 15N -labeled amino acids, only eight peaks are seen and the peak for G ly 18 is missing as 
identified from the resonance frequency determined during the structural studies in SDS 
(Chapter 3). The position of Gly 18 in the loop region makes it likely that its disappearance is 
due to the exchange between multiple conformations of this region of Mini-Box occurring at 
an intermediate rate, i.e, of the order of chemical shift difference. On the other hand, all nine 
peaks, including the one for Gly18, are seen in the HSQC spectra ofMini-BRED indicating the 
conformational exchange is absent when the disulfide bonds are reduced. This view that the 
disulfide bonds are associated with increased conformational heterogeneity is also supported 
by the observation of much fewer weak peaks (indicative of additional conformations) in the 
HSQC spectra ofMini-BREo compared to Mini-Box. 
The structuring of cationic Mini-B in zwitterionic lipid environment is likely driven 
by its direct binding to DPC micelles. This is further indicated by the substantially slower 
translational diffusion of the micelles upon inclusion of Mini-Box, and hence an increased 
size, as obtained from the 2D DOSY experiments (Figure 4.7). Two values of average 
diffusion coefficients are measured for pure DPC micelles and the Mini-B0 x/DPC complex 
using the attenuation of the two sharpest DPC peaks at 0.80 ppm (corresponding to CH3) and 
1.22 ppm (corresponding to (CH2) 3.11 ). The diffusion coefficients for the micelles alone are 
3.35 x 10"10 and 3.37 x 10"10 m2/s and that for the peptide/micelle complex are 2.58 x 10"10 
and 2.65 x 10"10 m2/s, respectively. The corresponding hydrodynamic diameters, calculated 
using the Stokes-Einstein equation, are 1.96 and 1.95 run for pure micelles and 2.54 and 2.48 
run for the peptide/micelle complex. Although under same experimental conditions, the sizes 
ofDPC and SDS micelles are unlikely to be drastically different [160, 161], the sizes of pure 
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DPC micelles and the Mini-Box/DPC complex found in this study are substantially smaller 
than those found for pure SDS micelles and the Mini-Box/SDS complex, respectively. Since 
the DOSY data corresponds to a weighted average from the free and micelle-bound lipid 
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Figure 4.5: lD 1H spectra of (A) 0.20 mM Mini-Box in 40 mM DPC in the presence of 4.5 
mM Hepes at pH 6.9 (acquired using 256 scans) and (B) 0.75 mM Mini-BREo in 75 mM DPC 
at pH 5 (acquired using 64 scans). Both experiments were performed at temperature 37 oc 
and the spectra were processed with 1 Hz line broadening. The intense peaks seen in the 
spectra are from DSS and Hepes. The 6-9 ppm regions, exhibiting the protein HN signals, are 
enlarged and shown in the bottom panels (C and D). 
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molecules, the smaller apparent size may be the result of a rapid exchange between the two 
DPC species. This is likely due to the lower DPC concentration of 20 mM used in this study, 
as opposed to 150 mM concentration used for the SDS study. 
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Figure 4.6 : 2D 15N-1H HSQC spectra of (A) 0.20 mM Mini-Box in 40 mM DPC in the 
presence of 4.5 mM Hepes at pH 6.9 (acquired using 160 scans) and (B) 0.75 mM Mini-BREo 
in 75 mM DPC at pH 5 (acquired using 64 scans). Both experiments were performed at 
temperature 37 °C. The base contour level shown in (A) is two times higher than (B). 
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Figure 4.7 : DPC micelles (ooo) and Mini-Box/DPC 
complex (•••) sizes as indicated by translational 
diffusion. Upper panels show 2D DOSY spectra of 
(A) 20 mM DPC and (B) 0.10 mM Mini-Box + 20 
mM DPC, at pH 7 and temperature 37 °C. Linear fits 
(C and D) show the attenuation of the peaks at 0.80 
and 1.22 ppm obtained from the DOSY data. The 
observed diffusion coefficients, represented by the 
slopes of the curves, and the corresponding 
hydrodynamic diameters, calculated using the 
Stokes-Einstein equation (Eq. 2.20), are shown in 
the table (E). 
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4.3.3 Mini-Bin LMPC Micelles 
To gain an insight into Mini-B ' s conformation in a more physiologically relevant 
lipid environment and to probe Mini-B's interactions with surfactant phospholipid analogues, 
only the oxidized version of Mini-B was used in the remaining studies for this chapter. First 
studied was Mini-Box in zwitterionic LMPC micelles. LMPC is a better mimetic for the most 
abundant surfactant phospholipid DPPC than DPC, as it contains identical head and neck 
regions to DPPC. The investigations were carried out at two different peptide/lipid ratios 
(indicated in the figure captions). The 1D 1H and 2D 15N-1H HSQC spectra look almost 
identical for both concentrations. The HN signals seen in the 1 D 1H spectrum are broader 
than SDS- or DPC-bound Mini-Box and likely more overlapped (Figure 4.8). The 15N- 1H 
correlations seen in the 2D HSQC spectra are also broader (Figure 4.9). This is consistent 
with a larger complex-size of Mini-BoxiLMPC than Mini-Box/SDS or Mini-Box/DPC. Like 
Mini-Box in DPC, eight strong HSQC peaks, along with some additional weak peaks, are 
seen and the Gly 18 peak is missing. Comparison with the spectra in SDS and DPC micelles 
indicates that Mini-Box is structured in LMPC micelle environment, along with additional 
minor conformations of some regions. However, some differences in the overall 
conformation of LMPC-bound Mini-Box and SDS- or DPC-bound Mini-Box are likely as the 
chemical shifts of most of the HSQC peaks are not exactly the same. 
The effects of Mini-Box on the structure of LMPC micelles are revealed from the 2D 
DOSY spectra (Figure 4.1 0). The- 7.2 nm hydrodynamic diameter of pure LMPC micelles, 
calculated using the observed translational diffusion coefficient of - 7.3 x 10-11 m2/s, is 
indeed much larger than the diameters of pure SDS and DPC micelles. Interestingly, in 
contrast to the SDS and DPC results, the inclusion of Mini-Box apparently decreases the 
diameter of LMPC micelles to - 6. 7 nm since the observed diffusion coefficient of the 
peptide/micelle complex is increased to - 6.7 x 10-11 m2/s. The faster diffusion of the 
complex may be a result of smaller size, changed shape and/or enhanced exchange between 
the free and micelle-bound LMPC molecules instigated by Mini-Box. 
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Figure 4.8 : 1 D 1H spectra of (A) 0.20 mM Mini-Box in 100 mM LMPC and (B) 0.25 mM 
Mini-Box in 50 mM LMPC, in the presence of 4.5 mM Hepes. The pH of both samples was 
6.9 and the experiments were performed at temperature 37 °C. The spectra were acquired 
using 160 scans and processed with 1 Hz line broadening. The intense peaks seen in the 
spectra are from LMPC, Hepes and DSS. The 6-9 ppm regions, exhibiting the protein HN 
signals, are enlarged and shown in the bottom panel (C). 
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Figure 4.9 : 2D 15N-1H HSQC spectra of (A) 0.20 mM Mini-Box in 100 mM LMPC and 
(B) 0.25 mM Mini-Box in 50 mM LMPC, in the presence of 4.5 mM Hepes. The pH of the 
samples was 6.9. The spectra were acquired at temperature 37 oc using 160 scans. 
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Figure 4.10 : LMPC micelles (ooo) and Mini-Box/ 
LMPC complex (•••) sizes as indicated by 
translational diffusion. Upper panels show 2D 
DOSY spectra of (A) 50 mM LMPC and (B) 0.25 
mM Mini-Box + 50 mM LMPC, at pH 6.9 and 
temperature 25 °C. Linear fits (C and D) show the 
attenuation of the peaks at 0.85 and 1.27 ppm 
obtained from the DOSY data. The observed 
diffusion coefficients, represented by the slopes of 
the curves, and the corresponding hydrodynamic 
diameters, calculated using the Stokes-Einstein 
equation (Eq. 2.20), are shown in the table (E). 
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4.3.4 Mini-Bin LMPG Micelles 
The studies of the conformation and lipid interactions of Mini-Box continued next 
with anionic LMPG micelles. LMPG contains an identical headgroup to surfactant PGs and 
hence is a much better mimetic than SDS. The NMR experiments were performed with two 
different peptide/lipid ratios (indicated in the figure captions) but the 1D 1H and 2D 15N- 1H 
HSQC spectra are almost identical (Figures 4.11 and 4.12). The signals are broader than 
SDS- and DPC-bound Mini-Box but similar to LMPC-bound Mini-Box. The Gly18 HSQC 
peak, absent in zwitterionic DPC and LMPC but present in anionic SDS, is present in LMPG 
as well. Comparison with the spectra from other micelle systems indicates an overall similar 
structure of Mini-Box in LMPG micelles. 
The findings about the change in the structure of LMPG micelles brought by the 
inclusion of Mini-Box, as obtained from the 2D DOSY experiments (Figure 4.13), are similar 
to the LMPC study. The observed translational diffusion coefficient of pure LMPG micelles 
increases from ~ 5.9 x 10-11 m2/s to ~ 6.8 x 10-11 m2/s when Mini-Box is added. Thus, the 
hydrodynamic diameter of the micelles apparently decreases from~ 8.3 nm to ~ 7.2 nm when 
bound to the peptide. 
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Figure 4.11 : 1D 1H spectra of (A) 0.20 mM Mini-Box in 100 mM LMPG and (B) 0.25 mM 
Mini-Box in 50 mM LMPG, in the presence of 4.5 mM Hepes. The pH of both samples was 
6.9 and the experiments were performed at temperature 37 °C. The spectra were acquired 
using 160 scans and processed with 1 Hz line broadening. The intense peaks seen in the 
spectra are from LMPG, Hepes and DSS. The 6-9 ppm regions, exhibiting the protein HN 
signals, are enlarged and shown in the bottom panel (C). 
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Figure 4.12 : 2D 15N-1H HSQC spectra of (A) 0.20 mM Mini-Box in 100 mM LMPG and 
(B) 0.25 mM Mini-Box in 50 mM LMPG, in the presence of 4.5 mM Hepes. The pH of the 
samples was 6.9. The spectra were acquired at temperature 37 oc using 160 scans. 
80 
,.-.., ,.-.., 
A. LMPG (50 mM) (/) B. Mini-Box (0.25 mM) (/) ....._ ....._ N N 
E + LMPG (50 mM) E 
'-" '-" 
0.0 0.0 
..9 ..9 
\~~~ ~~ ~,~ I 1 1 I !\ 0 I . ~Ill 0 ........ ........ I I 
r 
I ~ ~ I 0\ 0\ I I 
10 8 6 4 2 1H (ppm) 10 8 6 4 2 1H (ppm) 
ooooo LMPG Micelles 
••••• Mini-BoxiLMPG Complex 
0 From LMPG CH3 
8 -1 peak at 0.87 ppm 
~ -2 
2 
-3 (]) 
E -4 
-5 
-6 
0 20 40 60x109 
c 2 2 k [= (yog) (t.- 8/3 )] (s/m ) 
0 From LMPG (CH2)4_13 
8 -1 peak at 1.28 ppm 
~ -2 
2 
-3 (]) 
E -4 
-5 
-6 
0 20 40 60x109 
D k [= (yog)2(t.-o/3 )] (s/m2) 
Peak LMPG (ooo) Mini-Box/LMPG (•••) 
at D. Coeff. H. Dia. D. Coeff. H. Dia. 
ppm x1o-ll (m2/s) (run) x10- 11 (m2/s) (run) 
0.87 5.907 8.29 6.841 7.16 
(± 0.004) (± 0.014) 
1.28 5.909 8.29 6.849 7.15 
(± 0.003) (± 0.009) 
E 
Figure 4.13 : LMPG micelles (ooo) and Mini-Box/ 
LMPG complex (•••) sizes as indicated by 
translational diffusion. Upper panels show 2D 
DOSY spectra of (A) 50 mM LMPG and (B) 0.25 
mM Mini-B + 50 mM LMPG, at pH 6.9 and 
temperature 25 °C. Linear fits (C and D) show the 
attenuation of the peaks at 0.87 and 1.28 ppm 
obtained from the DOSY data. The observed 
diffusion coefficients, represented by the slopes of 
the curves, and the corresponding hydrodynamic 
diameters, calculated using the Stokes-Einstein 
equation (Eq. 2.20), are shown in the table (E). 
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4.3.5 Mini-Bin Mixed LMPC/LMPG Micelles 
Lastly for this Chapter, conformation of Mini-Box and its lipid interactions were 
investigated in a mixed LMPCILMPG micelle system. Again, two different peptide/lipid 
concentrations were used (indicated in the figure captions) but the 8.5 : 1.5 ratio of PC to PG 
was maintained in both samples to match the physiological condition. The 1 D 1 H and 2D 
15N-1H HSQC spectra indicate a structured Mini-Box in the mixed zwitterionic/anionic 
environment when compared to the spectra in individual micelle systems (Figures 4.14 and 
4.15). However, the HSQC spectra exhibit two more interesting features. Firstly, the Gly 18 
peak which was present in LMPG micelles but disappeared in LMPC micelles, reappears in 
the mixed micelles containing only 15% LMPG. Therefore, as little as 15% LMPG is enough 
to induce the same structure/dynamics of Mini-Box loop region as 100% LMPG. Secondly, 
for at least two cases, the two peaks representing a single 15N-labeled amino acid have 
similar intensities. This indicates the presence of multiple conformations of some regions of 
Mini-Box with similar populations. 
,/• I 
The 2D DOSY study confirms the formation of mixed micelles, containing both 
LMPC and LMPG molecules together, as there is only a single translational diffusion 
coefficient present for the LMPC/LMPG system (Figure 4.16). However, the change in the 
micelle structure caused by the inclusion of Mini-Box follows the same trend as of Mini-Box/ 
LMPC and Mini-Box/LMPG. The observed translational diffusion coefficient of micelles 
alone is ~ 5.9 X w - ll m2/s but that of the peptide/micelle complex is ~ 7.6 X 1 o-Il m2/s. Thus 
the hydrodynamic diameter of the mixed micelles apparently decreases from ~ 8.3 nm to 
- 6.5 nm when bound to Mini-Box. 
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Figure 4.14: ID 1H spectra of(A) 0.20 mM Mini-Box in 85 mM LMPC plus 15 mM LMPG 
and (B) 0.25 mM Mini-Box in 42.5 mM LMPC plus 7.5 mM LMPG, in the presence of 
4.5 mM Hepes. The pH of both samples was 6.9 and the experiments were performed 
at temperature 3 7 °C. The spectra were acquired using 160 scans and processed with 1 Hz 
line broadening. The intense peaks seen in the spectra are from LMPC, LMPG, Hepes and 
DSS. The 6-9 ppm regions, exhibiting the protein HN signals, are enlarged and shown in the 
bottom panel (C). 
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Figure 4.15: 2D 15N- 1H HSQC spectra of(A) 0.20 mM Mini-Box in 85 mM LMPC plus 15 
mM LMPG (acquired using 320 scans) and (B) 0.25 mM Mini-Box in 42.5 mM LMPC plus 
7.5 mM LMPG (acquired using 160 scans), in the presence of4.5 mM Hepes. The pH ofthe 
samples was 6.9 and the experiments were performed at temperature 37 °C. 
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Figure 4.16 : LMPCILMPG mixed micelles (ooo) 
and Mini-BoxiLMPC/LMPG complex sizes (•••) 
as indicated by translational diffusion. Upper 
panels show 2D DOSY spectra of (A) 42.5 mM 
LMPC + 7.5 mM LMPG and (B) 0.25 mM Mini-B 
+ 42.5 mM LMPC + 7.5 mM LMPG, at pH 6.9 and 
temperature 25 °C. Linear fits (C and D) show the 
attenuation of the peaks at 0.86 and 1.28 ppm 
obtained from the DOSY data. The observed 
diffusion coefficients, represented by the slopes of 
the curves, and the corresponding hydrodynamic 
diameters, calculated using the Stokes-Einstein 
equation (Eq. 2.20), are shown in the table (E). 
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4.4 Discussion 
SP-B's essential roles in lung surfactant function presumably come through its 
interactions with phospholipids [82-88]. A detailed mechanistic description of these 
interactions is still unavailable as the high resolution structure of full-length SP-B is not yet 
known. Biophysical studies suggest that SP-B facilitates large-scale rearrangements of lipids 
and stabilizes complex structures required for rapid adsorption of surfactant materials at the 
alveolar air-water interface, surface tension reduction during lung compression and 
respreading of the surface film during subsequent lung expansion [82-88]. Mini-B 1s a 
synthetic construct based on theN-terminal - C-terminal helical regions of SP-B that retains 
substantial biological activity of the full-length protein [1 09]. In this chapter, solution NMR 
was used to investigate the conformation of Mini-B and probe its interactions with a variety 
of micelle systems mimicking the lung lipid environment of SP-B. The micelles were 
composed of LMPC and LMPG, the analogues of the most abundant surfactant 
phospholipids with zwitterionic and anionic headgroups, as well as a mixture of both LMPC 
and LMPG at a physiological ratio. However, the studies began with smaller micelles 
composed of anionic detergent SDS and zwitterionic lipid DPC. Intriguing differences were 
found in how Mini-B interacts with the smaller DPC/SDS micelles compared to the larger 
LMPCILMPG micelles, suggesting that differences in the lipid structure can substantially 
impact Mini-B/lipid interactions. Interesting differences in the overall conformation and 
dynamics of Mini-B in zwitterionic versus anionic environments were also noticed. 
Moreover, despite the similarity in structuring of Mini-B in DPC to LMPC and SDS to 
LMPG, subtle differences in Mini-B's interactions were observed. 
Due to the high degree of hydrophobicity, SP-B and its peptide fragments are mostly 
insoluble and presumably unstructured in water alone. However, Mini-B takes on a well-
defined and mostly homogeneous conformation, with two a-helices connected by a loop, in 
the presence of organic solvent HFIP and detergent micelles composed of SDS ([II 0] and 
Chapter 3). Comparison of the lD 1H and 2D 15N- 1H HSQC spectra acquired for this chapter 
with similar spectra from the previous structural studies indicates that Mini-B is structured in 
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all DPC, LMPC, LMPG and mixed LMPC/LMPG micelle systems. Although small 
differences in the overall conformation would not be unexpected, as chemical shifts of some 
HSQC peaks are not identical, Mini-B likely adopts a generic amphipathic helical folding in 
all these physiologically relevant lipid environments. It is conceivable that the structuring is 
driven by Mini-B's direct interactions with both polar headgroups and hydrophobic core of 
the micelles. In native lung conditions, the corresponding terminal regions of full-length 
SP-B probably interact with surfactant phospholipids in a similar manner and also fold as 
amphipathic helices. 
In addition to the dominant major conformation, some regions of Mini-Box possess 
additional minor conformations in all micelle systems as indicated by the additional weak 
HSQC peaks of some 15N-labeled amino acids. At least in SDS-bound Mini-Box, these 
regions include the N-terminus and the middle loop (Chapter 3). In mixed LMPC/LMPG 
micelles, two or three 15N-labeled amino acids each show two HSQC peaks with similar 
intensities. The regions containing these amino acids therefore exhibit two conformations 
with similar populations. There is likely a slow exchange taking place between these 
conformations. It is conceivable that this conformational heterogeneity allows Mini-Box to 
form different types of associations with lipids and thus plays a functional role. 
Mini-BRED, in contrast to Mini-Box, does not appear to exhibit any significant 
conformational heterogeneity in either of SDS or DPC micelles since there are no additional 
weak peaks present in the HSQC spectra. The reduced Mini-B is an interesting SP-B based 
peptide for clinical applications. It has been shown that this version of Mini-B also retains 
some biological functions of SP-B in surfactant lavaged rat models [1 09]. It thus possesses a 
substantial therapeutic potential since making multiple disulfide bonds in synthetic SP-B 
based peptides is very challenging. However, in rat models, Mini-BRED exhibits lower 
activity than Mini-Box (Figure 1.6 on Page 17 and [1 09]), which can probably be attributed 
to its different three dimensional conformation. The helices of Mini-BRED are not spatially 
constrained by disulfide bonds, as they are in Mini-Box. Hence, in the presence of 
detergent/lipid molecules, Mini-BRED, in contrast to taking on a "compact" tertiary structure 
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like Mini-Box, presumably takes on an entropically more favorable "open" tertiary structure 
through necessary reorientation of its helices. This assumption is favorably supported by the 
difference in chemical shifts of Leu3 and Leu31, two amino acids located at the interface 
between the helices and close to the termini, when the HSQC spectra of both versions are 
compared. Also, the lack of disulfide bonds likely allows Mini-BRED to form a more rigid 
association with both anionic and zwitterionic amphiphiles and thereby adopt a temporally 
stable homogeneous and single conformation. This further underscores Mini-B's ability, 
irrespective of the disulfide bonds between its helices, to bind different lipid types. 
Although the dynamics of Mini-Box are not directly probed in these studies, based on 
the spectral features of HSQC, some inferences can be drawn about the flexibility of its 
regions exhibiting multiple conformations. For the regions that contain amino acids each 
with two (or more) HSQC peaks, there is either no chemical exchange taking place between 
the conformations or if there is any exchange going on that must be occurring at a rate much 
slower than the chemical shift difference. On the other hand, for the regions that contain 
amino acids each with a single peak which is weak as a result of line broadening, probably 
multiple conformations are still present but a chemical exchange is taking place at a rate 
close to the chemical shift difference, i.e. at an intermediate rate (of the order of a thousand 
per second). The peak for Gly 18, which is located in the loop region connecting the helices, 
is completely missing from the HSQC spectra of Mini-Box in DPC and LMPC micelles. 
Thus, in zwitterionic environment, the middle loop of Mini-Box is most likely undergoing a 
conformational exchange at an intermediate rate very close to the chemical shift difference. 
In contrast, a strong Gly 18 peak (and an additional weak peak) is present in the HSQC 
spectra of Mini-Box in SDS, LMPG and mixed LMPC/LMPG micelles. Hence, the middle 
loop of Mini-Box, though exhibiting a conformational heterogeneity, is probably rigid or at 
most exchanging very slowly in pure anionic or mixed lipid environments. In DPC micelles, 
although the Gly 18 peak is missing for Mini-Box indicating an intermediate conformational 
exchange of the loop region, interestingly, it is present for Mini-BRED indicating no such 
exchange for this version. Mini-B thus exhibits a distinctive structural flexibility which not 
only varies with the lipid environments but also depends on its own tertiary conformation. 
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The diffusion NMR spectroscopy reveals that the translational diffusion of all types 
of micelles changes upon the inclusion of Mini-Box. This indicates a Mini-Box-induced 
change of the micelle structure and provides an evidence of direct interactions between the 
peptide and the detergent/lipid molecules. However, the observations for SDS and DPC 
micelles, where Mini-Box causes the micelles to diffuse more slowly, and the observations 
for LMPC, LMPG and mixed LMPC/LMPG micelles, where Mini-Box causes the micelles 
to diffuse more quickly, are opposite. LMPC and LMPG each contain a 14-carbon acyl chain 
and a large head group (Figure 4.1, Page 62). On the other hand, DPC contains a 12-carbon 
acy I chain and a slightly smaller headgroup, while SDS also contains a 12-carbon acy I chain 
but a much smaller headgroup. From the translational diffusion measurements, SDS and DPC 
micelles are found to be much smaller in size than LMPC, LMPG or mixed LMPC/LMPG 
micelles. Hence, when Mini-Box is added, the smaller SDS or DPC micelles are presumably 
substantially stretched to accommodate the peptide within them, which would explain the 
slower translational diffusion and increased size of the peptide/micelle complexes. However, 
the effects of Mini-Box's interactions are seemingly different for much larger LMPC, LMPG 
or mixed LMPC/LMPG micelles as these micelles diffuse faster when bound to Mini-Box. 
There are three plausible explanations for this behavior. First, Mini-Box may contract the 
surface of these large micelles and thereby yield more compact and smaller peptide/micelle 
complexes. The self-assembly of detergent/lipid micelles is primarily driven by the 
hydrophobic interactions of their nonpolar hydrocarbon acyl chains [140, 141]. As both 
LMPC and LMPG headgroups carry charges, inclusion of Mini-Box, which also carries 
charges, may add an extra electrostatic component of interactions. This may bring a 
contraction at the surface of these micelles and thus causing the complexes to decrease in 
size. Second, pure LMPC/LMPG micelles may adopt a largely non-spherical shape and Mini-
Box may induce an increased curvature by restructuring these micelles to a more spherical 
shape that encounters decreased viscous drag in solution. This may be related to some 
predicted physiological functions of SP-B. One major proposed function depicts that SP-B 
squeezes out unsaturated phospholipids from the surface film during compression, which 
would require its association with highly curved lipid structures [86]. In addition, in vitro 
reconstitution of tubular myelin (TM) requires both SP-A and SP-B, where the positioning of 
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SP-B is likely in the highly curved comers ofTM [17]. Mini-Box, being a biologically active 
fragment of SP-B, may thus be involved in inducing an increased curvature to the micelle 
surfaces formed from surfactant phospholipid analogues. Third, Mini-Box, without changing 
the size or shape of the micelles substantially, may trigger a faster exchange between the free 
and micelle-bound LMPC/LMPG molecules present in these samples. Since the diffusion 
coefficient obtained from the DOSY data is a weighted average from the free and micelle-
bound lipid molecules, the faster exchange would also result in a quicker translational 
diffusion of the peptide/micelle complex. All of these possibilities, whether it is the change 
of micelle size, micelle shape, or lipid exchange rate, suggest that Mini-Box is capable of 
instigating a large-scale rearrangement of the lipid structures. 
The interactions between Mini-B and micelles are likely both electrostatic and 
hydrophobic in nature. The electrostatic interactions likely occur between the anionic amino 
acids of the peptide and the cationic or zwitterionic headgroups of the micelles, while the 
hydrophobic interactions likely occur between the nonpolar amino acids of the peptide and 
the core of the micelles formed by the hydrocarbon acyl chains. Given the strikingly 
amphipathic structure of Mini-Box and consequently presumed strong electrostatic 
interactions between cationic amino acids of Mini-B and anionic headgroups of SDS and 
LMPG micelles, it is possible that Mini-Box is comparatively tightly bound to these anionic 
micelles. Thus the positioning of Mini-Box may be relatively deep inside the anionic 
micelles. On the other hand, the electrostatic interactions between the same anionic amino 
acids and zwitterionic headgroups of DPC and LMPC micelles are unlikely to be so strong, 
and hence Mini-Box may be relatively loosely bound to these zwitterionic micelles. 
Therefore, the positioning of Mini-Box may be relatively shallow in the zwitterionic micelles. 
This hypothesis is favorably supported by the observation that SP-B63-78, consisting of the 
C-terminal half of Mini-B, takes a deeper position inside anionic phopspholipid-containing 
bilayers than purely zwitterionic bilayers [162]. However, despite the differences in 
electrostatic component of peptide/micelle interactions, the helical secondary structure of 
Mini-Box is unlikely to be drastically different in two micelle environments. 
90 
The presence of Gly18 peak in the HSQC spectra of Mini-Box in pure anionic or 
mixed micelles, but its disappearance from the spectra in pure zwitterionic micelles may 
directly be attributed to Mini-Box's differential electrostatic interactions with different 
micelle types. It is conceivable that the two Gly18-flanking positively charged amino acids, 
Lys17 and Arg20, experience strong electrostatic attractions from negatively charged 
headgroups of SDS and LMPG micelles. As a result, although the middle loop may be 
structurally flexible, the exchange between the conformations in these micelles, if any, is 
very slow, as pointed out earlier. In contrast, since DPC and LMPC headgroups contain both 
positive and negative charges, their interactions with positively charged Lys17 and Arg20 
would be much weaker and hence the loop region may be much more flexibile. Thus, an 
exchange between conformations is likely occurring in these micelles at an intermediate rate 
which, due to substantial line broadening, causes the Gly 18 HSQC peak to disappear. 
An additional novel result from this part of my research is an indication about the 
formation of the mixed LMPCILMPG micelles. From the DOSY experiments, for each type 
of micelles and peptide/micelle complex, two separate values of translational diffusion 
coefficients are calculated using the attenuation of the two sharpest proton peaks. For LMPC, 
LMPG and LMPC/LMPG mixture, each signal attenuation curve constitutes a single linear 
fit with less than 0.05% standard deviation and hence yields a single diffusion coefficient. 
Also, the two diffusion coefficients for each micelle type, including the LMPC/LMPG 
mixture, vary by less than 1% and thus are virtually the same. Therefore, there is only one 
homogeneous micelle structure present for each of the LMPC, LMPG or mixed 
LMPC/LMPG systems. The hydrodynamic diameters of these micelles, calculated using the 
measured diffusion coefficients, are - 7.2, - 8.3 and - 8.3 nm, respectively. The diameters 
of pure LMPC and LMPG micelles are quite different, but interestingly, the diameters of 
LMPG micelles and LMPCILMPG mixture are equivalent, although the mixture only 
contains 15% LMPG. Hence, the mixture sample consists of micelles formed from LMPC 
and LMPG together rather than their own separate micelles. Reappearance of the strong 
Gly18 peak in the HSQC spectra of Mini-Box in LMPCILMPG mixture also indicates to the 
formation of a mixed micelle system. Had there been separate micelles in the mixture, the 
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Gly 18 peak would not be present or would be very weak, since in LMPC micelles, which 
would then represent 85% of the micelle population in the mixture, the peak is absent. 
The strong reappearance of Mini-Box's Gly18 HSQC peak in the mixed LMPC/ 
LMPG system has another important implication. It shows that as little as 15% LMPG is 
enough to induce the same structure/dynamics ofthe middle loop as is seen in 100% LMPG. 
This likely indicates Mini-B's specificity, or at least a preference of interaction, for anionic 
amphiphiles over zwitterionic amphiphiles: In native lung conditions, the full-length SP-B 
may also exhibit similar behavior and preferentially bind lipids with PG headgroup from a 
pool that includes lipids with PC headgroup too. However, Mini-B interacts with PC-type 
lipid molecules as well. The parent protein SP-B may thus bind DPPC or other PCs also and 
contribute to the large scale rearrangement of lipids and stabilization of complex structures 
required for optimum surfactant function. 
Given the amphipathic profile of Mini-B, it is not unusual that the peptide would 
interact with amphiphiles such as detergents or lipids and take on a folded conformation in 
micelle environments. What is more intriguing, the peptide interacts differentially with 
amomc and zwitterionic surfactant phospholipid analogues. The strength of cationic 
Mini-B's binding with the micelles apparently depends on the charge profile of the micelle 
headgroups. Due to the variation in electrostatic component of interactions, Mini-B is 
probably loosely bound to the zwitterionic micelles and stays close to the surface but tightly 
bound to the anionic micelles and lies much deeper. There also exist subtle differences in 
Mini-B's structures in various micelle systems. The tertiary structures of oxidized and 
reduced Mini-B, however, appear substantially dissimilar even in a particular micelle 
environment. Mini-BREo takes on a single structure but Mini-Box exhibits a degree of 
conformational heterogeneity in all micelle systems. Furthermore, the structural flexibility or 
dynamics of Mini-Box are quite different in anionic versus zwitterionic micelles, at least for 
the middle loop. These findings about Mini-B, the most biologically active fragment of SP-B 
produced so far, help in figuring out some key features of SP-B, such as its conformation in 
native lung conditions and its interactions with different surfactant phospholipids. 
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SP-A in 
Chapter 5 
odel Surfactan · Li , tds: 
Conformat·ons and In act"'ons 
Note: SP-A was collected from cow lungs supplied by Ray Bishop (Bishops Meat, 
Foxtrap, NL). Isolation and purification of the protein was performed by Donna 
Jackman (Booth lab, Biochemistry, MUN). 
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5.1 Overview 
Surfactant protein A (SP-A) is a glycoprotein and, by weight, the most abundant 
protein component of the lung surfactant system [163]. Under native conditions, SP-A is 
presumed to be an octadecamer constructed by six trimers [164] although other smaller 
oligomers also coexist [165]. The monomer of human SP-A, and also of the bovine SP-A 
used in this study, consists of 248 amino acids [56] but its molecular weight varies from - 28 
to - 36 kDa depending on the extent of post-translational modifications [166]. SP-A belongs 
to the structurally homologous family of innate immune defense proteins known as collectins, 
so named for their collagen-like and lectin domains. SP-A consists of four structural domains: 
(1) a short N-terminal domain involved in intermolecular disulfide bond formation, (2) a 
proline-rich collagen-like domain important for oligomerization, (3) an a-helical coiled coil 
neck domain involved in trimerization, and ( 4) a globular C-terminal carbohydrate 
recognition domain (CRD) [17, 53, 167]. Figure 5.1 shows a schematic diagram of the 
structural domains of SP-A and how its octadecameric structure is assembled. 
N-ter Collagen-like Neck Carbohydrate 
Segment domain region recognition domain 
Monomer 
Trimer 
Octadecamer 
Figure 5.1 : A model for SP-A monomer, 
trimer and octadecamer, based on Ref. [53]. The 
protein consists of four distinct structural 
domains [17, 53]. The neck domains of three 
monomers become associated as a rigid a-
helical coiled-coil and the collagen-like domains 
fold into a staggered collagen triple-helix. A 
trimeric subunit is tethered by disulfide linkages 
in theN-terminal domains. Six trimeric subunits 
further assemble as an octadecamer by lateral 
association of the N-terminal halves of the 
triple-helices forming a stem. 
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Substantial evidence indicates that SP-A is a major player in innate host-defense and 
inflammatory immunomodulator processes of the lung [5, 57]. SP-A has been shown to bind 
to a broad range of microorganisms, including bacteria, fungi, viruses and mite extracts [ 168, 
169]. The binding neutralizes, agglutinates and/or enhances the uptake of pathogens by 
phagocytes of the innate immune system [17]. In vitro studies have also presented a long list 
of SP-A' s surfactant-related activities. SP-A mediates the formation of tubular myelin when 
added to DPPC, PO and SP-B mixtures in the presence of Ca2+ [59, 170], enhances 
adsorption of phospholipids along the air-water interface in a concerted action with SP-B (62, 
171 ], induces Ca2+ dependent aggregation of lipid vesicles with or without SP-B or SP-C 
(172, 173] and reduces inhibition of surfactant activity by foreign lipid binding proteins or 
serum lipoproteins [174, 175]. 
Several biophysical studies have indicated an in vitro interaction, either direct or 
indirect, between SP-B and SP-A [59, 62, 170, 171] that may be important in lung surfactant 
function. I have attempted to directly probe the interaction between Mini-B and SP-A in the 
presence of micelles composed of model surfactant lipids LMPC, LMPG and mixed 
LMPC/LMPG, alongside SDS and DPC (Chapter 6). In Chapter 4, I have reported the 
findings on Mini-B's interactions with these micelles along with its conformation. In this 
chapter, I report the findings on SP-A's conformation and lipid interactions under the same 
micelle conditions obtained using proton and diffusion NMR. These two chapters provide the 
foundation for investigating Mini-B/SP-A interaction, if any, in the presence of surfactant 
lipid analogues. 
5.2 Materials and Methods 
5.2.1 Protein Isolation and Purification 
The natural bovine SP-A used in these studies were collected from the lungs of young 
cows slaughtered at a local farm (Bishops Meat, Foxtrap, Newfoundland). Isolation and 
purification of SP-A were conducted by Donna Jackman (Booth lab, Biochemistry, Memorial 
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University of Newfoundland). The lungs were lavaged with 0.15 M NaCl solution and the 
lavage was centrifuged at 800g for 10 minutes. The supernatant was centrifuged at 7000g for 
60 minutes. The pellet was resuspended in 5 mM Tris-HCl/100 mM NaCl/1.64 M NaBr (pH 
7.4) and centrifuged overnight at 81500g. The pellicle was resuspended in 5 mM Tris-
HCI/1 00 mM NaCl (pH 7.4) and centrifuged at 65000g for 2 hours. SP-A was purified from 
the surfactant pellet by the method of Haagsman et al. [176] as follows. The surfactant pellet 
suspended in water was injected into stirred !-butanol and then centrifuged at lOOOOg for 20 
minutes. The precipitate was dried under nitrogen and washed twice in 10 mM Hepes/1 00 
mM NaCl/20 mM octyl ~-D-glucopyranoside (pH 7.4). Each wash was followed by 
centrifugation at lOOOOOg for 30 minutes. The material that was insoluble in the above buffer 
was suspended in 5 mM Hepes (pH 7.4) and the solution was dialyzed against 5 mM Hepes 
(pH 7.4). The dialyzed material was centrifuged at lOOOOOg for 30 minutes and the 
supernatant, which contained the purified SP-A, was concentrated using Amicon ultra 
centrifugal filters (Fisher Scientific, Ottawa, ON) and stored at -20 °C. The molecular mass 
of the final product was confirmed by SDS-polyacrylamide gel electrophoresis (PAGE) or 
matrix-assisted laser desorption/ionization -'time-of-flight (MALDI-TOF) mass spectrometry 
performed at the CREAIT Network facility at Memorial University of Newfoundland. The 
concentration of SP-A in Hepes buffer was confirmed by spectrophotometric analysis. 
5.2.2 Sample Preparation 
The NMR samples used in these studies were prepared from different preparations of 
SP-A. First, samples of SP-A alone (i.e., without detergents/lipids) were prepared in aqueous 
solution (90% H20 plus 10% D20) containing 0.4 mM DSS, 0.2 mM NaN3 and 4.5 mM 
Hepes. SP-A/micelle samples were then prepared by adding the required amounts of 
detergents/lipids. At least two samples were prepared for each micelle system (except for 
SDS) with varying ratios of the protein and detergent/lipid using different SP-A preparations. 
However, for each sample, the molar concentration of the lipid was kept at least 200 times 
higher than the monomeric concentration of the protein. The exact composition of each 
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sample is described in the results section with SP-A molar concentration specified as if it 
were 100% monomeric. Deuterated (98%) SDS and DPC were purchased from Cambridge 
Isotope Laboratories (Andover, MA). Non-deuterated LMPC and LMPG, purchased from 
Avanti Polar Lipids (Alabaster, AL) were used, as deuterated versions of these lipids are not 
available commercially to date. Hepes was also in the non-deuterated form. The pH of the 
samples was set at 6.9 to match the physiological condition in the lung. The pH was set using 
NaOH and HCl solutions without taking the isotope effects into account. 
5.2.3 NMR Data Collection and Processing 
A set of ID 1H and 2D DOSY experiments were performed for SP-A alone, 
individual micelle systems and SP-A/micelle complexes on a Bruker A vance II 14.1 Tesla 
(600 MHz) spectrometer (Billerica, MA) equipped with z-gradients and an inverse triple 
resonance TXI probe. The NMR data were collected and processed using the Bruker Topspin 
2.0 software. The pulse length (PI) and the transmitter offset (01) were optimized for each 
sample before running the full set of NMR experiments. The 1 D 1H spectra were acquired at 
37 oc to match the physiological temperature. In 1 D 1H experiments, data were collected 
with either 256 or 160 scans (indicated in the figure captions) using the water-gate water 
suppression technique [146] and processed using an exponential apodization function with 1 
Hz line broadening. The 2D DOSY spectra of SP-A alone and SP-A in SDS/DPC micelles 
were acquired at 37 °C. However, the DOSY spectra of SP-A in LMPC/LMPG micelles were 
acquired at 25 oc to minimize the effect of thermal convection. The diffusion time was kept 
constant at 100 ms. The gradient pulse length was optimized for each sample and set between 
5 and 8 ms. The maximum amplitude of the gradient strength was 35 G/cm and the 1H 
signals were attenuated in 32 steps. The translational diffusion coefficient was determined 
from the slope of the signal attenuation curve plotted using Eq. 2.17. The hydrodynamic 
diameter was calculated using the Stokes-Einstein equation [Eq. 2.20]. The viscosity of pure 
water was used for the viscosity of solution in the calculation and the values were 8.91 x 10-4 
kg/m.s at 25 oc (298 K) and 6.92 X 1 o-4 kg/m.s at 37 oc (31 0 K). 
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5.3 Results 
5.3.1 SP-A Alone in Aqueous Solution 
Before studying the conformation of SP-A in lipid mimetic micelle environments and 
its interactions with surfactant lipid analogues, I first investigated its conformation when 
alone in the aqueous environment (90% H20 and 10% D20). Also, since SP-A was collected 
from a natural source (cow lungs) and the protein preparation (isolation and purification) was 
performed using different batches as required, acquisition of a 10 1H spectrum was routinely 
performed for each preparation of SP-A in aqueous solution to check the consistency of the 
samples. The 10 1H spectra of all SP-A preparations looked almost identical confirming the 
consistency among different protein preparations. Figure 5.2 shows one such 1 D 1 H spectrum 
of SP-A alone in 90% H20 and 10% D20 in the presence of 4.5 mM Hepes. The intense 
proton signals are mostly generated by Hepes and OSS. However, a few broad signals from 
SP-A, having a much lower intensity, are also present. The overall appearance of the 
spectrum is consistent with a high molecular mass protein specimen. The observed protein 
signals, including the 2 or 3 peaks in the amide proton region, are likely generated by some 
highly mobile region(s) of SP-A (e.g., a flexible loop) undergoing fast motion or 
conformational exchange. Therefore, under this condition, SP-A is likely present in a large 
oligomeric form, perhaps the long-presumed native octadecameric form with a molecular 
weight of- 550 kDa. If there are any smaller subunits also present, such as monomers or 
trimers, those are most probably associated with the large structures. 
The size(s) of SP-A particles in the aqueous solution, as determined from 
translational diffusion measurements, confirm the presence of a large structure of the protein. 
Two values of the diffusion coefficients of SP-A are determined from the 2D OOSY spectra 
(Figure 5.3) using the attenuation of the peak at 2.03 ppm and the HN region. The observed 
diffusion coefficients are 5.40 x 10"11 and 6.52 x 10"11 m2/s, respectively. The corresponding 
hydrodynamic diameters, calculated using the Stokes-Einstein equation (Eq. 2.20), are 12.15 
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and 10.06 run, respectively. The apparent faster diffusion implied by the HN region is likely 
a result of the exchange between the labile amide protons and the solvent protons/deuterons. 
Thus the translational diffusion measurements indicate that the hydrodynamic diameter of 
SP-A alone is greater than 12 nm under the conditions used in this study. 
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Figure 5.2: ID 1H spectrum of0.2 mM SP-A in 90% H20 and 10% D20 , in the presence of 
4.5 mM Hepes at pH 6.9 and temperature 37 °C. The molar concentration of SP-A 
corresponds to the monomeric form of the protein. The spectrum was acquired using 256 
scans and processed with I Hz line broadening. 
99 
A. SP-A (0.2 mM) ~ 
••••• SP-A peak at 2.03 ppm Cll ........ B N a ooooo SP-A HN region 
I 
...._.. 
I ~ OJ) I~ ..s 0 0.0 0 
....-< ....-. 
-
I 0 r ~ -(/) -1 .0 .._ -..:.t. 
-> I ~ I I ,, 
Il l I 
c 
-2.0 0 I 0\ I 
II 
-3.0 
V) 
0 5 10 15 20x109 00 
I 
2 2 k [= (y8g) (6-8/3)] (s/m ) 
10 8 6 4 2 1H (ppm) 
c Peak SP-A (alone) 
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ppm X 10-ll (m2/s) (nm) 
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(± 0.01) 
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Figure 5.3 : Size of SP-A as indicated by translational diffusion. Left panel (A) shows 2D 
DOSY spectra of 0.2 mM SP-A in aqueous solution (90% H20 plus I 0% D20), in the 
presence of 4.5 mM Hepes at pH 7 and temperature 37 °C. Linear fits in the right panel (B) 
show the attenuation of the peaks at 2.03 ppm and HN region obtained from the DOSY data. 
The observed diffusion coefficients, represented by the slopes of the signal attenuation 
curves, and the corresponding hydrodynamic diameters, calculated using the Stokes-Einstein 
equation (Eq. 2.20), are shown in the table (C). 
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5.3.2 SP-A in SDS Micelles 
Studies of SP-A's conformation in the micelle environments and its lipid interactions 
began with smaller anionic micelles composed from the detergent SDS. Figure 5.4 shows the 
1D 1H spectrum of SP-A in SDS micelles. Surprisingly, SP-A displays a major 
conformational change with the addition of SDS as the enlarged 6-9 ppm region shows a lot 
more signals from the backbone amide protons with increased intensity when compared to 
SP-A alone. The signals are broad and overlapped, as would be expected from a multimeric 
protein consisting of 248 amino acids and bound to a micelle, but well-dispersed. As 
elaborated in the discussion, the well-dispersed HN signals may arise from a subpopulation 
of the protein having a lower molecular mass and hence a smaller oligomeric form that 
dissociate from the higher molecular mass oligomers in the presence of SDS micelles. 
The translational diffusion coefficients, obtained from the 2D DOSY spectra (Figure 
5.5), confirm the presence of lower molecular mass SP-A species when the protein is bound 
to the micelles. The observed diffusion coefficient of SP-A/SDS complex, determined from 
the attenuation of the HN signals, is 1.166 x 10-10 m2/s, which represents a hydrodynamic 
diameter of 5.63 nm. Thus the apparent size of SP-A/SDS complex is substantially smaller 
than the size of SP-A alone (hydrodynamic diameter - 12.2 nm). The DOSY data also 
illustrates the effect of SP-A on the size or shape of SDS micelles. The diffusion coefficient 
of micelles, determined from the SDS peak at 1.22 ppm, decreases from 5.323 x 10-10 to 
1.670 x 10-10 m2/s upon binding to SP-A. Therefore the hydrodynamic diameter of SDS 
micelles apparently increases from 1.23 to 3. 93 nm as a result of SP-A binding. 
The apparent size of SDS micelles found in this study is substantially smaller than 
that of earlier study (Chapter 4, Page 69). Since the DOSY data corresponds to a weighted 
average from the free and micelle-bound molecules, the smaller apparent size may be the 
result of a faster exchange between the two SDS species. This is likely due to the lower SDS 
concentration of 40 mM used in this study, as opposed to 150 mM concentration used in the 
previous study. The faster exchange of SDS molecules may also be the reason for the 
difference in the apparent hydrodynamic diameter of SP-A/SDS complex, which is 5.63 nm 
when determined from the protein HN region, but 3.93 nm when determined from the SDS 
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1.22 ppm peak. Also, the signal attenuation curves of pure SDS micelles, plotted using either 
of the peaks at 0.80 or 1.22 ppm, are not fit well by a single linear fit (Figure 5.5). This likely 
indicates the presence of multi-size SDS assemblies at lower concentrations and a relatively 
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Figure 5.4 : 1D 1H spectra of (A) 0.2 mM SP-A (alone) and (B) 0.2 mM SP-A in 40 mM 
SDS, in the presence of 4.5 mM Hepes. The pH of both samples was 6.9 and the experiments 
were performed at 37 °C. The spectra were acquired using 256 scans and processed with 
1 Hz line broadening. The intense peaks seen in the spectrum (B) are from DSS and Hepes. 
The 6-9 ppm regions, exhibiting the protein HN signals, are enlarged and shown in the 
bottom panel (C). 
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slower exchange between the species. However, the single linear fits for the SDS/SP-A 
complex indicate a single average size and a relatively fast exchange between the species. 
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Figure 5.5 : SDS micelles (ooo) and SP-A/SDS 
complex (•••) sizes as indicated by translational 
diffusion. Upper panels show 2D DOSY spectra of 
(A) 40 mM SDS and (B) 0.2 mM SP-A + 40 mM 
SDS, at pH 7 and temperature 37 °C. Linear fits (C 
and D) show the attenuation of the SDS peaks at 
0.80 and 1.22 ppm and the protein HN region 
obtained from the DOSY data. For SDS micelles, the 
fits correspond to the larger size only. The observed 
diffusion coefficients, represented by the slopes of 
the curves, and the corresponding hydrodynamic 
diameters, calculated using the Stokes-Einstein 
equation (Eq. 2.20), are shown in the table (E). 
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5.3.3 SP-A in DPC Micelles 
The conformation of SP-A and its lipid interactions were studied next in the 
zwitterionic DPC micelle system. The ID 1H spectra of two SP-A samples, with different 
protein/lipid concentrations (indicated in the figure captions), look almost identical (Figure 
5.6). As in SDS, SP-A displays a major conformational change in DPC micelles when 
compared to SP-A alone. The enlarged 6-9 ppm region shows well-dispersed signals with 
increased intensity, although, as expected, . the signals are broad and overlapped. Again, the 
proton signals are generated most probably by a subpopulation of lower molecular mass 
SP-A species that are dissociated from the large oligomers in the presence of DPC micelles. 
Furthermore, similar to SDS, the translational diffusion measurements support the 
presence of smaller molecular mass SP-A species and formation of a complex through 
interactions between SP-A and DPC micelles. The observed diffusion coefficient of pure 
DPC micelles, as determined from the attenuation of the DPC peak at 1.22 ppm, decreases 
from 3.37 x 10-10 to 1.92 x 10-10 m2/s upon binding to SP-A. This corresponds to an apparent 
increase of the micelle hydrodynamic diameter from 1.95 to 3.42 nm. The observed diffusion 
coefficient of the complex, when determined from the attenuation of the SP-A HN region, is 
1.62 x I o-10 m2/s and the corresponding hydrodynamic diameter is 4.05 nm. Thus the 
apparent size of the SP-A/DPC complex is much smaller than SP-A alone(~ 12.2 nm). 
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Figure 5.6 : 1D 1H spectra of (A) 0.20 mM SP-A in 40 mM DPC (acquired using 256 scans) 
and (B) 0.10 mM SP-A in 20 mM DPC (acquired using 160 scans), in the presence of 4.5 
mM Hepes. Samples were made from two different preparations of SP-A. The pH of both 
samples was 6.9 and the experiments were performed at 37 °C. The spectra were processed 
with 1 Hz line broadening. The intense peaks seen in the spectra are from DSS and Hepes. 
The 6-9 ppm regions, exhibiting the protein HN signals, are enlarged and shown in the 
bottom panel (C). 
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Figure 5.7 : DPC micelles (ooo) and SP-A/DPC 
complex (•••) sizes as indicated by translational 
diffusion. Upper panels show 20 DOSY spectra of 
(A) 20 mM DPC and (B) 0.10 mM SP-A + 20 mM 
DPC, at pH 7 and temperature 37 °C. Linear fits (C 
and D) show the attenuation of the DPC peaks at 
0.80 and 1.22 ppm and the protein HN region 
obtained from the DOSY data. The observed 
diffusion coefficients, represented by the slopes of 
the curves, and the corresponding hydrodynamic 
diameters, calculated using the Stokes-Einstein 
equation (Eq. 2.20), are shown in the table (E). 
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5.3.4 SP-A in LMPC Micelles 
To gain an insight into SP-A's conformation in a more physiologically relevant lipid 
environment and to probe SP-A's interactions with surfactant phospholipid analogues, the 
investigations continued with LMPC, LMPG and mixed LMPCILMPG micelles. First 
studied was SP-A in zwitterionic micelles composed of LMPC that mimic the lung lipid 
environment created by the most abundant surfactant phospholipid DPPC. Figure 5.8 shows 
the 1 D 1H spectra of two SP-A samples having two different protein/lipid ratios (indicated in 
the figure captions). The enlarged 6-9 ppm regions of both samples look almost identical. 
The HN signals of SP-A in LMPC are also not substantially different from those in DPC. 
However, the signals are slightly broader and likely more overlapped as SP-A is now bound 
to the larger LMPC micelles. The overall appearance of the 1 D 1 H spectrum further indicates 
the dominance of a lower molecular mass SP-A subpopulation in the LMPC micelle 
environment. 
The 2D DOSY experiments (Figure 5.9) confirm the presence of a smaller SP-A 
oligomer in LMPC micelles. The - 10.3 run hydrodynamic diameter of SP-A/LMPC 
complexes, calculated using the observed translational diffusion coefficient of- 4.8 x 1 o-tt 
m
2/s, is much larger than the SP-A/SDS or SP-A/DPC complexes, but still smaller than SP-A 
alone (- 12.2 run). The increase from the - 7.3 run hydrodynamic diameter of pure micelles 
upon addition of SP-A, calculated using the observed diffusion coefficient of - 6.8 x 10-tt 
m
2/s, confirms the binding ofLMPC micelles to SP-A molecules. 
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Figure 5.8 : 1 D 1H spectra of (A) 0.20 mM SP-A in 100 mM LMPC and (B) 0.25 mM SP-A 
in 50 mM LMPC, in the presence of 4.5 mM Hepes. Samples were made from two different 
preparations of SP-A. The pH of both samples was 6.9 and the experiments were performed 
at 37 oc. The spectra were acquired using 160 scans and processed with 1 Hz line broadening. 
The intense peaks seen in the spectra are from LMPC, Hepes and DSS. The 6-9 ppm regions, 
exhibiting the protein HN signals, are enlarged and shown in the bottom panel (C). 
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Figure S.9 : LMPC micelles (ooo) and SP-AILMPC 
complex (•••) sizes as indicated by translational 
diffusion. Upper panels show 2D DOSY spectra of 
(A) 50 mM LMPC and (B) 0.25 mM SP-A + 50 mM 
LMPC, at pH 6.9 and temperature 25 °C. Linear fits 
(C and D) show the attenuation of the peaks at 0.85 
and 1.27 ppm obtained from the DOSY data. The 
observed diffusion coefficients, represented by the 
slopes of the curves, and the corresponding 
hydrodynamic diameters, calculated using the 
Stokes-Einstein equation (Eq. 2.20), are shown in 
the table (E). 
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5.3.5 SP-A in LMPG Micelles 
The investigations on the conformation and lipid interactions of SP-A continued next 
with anionic micelles composed of LMPG that mimic the lung lipid environment created by 
the surfactant phospholipids with PG headgroups. Again, the 1 D 1H spectra were acquired 
for two different samples of SP-A having two different protein/lipid ratios (indicated in the 
figure captions) and both spectra look almost identical (Figure 5.1 0). Besides, as in the 
previously studied micelle systems, the dispersion and intensity of backbone HN signals 
indicate the presence of a smaller molecular mass species of SP-A in the LMPG micelle 
environment as well. 
The findings about the interactions between SP-A and LMPG micelles and the 
complex size, as obtained from the 2D DOSY experiments (Figure 5.11 ), are similar to the 
LMPC study. The observed translational diffusion coefficient of pure LMPG micelles 
decreases from - 5.9 X w-ll m2/s to - 4.4 X w-ll m2/s when SP-A is added. Thus, the 
hydrodynamic diameter of the micelles apparently increases from - 8.3 nm to - 11.2 nm 
when bound to the protein, which is still smaller than SP-A alone(- 12.2 nm). 
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Figure 5.10 : 10 1H spectra of (A) 0.20 mM SP-A in 100 mM LMPG and (B) 0.25 mM 
SP-A in 50 mM LMPG, in the presence of 4.5 mM Hepes. Samples were made from 
two different preparations of SP-A. The pH of both samples was 6.9 and the experiments 
were performed at 3 7 oc. The spectra were acquired using 160 scans and processed with 
1 Hz line broadening. The intense peaks seen in the spectra are from LMPG, Hepes and DSS. 
The 6-9 ppm regions, exhibiting the protein HN signals, are enlarged and shown in the 
bottom panel (C). 
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Figure 5.11 : LMPG micelles (ooo) and SP-A/LMPG 
complex (•••) sizes as indicated by translational 
diffusion. Upper panels show 2D DOSY spectra of 
(A) 50 mM LMPG and (B) 0.25 mM SP-A + 50 mM 
LMPG, at pH 6.9 and temperature 25 °C. Linear fits 
(C and D) show the attenuation of the peaks at 0.87 
and 1.28 ppm obtained from the DOSY data. The 
observed diffusion coefficients, represented by the 
slopes of the curves, and the corresponding 
hydrodynamic diameters, calculated using the 
Stokes-Einstein equation (Eq. 2.20), are shown in the 
table (E). 
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5.3.6 SP-A in Mixed LMPC/LMPG Micelles 
'' 
Lastly for this chapter, the conformation of SP-A and its lipid interactions were 
investigated in a mixed LMPCILMPG micelle system. As usual, two different protein/lipid 
concentrations were used (indicated in the figure captions) but 8.5 : 1.5 ratio of PC to PG 
was maintained to match the physiological conditions. The 1D 1H spectra of both SP-A 
samples look almost identical (Figure 5.1 2). The dispersion and intensity of the backbone 
HN signals, when compared to SP-A alone, indicate the presence of a lower molecular mass 
species of SP-A also in the mixed micelle environment. 
The smaller size of SP-A/micelle complex than SP-A alone is confirmed again by the 
2D DOSY experiments (Figure 5.13). The size-increase of mixed LMPCILMPG micelles, 
caused by the inclusion of SP-A, follows the same trend as of SP-A/LMPC and SP-A/LMPG. 
The observed translational diffusion coefficient of micelle alone is ~ 5.9 x 10- 11 m2/s but that 
of protein/micelle complex is ~ 4.6 X 1 o -I l m2/s. Thus the hydrodynamic diameter of the 
mixed micelles apparently increases from~ 8.3 nm to~ 10.7 nm when bound to SP-A. The 
size of SP-A/ LMPCILMPG complex still remains smaller than SP-A alone(~ 12.2 nm). 
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Figure 5.12 : 1 D 1H spectra of (A) 0.16 mM SP-A in 85 mM LMPC plus 15 mM LMPG and 
(B) 0.25 mM SP-A in 42.5 mM LMPC plus 7.5 mM LMPG, in the presence of 4.5 mM 
Hepes. Samples were made from two different preparations of SP-A. The pH of both samples 
was 6.9 and the experiments were performed at 37 oc. The spectra were acquired using 160 
scans and processed with 1 Hz line broadening. The intense peaks seen in the spectra are 
from LMPC, LMPG, Hepes and DSS. The 6-9 ppm regions, exhibiting the protein HN 
signals, are enlarged and shown in the bottom panel (C). 
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Figure 5.13 : LMPC/LMPG mixed micelles (ooo) 
and SP-A/LMPC/LMPG complex (•••) sizes as 
indicated by translational diffusion. Upper panels 
show 2D DOSY spectra of (A) 42.5 mM LMPC + 
7.5 mM LMPG and (B) 0.25 mM SP-A + 42.5 mM 
LMPC + 7.5 mM LMPG, at pH 6.9 and temperature 
25 °C. Linear fits (C and D) show the attenuation of 
the peaks at 0.86 and 1.28 ppm obtained from the 
DOSY data. The observed diffusion coefficients, 
represented by the slopes of the curves, and the 
corresponding hydrodynamic diameters, calculated 
using the Stokes-Einstein equation (Eq. 2.20), are 
shown in the table (E). 
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5.4 Discussion 
The innate host defense activity that SP-A performs in alveolar airspaces is essential 
to maintain the sterile condition of the respiratory surface [27, 177]. In addition, SP-A may 
also contribute to the surface activity of lung surfactant. The presence of SP-A is necessary 
for the formation of tubular myelin, considered one of the possible structural intermediates in 
constructing the surface film. Tubular myelin enhances surfactant adsorption although it is 
not essential for normal breathing in in vivo models [58]. SP-A has also been shown to 
improve the surface activity of the surfactant under several challenging conditions such as 
low surfactant concentrations [178] or presence of inhibitory plasma proteins [174] or 
oxidants [179]. The binding capabilities of SP-A to surfactant phospholipids, pathogen-
associated molecular patterns and receptors on cell surfaces depend on its complex 
oligomeric structure [180]. As presumed by the current models, SP-A assembles as a 
hexamer of trimeric subunits, i.e., a total of 18 SP-A molecules join together to form the 
quaternary structure [53]. However, there is evidence that the protein also coexists as a 
tetramer of trimers (i.e., 12 molecules), dimer oftrimers (i.e. , 6 molecules), just dimer (i.e., 2 
molecules) and even monomer (i.e., a single molecule) [165]. According to the structural 
models, the trimerization of a subunit occurs through the collagen-like and neck domains and 
a lateral association at the N-terminal region stem to form higher octadecameric structures 
[17, 53]. The oligomers are further stabilized by interchain disulfide bonds formed at the 
short N-terminal domains [167]. Researchers believe that the oligomerization of SP-A occurs 
in a zipper-like fashion along the C-terminal toN-terminal axis [181]. The high-resolution 
crystal structures of trimeric carbohydrate recognition and neck domains of rat SP-A, in both 
native and ligand-bound forms, have been determined (PDB IDs 1R13 and 1R14, [73]) but 
the complete structures of the full protein or its higher oligomers are still unavailable. 
The pnmary structure of mature SP-A is highly conserved among different 
mammalian species [ 182]. The 248-residue bovine SP-A, used in the present work, consists 
of 30 negatively charged and 26 positively charged amino acids, yielding a net charge of -4 
at neutral pH. The high proportion of charged amino acids, along with an abundance of other 
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polar amino acids, makes SP-A largely hydrophilic and hence soluble in water. However, in 
the lungs, approximately 90% of SP-A is lipid-associated, the bulk of which is within tubular 
myelin, and only 10% is in the fluid phase [183]. Therefore, interactions with phospholipids 
are presumably essential for SP-A's biological function(s). This work attempts to investigate 
the conformation of the wild-type SP-A in both aqueous and micelle environments and probe 
its lipid interactions using solution NMR. The studies start with a lipid-free simple aqueous 
solution, then proceed to the anionic and zwitterionic micelles composed of model surfactant 
lipids, and end in a mixed micelle system. The wide array of the micelle systems enable 
exploring the effects that different detergents/lipids have on the conformation of SP-A as 
well as the effects that SP-A has on the micelle structures. 
To my knowledge, this is the first attempt to study SP-A in detergent/lipid micelles 
using solution NMR. Since, there is no prior information available with which to compare the 
results obtained from my NMR experiments, theoretical values of some basic NMR 
parameters, calculated for different oligomeric forms of SP-A, help in interpreting the 
spectral features. Table 5.1 lists the predicted hydrodynamic diameter (dH), rotational 
correlation time ('tc), proton linewidth (~v 112) and relative intensity (I) for six different 
oligomeric forms of SP-A from monomer to octadecamer. The MALDI-TOF mass 
spectrometry of purified SP-A showed a monomeric molecular mass of - 29 kDa. In the 
calculation, the masses of oligomeric forms of SP-A are predicted from the number of 
molecules involved without taking the effects of post-translational modifications (e.g., 
glycosylation) into account. The hydrodynamic diameter (rH) is calculated from the equation 
(Eq. 1.45, Page 21, Ref. [123]), 
5.1 
where, V is the specific volume of the protein (taken to be 0.73 cm3.g-1) , M is the molecular 
mass ofthe protein (29000 g.mor1 and its multiples), NA is Avogadro's number (6.022 x 1023 
mor
1) and rw is the thickness of one hydration shell (taken to be 3.2 A). The rotational 
correlation time ('tc) is determined from Stoke's law ((Eq. 1.44, Page 21, Ref. [123]), 
'tc = (4JtllwrH3)/(3KsT), 5.2 
in which llw is the viscosity of the solvent, K8 is the Boltzmann constant (1.38 x 10-23 J/K) 
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and T is the absolute temperature (31 0 K). The solvent is considered to be pure H20, 
ignoring the effect of 10% D20 , and the viscosity value used is 6.92 x 10-4 kg/m.s (at 310 K 
or 37 °C). The proton resonance linewidth (t1v 112) is determined from the equation, 
L1v112 = 1.2'tc + 0.3. 5.3 
This equation is developed using the linear fit representing the proton linewidth (in Hz) as a 
function of rotational correlation time (inns) (Figure 1.6, Page 20, Ref. [123]). The spin-spin 
or transverse relaxation time (T2) is determined from the equation (Page 18, Ref. [123]), 
i1Y1 12 = l /JtT2. 5.4 
The relaxation processes follow a first-order rate equation, characterized by a characteristic 
time constant (T) or a rate constant (R) (Page 16, Ref. [119]), 
l(t) = Ioexp(-t/T) = Ioexp(-Rt). 5.5 
Thus the relative signal intensity of SP-AMultimer 0Multimer) with respect to SP-AMonomer 
0Monomer) can be calculated from, 
IMultimerfiMonorner = T 2(MultirneryT 2(Monomer)· 5.6 
The theoretical calculation indicates, if SP-A is present in the octadecameric form, the 
proton signallinewidth would be~ 147Hz (i.e., 0.245 ppm on a 600 MHz spectrometer) and 
thus the weak signal intensity caused by the massive line-broadening would probably bury 
almost all signals under the noise. However, if SP-A is present in the monomeric form, the 
signallinewidth would be - 11 Hz (i.e., 0.018 ppm on the same 600 MHz spectrometer) and 
hence intense signals would appear in the lD 1H spectrum. For the intermediate oligomers of 
SP-A, the 1 D 1H spectra would probably contain a number of signals but they would likely 
be substantially broad and overlapped. The intensity of proton peaks would also decrease as 
SP-A oligomers become larger. For example, in comparison with SP-AMonomer, SP-Aoctadecamer 
would retain only 7% of the relative peak intensity. 
Since the 1 D 1H spectrum of SP-A alone in aqueous solution (Figure 5.2) contains 
only a few weak HN signals, the spectrum is consistent with a high molecular mass species 
of SP-A, presumably the wild-type octadecameric form. The observed signals are likely 
generated by some highly mobile regions of the protein (e.g., flexible loops) that are 
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exhibiting fast motions on the NMR time-scale due to conformational exchange or other 
internal dynamics. Prevalence of large assemblies of SP-A, when alone in water, is not 
unexpected as the protein is isolated and purified from a natural source and is not exposed to 
any denaturing treatment. It is difficult to comment on the degree of SP-A's structuring when 
alone in water from such low-signal 10 1H spectrum. However, since SP-A is known to be 
water-soluble and the protein preparation followed the same procedure as previously used in 
all kinds of functional studies, it is plausible that SP-A is properly folded in the aqueous 
environment but, as predicted from the theoretical calculation, the overall size of the 
oligomeric assembly is too large to yield any well-dispersed and intense HN signals. 
Table 5.1 : Estimates of rotational correlation times, proton linewidths and relative signal 
intensities for SP-A oligomers at 37 °C. The increase of SP-A' s mass due to post-
translational modifications is not taken into account. The calculations are performed using 
the equations and plot from Refs. [123] and [119]. 
Oligomeric No. of Molecular Hydrodynamic Rotational Proton Relative 
Form SP-A Mass Diameter Correlation Time Linewidth Intensity 
of SP-A Molecules (Da) (nm) (ns) (Hz) (%) 
Monomer 1 29000 4.7 8.8 10.9 100 
Dimer 2 58000 5.8 16.2 19.7 55 
Trimer 3 87000 6.5 23.3 28.3 39 
Hexamer 6 174000 8.0 43 .8 52.9 21 
Dodecamer 12 348000 9.9 83.4 100.3 11 
Octadecamer 18 522000 11.3 122.0 146.7 7 
Much to my surprise, the 1D 1H spectra of SP-A in all types of micelles exhibit 
strikingly strong and dispersed HN signals when compared to SP-A alone (Figures 5.14 A 
and B). This implies that the protein/micelle complex is substantially smaller than the protein 
alone and tumbles much faster in the solution (Table 5.1). The spectra of micelle-bound 
SP-A are thus consistent with a lower molecular mass species, i.e., a smaller oligomeric form 
of the protein. However, the HN signals are still broad and severely overlapped. Again, this 
is not unexpected from a large micelle-bound protein, especially when the protein is likely 
present in multimeric forms. The spectral features also indicate that SP-A is structured in all 
micelle environments. 
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Figure 5.14 : Overlay of the HN (6-9 ppm) regions of I D 1H spectra of SP-A in different 
environments. The spectra are the same as presented in the Results section. The height of the 
top spectrum in each panel has been scaled to match the other(s). 
Translational diffusion measurements confirm a substantial reduction in the size of 
SP-A, and hence in its mass and oligomeric state, when the micelles are added. Table 5.2 
shows the molecular masses of in-water and in-micelle SP-A species, estimated from the 
experimentally determined translational diffusion coefficients (De), and the matching 
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oligomeric states of the protein. For the micelle-bound form, the molecular mass of SP-A is 
determined as follows. The structures of pure micelles, as well as SP-Nmicelle complexes, 
are considered to be perfectly spherical. The volume of the sphere (V) is determined from the 
hydrodynamic diameter ( dH) calculated from the translational diffusion coefficient (De), 
and 
dH = (Ks T)/(3nT]Dc), 
V = (4/3)n(dH12l 
5.6 
5.7 
The volume of SP-A (V SP-A) is determined from its contribution to the SP-Nmicelle complex, 
V SP-A = V SP-NMicelle - V Micelle· 5.8 
The molecular mass of SP-A (MsP-A) is calculated from its volume using the average protein 
density (PProtein, taken to be 1.37 g/cm\ 
MsP-A = PProtein X V SP-A· 5.9 
Table 5.2 : Molecular masses of SP-A species, calculated using the experimentally 
determined translational diffusion coefficients, and their matching oligomeric states. 
Sample Complex Micelle SP-A Estimated Matching 
Composition Volume Volume Volume SP-A Mass Oligomeric 
(cm3) (cm3) (cm3) (g) (Da) State 
SP-A Alone 9.39E-19 XXX 9.39E-19 1.29E-18 774,799 18+ 
SP-NSDS 9.34E-20 9.74E-22 9.25E-20 1.27E-19 76,284 - 2-3 
SP-NDPC 3.48E-20 3.88E-21 3.09E-20 4.23E-20 25,493 - 1 
SP-NLMPC 5.64E-19 2.00E-19 3.63E-19 4.98E-19 299,892 - 6-9 
SP-AILMPG 7.36E-19 2.98E-19 4.37E-19 5.99E-19 360,789 - 6-9 
SP-AILMPCILMPG 6.43E-19 3.05E-19 3.38E-19 4.64E-19 279,185 - 6-9 
As per the estimation, SP-A, when alone in the aqueous solution, predominantly 
exists in an octadecameric or even larger form. However, when the smaller SDS/DPC 
micelles are added, the large SP-A assembly appears to dissociate and the protein takes on a 
much smaller form in the monomer to trimer range. In contrast to both extremes, when the 
larger LMPCILMPG micelles are added, SP-A apparently takes on an intermediate 
multimeric form between two and three trimers. Since this diffusion-based mass-estimation 
relies on many approximations, such as spherical structures of the particles, free diffusion 
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and the same number of detergent/lipid molecules in both pure micelles and protein/micelle 
complexes, as well as ignores the effects of post-translational modifications and exchanges 
between free and micelle-bound species, an exact measure of the molecular mass is not 
expected. However, the calculation clearly illustrates that the mass of SP-A species are 
reduced substantially when the micelles are added to the aqueous form of the protein. The 
reduction of SP-A mass, and hence its oligomeric state, is also verified by a non-reducing 
SDS-PAGE that demonstrates a large assembly of the protein when alone but between 
monomers and trimers in the presence ofSDS and DPC (data not shown). 
The question that immediately emerges is what is causing the larger SP-A species to 
dissociate when the micelles are added? Most likely not all of the monomers in the 
supramolecular SP-A assembly are covalently attached by disulfide bonds and many of the 
subunits are associated only through non-covalent protein-protein interactions. The addition 
of amphipathic lipids/detergents appears to disrupt these non-covalent interactions thus 
causing the sub-units to dissociate. It is plausible that the electrostatic interactions, and 
perhaps the hydrophobic interactions as well, between the protein and the lipid/detergent 
molecules overwhelm many of SP-A's inter-subunit non-covalent interactions and thus 
micelle complexes containing smaller SP-A oligomers are formed. However, the protein-
micelle interactions may not dissociate all of the subunits and a subpopulation of 
octadecameric SP-A species may still prevail in the micelle environments but just that the 
complexes are too large to generate any observable NMR signals. Also, the oligomeric state 
of SDS/DPC-bound SP-A species (between a monomer and a trimer) appears to be 
substantially smaller than LMPC/LMPG-bound SP-A species (between two and three 
trimers). This indicates, the larger the size of micelles, the less affected the supramolecular 
assembly of the protein and, presumably, . the less affected the non-covalent interactions 
among the protein subunits. Despite the dramatic effects of the micelles on the degree of SP-
A's oligomerization, it is extremely unlikely that SP-A monomers that are covalently 
attached through disulfide bonds also dissociate as a result of protein-micelle interactions. 
The next question that arises is why SP-A is present in smaller oligomeric forms in 
the micelles when its predominant conformation is widely referred to as octadecameric? The 
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long-presumed octadecamic structure of SP-A is elucidated by analytical methods such as gel 
filtration analysis and sedimentation equilibrium studies [ 184] and also verified by 
transmission electron microscopy (TEM) [185]. However, these studies are performed with 
purified SP-A and in lipid-free aqueous environments. In contrast, the gel filtration and 
sucrose density gradient centrifugation of unpurified SP-A show that the protein does not 
exist purely as fully assembled octadecamers but is consistently found in smaller oligomeric 
forms [ 165]. The TEM image of recombinant SP-A by itself also displays smaller aggregates 
like tetramers, trimers and dimers, and even monomers under mild reducing condition [185]. 
The TEM image of tubular myelin, on the other hand, shows X-shaped structures in the 
square lattice regions [61] which are modeled as SP-A octadecamers [17]. Thus the 
commonly referred pure octadecameric assembly of SP-A appears to be an over-
simplification about the quaternary structure of the protein. 
Another question would be about the differences in SP-A's conformation and lipid 
interactions between the micelle systems. The HN signals seen in the I D 1H spectra of SP-A 
in DPC, LMPC and LMPG are quite similar but noticeably different from SDS (Figures 5.14 
C and D). Hence, SP-A likely takes on a similar tertiary structure in DPCILMPC/LMPG 
micelles that contain identical headgroups to surfactant PC and PG, but may take on a 
different structure in SDS micelles that contain a non-surfactant headgroup. Moreover, the 
DOSY data reveals that the oligomeric state of SP-A in the larger micelles (LMPC/LMPG) 
are substantially higher than the smaller micelles (SDS/DPC). SP-A's micelle interactions 
thus appear to be dependent on the size of the micelles. These intriguing differences in the 
conformation and mechanisms of lipid interactions may be important for SP-A's functions in 
the native lung environment. 
Many of SP-A's biological functions are thought to come about via its interactions 
with a broad range of amphipathic lipids present in lung surfactant and cellular membranes or 
bacterial envelopes [186]. Several studies indicate that SP-A binds avidly to DPPC but less 
strongly to unsaturated PCs [ 187, 188]. SM is also demonstrated as a preferred ligand of SP-
A [189]. However, there are reports that claim SP-A does not bind to PG, except to DPPG, 
and to PI, PE or PS [53]. Morphological studies show that in vitro reconstitution of SP-A 
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with DPPC-rich phospholipid bilayers containing SP-B in the presence of calcium produces a 
lattice-like array of bilayer structures similar to that of the native tubular myelin [59, 60]. 
Other than phospholipids, SP-A binds to many carbohydrates, preferentially to mannose and 
fucose that are commonly found on fungal and microbial surfaces [190]. SP-A also interacts 
with rough lipopolysaccharide (Re-LPS) and permeabilizes bacterial membrane through self-
aggregation [191]. In relation to the surface activity, interactions of SP-A with lipid extract 
surfactant (LES), an organic extract of lung surfactant containing all of the phospholipids and 
SP-B and SP-C, has been shown to reduce the minimum surface tension that the surfactant 
films can achieve when they are cyclically compressed and expanded [174]. 
SP-A's biological roles, in relation to either anti-microbial activities or surfactant 
biophysical activities, are almost always attributed to its octadecameric structure and 
preferential interactions with DPPC [17, 53, 56]. However, this part of my work 
demonstrates at least two novel features about SP-A's conformation and lipid interactions. 
First, the micelle-bound SP-A exists predominantly as smaller oligomers, in sharp contrast to 
octadecamers (or even larger) when alone in the aqueous environment. Second, SP-A binds 
not only to zwitterionic micelles but also to anionic micelles. The investigations are carried 
out in pure micelles composed of the analogues of surfactant PC and PO, as well as in a 
mixed micelle system where the ratio of two lipids is kept close to the physiological level. 
Moreover, the experimental conditions, such as the pH and the temperature, are appropriately 
matched with the real lung conditions. The findings thus appear to lead towards a new 
thinking on the in vivo properties of SP-A. Perhaps, the current octadecameric SP-A models 
require some modifications to portray how SP-A may function as smaller oligomers. 
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Chapter 6 
Interaction b , tween ini- and 
SP-A ·n · odel Surfactan Lipids 
Note : Mini-B was synthesized and purified by Prof Alan J Waring and his group 
(Waring lab, Medicine, UCLA). SP-A was collectedfrom cow lungs supplied by Ray 
Bishop (Bishops Meat, Foxtrap, NL). Isolation and purification of SP-A was done by 
Donna Jackman (Booth lab, Biochemistry, MUN). 
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6.1 Overview 
Several studies have indicated interactions, either direct or indirect, between SP-A, 
the most abundant protein of lung surfactant by weight [163], and SP-B, an indispensable 
protein for lung surfactant function [37, 38], in model surfactant systems. Although the 
presence of SP-A is not strictly required for the biophysical function of lung surfactant [58], 
SP-A improves the surface activity of lipid-protein preparations only if SP-B is present, and 
especially in the presence of anionic phospholipids [62, 192]. Synergy between SP-A and 
SP-B observed in the process of phospholipid membrane fusion has been attributed to 
specific calcium-dependent SP-A/SP-B interactions [193, 194]. The perturbation of model 
surfactant bilayers prepared using DPPC/DPPG mixtures by SP-A and SP-B together is 
different from that of individual proteins, which is likely an outcome of the two proteins' 
interactions [195]. The proteins demonstrate a cooperative calcium-dependent action in 
improving the resistance to surfactant inhibition by blood and plasma proteins [ 196]. 
Formation of specific SP-A/SP-B complexes has been observed in lipid-protein interfacial 
films [197]. However, probably the most dramatic exhibition of a concerted action of SP-A 
and SP-B is the in vitro reconstitution of tubular myelin when SP-A is added to the mixtures 
ofDPPC, PG and SP-B in the presence of calcium [59-61]. 
A direct examination of SP-A/SP-B interaction, even in laboratory experimental 
conditions, has long been hampered by the lack of a clear understanding regarding the 
structure-function relationships of both proteins, especially that of SP-B. Knowledge of the 
high-resolution structure of Mini-B, a synthetic construct that presumably corresponds to the 
key functional regions of full-length SP-B, provides an opportunity to directly probe 
Mini-B/SP-A interaction in the presence of model surfactant phospholipids. The findings 
from such a study may unveil critical features of SP-A/SP-B interactions and their 
consequences in native lung conditions. The conformations of Mini-B and SP-A and their 
lipid interactions have been characterized individually using an array of five different micelle 
systems. Based on those findings, I have attempted to investigate the interaction between 
Mini-Band SP-A, if any, in the presence of same model surfactant phospholipids. 
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6.2 Materials and Methods 
6.2.1 Protein Preparation 
The synthetic Mini-B was produced and purified by the Waring lab (Medicine, 
UCLA). The peptide was produced by solid phase chemical synthesis using 0-fluorenyl-
methyloxycarbonyl (Fmoc) chemistry and purified by preparative reverse phase HPLC in a 
Vydac C-18 column as described previously (Chapter 3 and [156]). The natural bovine SP-A 
was collected from the lungs of young cows slaughtered at a local farm (Bishops Meat, 
Foxtrap, Newfoundland). The protein was isolated and purified by Donna Jackman (Booth 
lab, Biochemistry, Memorial University of Newfoundland) from the surfactant pellet by 
extraction with 1-butanol as described previously (Chapter 5). 
6.2.2 Sample Preparation 
No new NMR samples were prepared exclusively for this chapter but the 
corresponding Mini-B and SP-A samples, used for their individual studies presented in 
Chapters 4 and 5, were mixed together. Thus, like the individual proteins, at least two 
mixtures of Mini-B and SP-A were obtained for each micelle system with varying peptide/ 
lipid ratios. However, in all samples, molar concentrations of the detergents/lipids still 
remained at least 100 times higher than the proteins. The exact composition of each sample is 
described in the results section with protein molar concentrations specified as if they were 
100% monomeric. Mini-Box/SP-A samples were prepared with SDS, DPC, LMPC, LMPG 
and mixed LMPC(85%)/LMPG(l5%) micelles but Mini-BREo/SP-A samples were prepared 
with SDS and DPC micelles only. Consistent with the samples containing individual proteins, 
the pH of the Mini-Box/SP-A samples was found to be 6.9. However, the pH of the original 
Mini-BRED samples was 5.0 and hence that of Mini-BREo/SP-A samples was raised to 7.0 
using NaOH solution without taking the isotope effects into account. The pH of all samples 
thus closely matched the native condition of alveolar water hypophase. 
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6.2.3 NMR Data Collection and Processing 
A set of 1D 1H, 20 1 ~-1H HSQC and 2D DOSY experiments was performed for 
each ofthe Mini-B/SP-A samples on a Bruker Avance II 14.1 Testa (600 MHz) spectrometer 
(Billerica, MA) equipped with z-gradients and an inverse triple resonance TXI probe. The 
NMR data were collected and processed using the Bruker Topspin 2.0 software. The pulse 
length (P1) and the transmitter offset (01) were optimized for each sample before running 
the full set ofNMR experiments. The 1D 1H and 2D 15N- 1H HSQC spectra were acquired at 
37 oc to match the physiological temperature. In 1 D 1H experiments, data were collected 
with 128 to 320 scans (indicated in the figure captions) using the water-gate water 
suppression technique [146] and processed using an exponential apodization function with 1 
Hz line broadening. The 2D 15H-1H HSQC spectra were acquired with 160 to 640 scans 
(indicated in the figure captions) using the flip-back water suppression technique [145] and 
processed using the Qsine apodization function with a sine bell shift of 2. The 20 DOSY 
experiments were performed using PFG NMR [157]. The pulse sequence used a stimulated 
echo with bipolar gradient pulses and one spoil gradient [158] , followed by a 3-9-19 pulse for 
water suppression [159]. The OOSY spectra were acquired for SDS and OPC samples at 
37 °C. However, for LMPC and LMPG samples, the DOSY spectra were acquired at 25 oc 
to minimize the effect of thermal convection. The diffusion time was kept constant at 100 ms. 
The gradient pulse length was optimized for each sample and set between 3 and 8 ms. The 
maximum amplitude of the gradient strength was 35 G/cm and the 1H signals were attenuated 
in 32 steps. The translational diffusion coefficient was determined from the slope of the 
signal attenuation curve plotted using Eq. 2.17. The hydrodynamic diameter was calculated 
using the Stokes-Einstein equation [Eq. 2.20]. The viscosity of pure water was used for the 
viscosity of solution in the calculation and the values were 8.91 x 10-4 kg/m.s at 25 oc (298 
K) and 6.92 X 10-4 kg/m.s at 37 oc (310 K). 
Although NMR data were acquired for at least two separately prepared mixtures of 
Mini-B and SP-A in each micelle system, spectra of both samples essentially looked identical 
and hence only one is shown in the results section. For the ease of comparison, the spectra of 
individual proteins acquired under the same micelle condition are also included in the figures. 
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6.3 Results 
6.3.1 Mini-Band SP-A in SDS Micelles 
As previously done for studying the conformations and lipid interactions of the 
proteins individually, the examination of Mini-B/SP-A interaction began with smaller 
anionic micelles composed of the detergent SDS. The study was performed using both 
Mini-Box and Mini-BRED· SP-A was added to both versions of Mini-B at a monomeric ratio 
of I: I , calculated assuming SP-A as a monomer. Figures 6.I and 6.2 show the I D 1H spectra 
of Mini-Box and Mini-BRED, respectively, plus SP-A in SDS micelles, along with the 
corresponding spectra of the individual proteins. The signals seen in the 6-9 ppm region, 
enlarged and displayed in the bottom panels, correspond mostly to backbone amide protons 
(HNs) of the proteins. However, the signals from Mini-B/SP-A mixtures, for both Mini-B 
versions, look almost identical to that of SP-A alone. This is not unexpected as SP-A (248 
amino acids) is over 7 times larger than Mini-B (34 amino acids) and thus the signals of 
Mini-B are buried under the many signals of SP-A. A comparison of the spectral dispersion 
and intensity of HN signals indicates that the structure of SDS-bound SP-A remains 
essentially unchanged in the presence of SDS-bound Mini-B. 
The structures of SDS-bound Mini-Box and Mini-BRED also remain the same in the 
presence of SDS-bound SP-A. This is revealed by the 2D 15N- 1H HSQC spectra (Figures 6.3 
and 6.4) which show that all nine major peaks corresponding to the 15N-Iabeled amino acids 
of Mini-B, and even the additional weaker peaks in most cases, remain unaffected by the 
inclusion of SP-A. Addition of more SDS, followed by CaCh, does not change the position 
or intensity of Mini-B HSQC peaks either (Figure 6.3 C and D). 
The ID 1H and 2D HSQC spectra appear to provide no evidence of interactions 
between Mini-B and SP-A in SDS micelles. However, the 2D DOSY spectra of Mini-Box/ 
SP-A, when compared to the individual proteins, indicate a somewhat different scenario 
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(Figures 6.5 & 6.6 and Table 6.1 ). A total of four signal attenuation curves are produced, two 
from the SDS peaks at 0.80 and 1.22 ppm and two from the protein peaks at 0.92 ppm and 
HN region, but only two are shown in Figure 6.5 (from 1.22 ppm and HN region). 
Interestingly, the signal attenuation curve does not fit well with a single line (i.e., a single 
component). However, approximately the first and the last halves of the data are fit 
reasonably well with two lines having two different slopes. Thus, two observed translational 
diffusion coefficients are obtained and there are, at least, two distinct populations of 
protein/micelle complexes present in the solution. The apparent hydrodynamic diameters of 
the subpopulations are ~ 6.8 nm [from HN Fit 1 (~ first half of the data)] and ~ 19.4 nm 
[from HN Fit 2 ( ~ last half of the data)]. Although the first subpopulation is not substantially 
different in size from the SP-A/SDS complex ( ~ 5.6 nm), the second is much larger. A 
fraction of the total Mini-Box and SP-A molecules present in the mixture hence form large 
protein/micelle complexes. The approximate ratio of the small-to-large subpopulations is 
85%: 15%, as estimated from they-axis (relative signal intensity) intercepts of the two linear 
fits representing the two diffusion coefficients. The average hydrodynamic diameter, which 
is not an arithmetic average of the two sizes, but calculated from the average linear fit of the 
HN signal attenuation data, is ~ 9.3 nm. This apparent size is also larger than the sizes 
obtained for the individual proteins. For both Fit 1 and Fit 2 of the Mini-Box/SP-A mixture, 
the diffusion coefficients, and hence the corresponding hydrodynamic diameters, obtained 
from the SDS peaks are different from that obtained from the protein peaks. For Fit 2, the 
apparent hydrodynamic diameters calculated from the SDS peaks are ~ 13 nm while that 
from the protein peaks are ~ 20 nm. As observed previously for the individual proteins, the 
smaller apparent size of the complex when calculated from the detergent peaks is likely the 
result of a rapid exchange between the free and micelle-bound SDS species. 
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Figure 6.1 : 1D 1H spectra of (A) 0.2 mM Mini-Box, (B) 0.2 mM SP-A and (C) 0.1 mM 
Mini-Box+ 0.1 mM SP-A in 40 mM SDS, in the presence of 4.5 mM Hepes at pH 6.9 and 
temperature 37 °C. The spectra were acquired using 256 scans and processed with 1 Hz 
line broadening. The 6-9 ppm regions of all spectra are enlarged and shown in the 
bottom panel (D). 
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Figure 6.2 : 10 1H spectra of (A) 0.15 mM Mini-BRED in 30 mM SDS (acquired using 128 
scans), (B) 0.2 mM SP-A in 40 mM SDS (acquired using 256 scans) and (C) 0.075 mM 
Mini-BRED+ 0.08 mM SP-A in 15 mM SDS (acquired using 128 scans), in the presence of 
4.5 mM Hepes at pH 7.0 and temperature 37 °C. The spectra were processed with 1 Hz 
line broadening. The 6-9 ppm regions of all spectra are enlarged and shown in the 
bottom panel (D). 
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Figure 6.3 : 2D 15N- 1H HSQC spectra of (A) 0.2 mM Mini-Box in 40 mM SDS (acquired 
using 160 scans), (B) 0.1 mM Mini-Box+ 0.1 mM SP-A in 40 mM SDS (acquired using 640 
scans), (C) 0.1 mM Mini-Box+ 0.1 mM SP-A in I 00 mM SDS (acquired using 320 scans) 
and (D) 0.1 mM Mini-Box + 0.1 mM SP-A in 100 mM + 5 mM CaCh (acquired using 320 
scans), in the presence of 4.5 mM Hepes at pH 6.9 and temperature 37 °C. The base contour 
level shown in (B) is 2 times higher than others. 
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Figure 6.4:20 15N- 1H HSQC spectra of(A) 0.15 mM Mini-BREo in 30 mM SDS (acquired 
using 160 scans) and (B) 0.075 mM Mini-BRED+ 0.08 mM SP-A in 15 mM SDS (acquired 
using 320 scans), in the presence of 4.5 mM Hepes at pH 7.0 and temperature 37 °C. The 
base contour level shown in (B) is 1.5 times higher than (A). 
134 
------- ~ -- - --i l --"' ' ~ :1i I I ·rg . '-' 01) 01) ' 01) 
II I II 
: ..s: ~ ~ ~ .£: .£: · o if! · o {j \rl ~1' ' 0 [ ~ ' ci ' . , 0 
1,1 ,~:r-~\11 ' ' .~ . ' !:'lj r'0 ; '0 II') · ~ · ~ o\ 
1: I I ~ 
I , 
' I I 
1 0 
' . 
111 I I 1: A. Mini-Box I roo B. SP-A t ~ C. Mini-Box+ SP-A foo t ' ' ' in SDS r in SDS in SDS ~-· J 
10 8 6 4 2 1H (ppm) 10 8 6 4 2 1H (ppm) 10 8 6 4 2 1H (ppm) 
0 From SDS peak 0 From Protein 
8 -1 at 1.22 ppm e: -1 HN region ~ -2 ~ -2 g 
-3 2 -3 ~ (]) 
.£ -4 .£ -4 
-5 -5 
-6 -6 
D 0 
10 20 30 40 50x1 09 
E 
0 10 20 30 40 50x1 09 
2 2 2 2 k [= (yog) (~-o/3)] (s/m ) k [= (yog) (~-o/3 )] (s/m ) 
Figure 6.5 : Translational diffusion measurements of Mini-Box and SP-A in SDS. Top 
panels show the 2D DOSY spectra of 0.2 mM Mini-Box (A), 0.2 mM SP-A (B) and 0.1 mM 
Mini-Box+ 0.1 mM SP-A (C) in 40 mM SDS, in the presence of 4.5 mM Hepes at pH 6.9 
and temperature 37 °C. The observed diffusion coefficients are determined from the slopes of 
the 1H signal attenuation curves using two SDS signals (at 0.80 and 1.22 ppm) and two 
protein signals (0.92 ppm and HN regions). Only two signal attenuation curves for the 
Mini-Box/SP-A/SDS complexes, obtained from the SDS peak at 1.22 ppm (D) and the 
protein HN region (E), are shown in the bottom panels. None of the signal attenuation 
curves for Mini-Box/SP-A/SDS complexes fit well with a single line. However, 
approximately the first and the last halves of the data are fit reasonably well with two lines 
having two different slopes. 
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Table 6.1 : Observed translational diffusion coefficients and the corresponding 
hydrodynamic diameters of pure SDS micelles and protein/SDS complexes. The diffusion 
coefficients are represented by the slopes of the 1H signal attenuation linear fits obtained 
from the 2D DOSY data. The hydrodynamic diameters are calculated using the Stokes-
Einstein equation (Eq. 2.20). 
Micelle/Complex 
Composition 
Pure SDS 
Micelle 
Mini-Box/SDS 
Complex 
SP-A/SDS 
Complex 
Mini-Box/SP-A/ 
SDS (Average) 
Mini-Box/SP-A/ 
SDS (Fit I) 
Mini-Box/SP-A/ 
SDS (Fit 2) 
2 1 
f ts 
.... 
~ 15 
E 
"' 0 12 
u 
.E 9 
"' c: 
~ 6 
0 
i 3 
::r: 
Diff. Coeff. X I o -IO (m2/s) from Peak at 
0.80 1.22 0.92 HN 
ppm ppm ppm region 
5.466 5.323 X X 
± 0.043 ± 0.027 
3.497 3.423 2.885 2.507 
± 0.061 ± 0.037 ± 0.047 ± 0.087 
2.512 1.670 0.943 1.166 
± 0.037 ± 0.008 ± 0.005 ± 0.014 
0.896 1.096 0.701 0.705 
± 0.038 ± 0.048 ± 0.027 ± 0.025 
1.610 1.71 2 1.022 0.964 
± 0.016 ± 0.019 ± 0.006 ± 0.021 
0.521 0.481 0.318 0.338 
± 0.017 ± 0.021 ± 0.008 ± 0.010 
Hydro. Dia. (nm) from Peak at 
0.80 1.22 
ppm ppm 
1.20 1.23 
1.88 1.92 
2.61 3.93 
7.32 5.98 
4.07 3.83 
12.59 13.64 
0.92 HN 
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X X 
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Figure 6.6 : Bar graphs representing the apparent hydrodynamic diameters of pure SDS 
micelles and protein/SDS complexes, as presented in Table 6.1. 
136 
6.3.2 Mini-Band SP-A in DPC Micelles 
The interaction between Mini-B and SP-A was studied next in smaller zwitterionic 
micelles composed of DPC. Again, this was investigated for both versions of Mini-B. SP-A 
was added to Mini-BREo in one step at the monomeric ratio of 1:1 . However, Mini-Box was 
titrated with SP-A in three steps, starting with a monomeric ratio of 4:1 and ending at 1:1. 
Figures 6.7 and 6.8 show the 1D 1H spectra of Mini-Box and Mini-BRED, respectively, plus 
SP-A in DPC micelles, along with the corresponding spectra of the individual proteins. As in 
SDS, the backbone HN signals from Mini-B/SP-A mixtures in DPC are almost identical to 
that of SP-A alone. Therefore, the conformation of SP-A likely remains the same in the 
presence ofMini-B, even ifthe proteins interact with each other. 
Interestingly, the intensity of 2D 15N- 1H HSQC peaks of Mini-Box gradually decrease 
with the addition of SP-A but their positions (chemical shifts) do not change (Figures 6.9 
A-C). At the last step of titration, i.e., at 1:1 monomeric ratio of Mini-Box to SP-A, all of the 
Mini-Box peaks essentially disappear leaving much weaker traces of only one or two (Figure 
6.9 D). The HSQC peaks of Mini-BREo also disappear in the presence of SP-A (Figure 6.1 0). 
This likely indicates all or most of Mini-Bare bound in complexes, presumably complexes of 
SP-A plus DPC, which are too large to yield the HSQC signals. Since there are enough DPC 
present to provide about 7 times as many micelles as Mini-B molecules, it seems that Mini-B 
has a strong preference to interact with SP-NDPC complexes over DPC micelles without 
SP-A. This interpretation is supported by the absence of any changes in the HSQC spectra of 
Mini-Box when more DPC is added (Figure 6.9 E). However, a subsequent addition of CaC}z, 
at a concentration 50 times more than the proteins, causes the HSQC peaks of Mini-Box to 
reappear (Figure 6.9 F). In this condition, the large Mini-B0 x/SP-NDPC complexes likely 
disassemble and the smaller Mini-Box/DPC complexes reform. 
The translational diffusion measurements confirm the formation of larger particles in 
the mixture of Mini-Box and SP-A when compared to the individual proteins (Figures 6.11 & 
6.12 and Table 6.2). As in SDS, the signal attenuation curves of Mini-Box/SP-A/DPC, 
produced from the 2D DOSY spectra, do not fit well with a single line but reasonably well 
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with two lines based on approximately the first and the last halves of the data (Figure 6.11 ). 
Thus, two different observed translational diffusion coefficients are obtained. The 
hydrodynamic diameters calculated from both fits, - 12.8 nm [from HN Fit 1 (- first half of 
the data)] and - 20.4 [from HN Fit 2 (-last half of the data)], are much larger than SP-A/ 
DPC (- 4.1 nm) and Mini-B0 x/DPC (- 2.3 nm) complexes. The approximate ratio of small-
to-large subpopulations of Mini-Box/SP-A/DPC is 62% : 38%, as estimated from they-axis 
(relative signal intensity) intercepts of the two linear fits. The average diameter of - 14.9 nm, 
calculated from the average linear fit, is also much larger than the individual protein/micelle 
complexes. Thus, the two proteins likely interact and form larger complexes, but with 
heterogeneous sizes. As in SDS, the apparent sizes of the complexes are smaller when 
calculated from the DPC peaks(- 12 nm, from Fit 2) than when calculated from the protein 
peaks (- 20 nm, from Fit 2). Again, this is likely the result of a rapid exchange between the 
free and micelle-bound DPC species. 
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Figure 6.7 : lD 1H spectra of (A) 0.2 mM Mini-Box, (B) 0.2 mM SP-A and (C) 0.1 mM 
Mini-Box+ 0.1 mM SP-A in 40 mM DPC, in the presence of 4.5 mM Hepes at pH 6.9 and 
temperature 37 °C. The spectra were acquired using 256 scans and processed with 1 Hz line 
broadening. The 6-9 ppm regions of all spectra are enlarged and shown in the bottom panel 
(D), including that from 0.16 mM Mini-Box + 0.04 mM SP-A and 0.133 mM Mini-Box + 
0.67 mM SP-A samples. 
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Figure 6.8 : 1D 1H spectra of (A) 0.075 mM Mini-BRED, (B) 0.08 mM SP-A and (C) 0.075 
mM Mini-BREo + 0.08 mM SP-A in 15 mM DPC, in the presence of 4.5 mM Hepes at pH 7.0 
and temperature 37 °C. The spectra were acquired using 256 scans and processed with 1 Hz 
line broadening. The 6-9 ppm regions of all spectra are enlarged and shown in the 
bottom panel (D). 
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Figure 6.9 : 20 15N-1H HSQC spectra of (A) 0.2 mM Mini-Box in 40 mM DPC (acquired 
using 160 scans), (B) 0.16 mM Mini-Box+ 0.04 mM SP-A in 40 mM DPC (acquired using 
240 scans), (C) 0.133 mM Mini-Box + 0.067 mM SP-A in 40 mM DPC (acquired using 352 
scans), (D) 0.1 mM Mini-Box+ 0.1 mM SP-A in 40 mM DPC (acquired using 640 scans), (E) 
0.1 mM Mini-Box + 0.1 mM SP-A in 100 mM DPC (acquired using 320 scans) and (F) 0.1 
mM Mini-Box + 0.1 mM SP-A in 100 mM DPC + 5 mM CaCh (acquired using 320 scans), 
in the presence of 4.5 mM Hepes at pH 6.9 and temperature 37 °C. 
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Figure 6.10 : 2D 15N- 1H HSQC spectra of (A) 0.075 mM Mini-BRED and (B) 0.075 mM 
Mini-BRED+ 0.08 mM SP-A in 15 mM DPC, in the presence of 4.5 mM Hepes at pH 7.0 and 
temperature 37 °C. Both spectra were acquired using 320 scans. 
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Figure 6.11 : Translational diffusion measurements of Mini-Box and SP-A in DPC. Top 
panels show the 2D DOSY spectra of 0.1 mM Mini-Box in 20 mM DPC (A), 0. 1 mM SP-A 
in 20 mM DPC (B) and 0.1 mM Mini-Box + 0.1 mM SP-A in 40 mM DPC (C), in the 
presence of 4.5 mM Hepes at pH 6.9 and temperature 37 °C. The observed diffusion 
coefficients are determined from the slopes of the 1H signal attenuation curves using two 
DPC signals (at 0.80 and 1.22 ppm) and two protein signals (0.92 ppm and HN regions). 
Only two signal attenuation curves for the Mini-Box/SP-A/DPC complexes, obtained from 
the DPC peak at 1.22 ppm (D) and the protein HN region (E), are shown in the bottom panels. 
None of the signal attenuation curves for Mini-Box/SP-A/DPC complexes fit well with a 
single line. However, approximately the first and the last halves of the data are fit reasonably 
well with two lines having two different slopes. 
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Table 6.2 : Observed translational diffusion coefficients and the corresponding 
hydrodynamic diameters of pure DPC micelles and protein/DPC complexes. The diffusion 
coefficients are represented by the slopes of the 1H signal attenuation linear fits obtained 
from the 2D DOSY data. The hydrodynamic diameters are calculated using the Stokes-
Einstein equation (Eq. 2.20). 
Micelle/Complex 
Composition 
Pure DPC 
Micelle 
Mini-Box/DPC 
Complex 
SP-A/DPC 
Complex 
Mini-Box/SP-A/ 
DPC (Average) 
Mini-Box/SP-A/ 
DPC (Fit I) 
Mini-Box/SP-A/ 
OPC (Fit 2) 
21 
I 18 
... 
~ 15 
E 
"' 0 12 
u 
.E 9 
"' c ~ 6 
e 
~ 3 
I 
Diff. Coeff. X 1 o -IO (m2/s) from Peak at 
0.80 1.22 0.90 HN 
ppm ppm ppm region 
3.356 3.367 
± 0.021 ± 0.010 
X X 
2.585 2.657 2.337 2.844 
± 0.023 ± 0.013 ± 0.015 ± 0.061 
1.759 1.915 1.511 1.620 
± 0.011 ± 0.004 ± 0.008 ± 0.011 
0.724 0.971 0.501 0.440 
± 0.018 ± 0.022 ± 0.010 ± 0.008 
0.922 1.214 0.610 0.511 
± 0.007 ± 0.011 ± 0.004 ± 0.007 
0.522 0.575 0.332 0.322 
± 0.009 ± 0.027 ± 0.013 ± 0.012 
Hydro. Dia. (nm) from Peak at 
0.80 1.22 
ppm ppm 
1.96 1.95 
2.54 2.48 
3.72 3.42 
9.06 6.76 
7. 11 5.40 
12.57 11.41 
0.90 HN 
ppm region 
X X 
2.81 2.31 
4.34 4.05 
13.09 14.91 
10.75 12.84 
19.76 20.37 
o 0 80 ppm (DPC) 
C3 1 22 ppm (DPC) 
t!l 0 90 ppm (Protem) 
I m HN Region (Protein) 
DPC Micelle Mlni-8/DPC SP-AIDPC Mini-8/SP-A/ Mlni-8/SP-A/ Mini-8/SP-A/ 
DPC {Avg.) DPC (Fit 1) DPC (Fit 2) 
Figure 6.12 : Bar graphs representing the apparent hydrodynamic diameters of pure DPC 
micelles and protein/DPC complexes, as presented in Table 6.2. 
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6.3.3 Mini-Band SP-A in LMPC Micelles 
To gain an insight into Mini-B/SP-A interaction in a more physiologically relevant 
lipid environment, the investigations continued with LMPC, LMPG and mixed LMPC/ 
LMPG micelles. For these micelles, the studies were performed using Mini-Box only. SP-A 
was added to Mini-Box in one step at a monomeric ratio of 1:1 . First studied were Mini-Box 
and SP-A in zwitterionic micelles composed of LMPC that mimic the lung lipid environment 
created by the most abundant surfactant phospholipid DPPC. Again, the 1D 1H spectrum of 
Mini-Box/SP-A in LMPC looks almost identical to SP-A in LMPC indicating that the 
Mini-Box signals are buried under the much stronger SP-A signals (Figure 6.13). The 
observed changes in the 2D 15N-1H HSQC spectra are quite similar to that of the smaller 
zwitterionic micelles ofDPC (Figure 6.14). The HSQC peaks of Mini-Box disappear with the 
addition of SP-A leaving behind just a few much weaker traces. 
The translational diffusion measurements in LMPC, however, demonstrate a result 
which is quite different from that of DPC or SDS (Figures 6.15 & 6.16 and Table 6.3). Again, 
four signal attenuation curves are produced from the 2D DOSY spectra, but now all are 
obtained from the lipid peaks since the protein signals are too weak to produce meaningful 
signal attenuation curves in the presence of nondeuterated LMPC (Figure 6.15). Unlike in 
SDS or DPC, each of the signal attenuation curves constitutes a single linear fit and hence 
yields a single translational diffusion coefficient. Thus, protein/lipid complexes of only a 
single homogeneous size are apparently present in the Mini-Box/SP-A mixture in LMPC. 
Interestingly, the hydrodynamic diameter of the mixed complexes, calculated using the 
observed translational diffusion coefficient, is - 8.5 nm, which is smaller than SP-A/LMPC 
complexes (- 10.3 nm) but larger than Mini-BoxiLMPC complexes (- 6.7 nm). As 
elaborated in the discussion, this may be an outcome of rearrangements of the protein/lipid 
structures induced by the protein-protein interactions. 
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Figure 6.13 : 1D 1H spectra of (A) 0.25 mM Mini-Box (acquired using 160 scans), (B) 0.25 
mM SP-A (acquired using 160 scans) and (C) 0.125 mM Mini-Box + 0.125 mM SP-A 
(acquired using 320 scans) in 50 mM LMPC, in the presence of 4.5 mM Hepes at pH 6.9 and 
temperature 37 °C. The spectra were processed with 1 Hz line broadening. The 6-9 ppm 
regions of all spectra are enlarged and shown in the bottom panel (D). 
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Figure 6.14: 2D 15N- 1H HSQC spectra of (A) 0.25 mM Mini-Box (acquired using 160 scans) 
and (B) 0.125 mM Mini-Box + 0.125 mM SP-A (acquired using 320 scans) in 50 mM LMPC, 
in the presence of 4.5 mM Hepes at pH 6.9 and temperature 37 °C. 
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Figure 6.15 : Translational diffusion measurements of Mini-Box and SP-A in LMPC. Top 
panels show the 2D DOSY spectra of 0.25 mM Mini-Box (A), 0.25 mM SP-A (B) and 0.125 
mM Mini-Box + 0.125 mM SP-A (C) in 50 mM LMPC, in the presence of 4.5 mM Hepes at 
pH 6.9 and temperature 25 °C. The observed diffusion coefficients are determined from the 
slopes of the 1H signal attenuation curves using four LMPC peaks (at 0.85, 1.27, 1.58 and 
2.36 ppm). Only two sets of signal attenuation curves for pure micelle and protein/micelle 
complexes, obtained from the peaks at 0.85 ppm (D) and 1.27 ppm (E), are shown in the 
bottom panels. 
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Table 6.3 : Observed translational diffusion coefficients and the corresponding 
hydrodynamic diameters of pure LMPC micelles and protein!LMPC complexes. The 
diffusion coefficients are represented by the slopes of the 1H signal attenuation linear fits 
obtained from the 2D DOSY data. The hydrodynamic diameters are calculated using the 
Stokes-Einstein equation (Eq. 2.20). 
Micelle/Complex 
Diff. Coeff. X I o -I l (m2/s) from Peak at 
Composition 
Pure LMPC 
Micelle 
Mini-BoxiLMPC 
Complex 
SP-A/LMPC 
Complex 
Mini-Box/SP-A/ 
LMPC Complex 
12 
I 10 
.... 
.. 
-.; 8 
E 
cG 
0 
.., 6 
·e 
cG 
~ 4 
'0 
0 
~ 2 
I 
0.85 
ppm 
6.790 
± 0.006 
7.364 
± 0.047 
4.774 
± 0.007 
5.762 
± 0.008 
LMPC Micelle 
1.27 1.58 2.36 
ppm ppm ppm 
6.741 6.578 6.735 
± 0.003 ± 0.014 ± 0.004 
7.332 7.390 7.373 
± 0.043 ± 0.055 ± 0.042 
4.783 4.580 4.755 
± 0.003 ± 0.015 ± 0.011 
5.760 5.609 5.764 
± 0.005 ± 0.013 ± 0.008 
Mini-B/LMPC SP-AILMPC 
Hydro. Dia. (nm) from Peak at 
0.85 1.27 
ppm ppm 
7.21 7.26 
6.65 6.68 
10.26 10.24 
8.50 8.50 
Mini-B/SP-A/LMPC 
1.58 2.36 
ppm ppm 
7.44 7.27 
6.63 6.64 
10.69 I 0.30 
8.73 8.50 
o 0 85 ppm (Lipid) 
liS'l 1 27 ppm (Lipid) 
i::l 1 58 ppm (Lipid) 
Iii 2.36 ppm (Lipid) 
Figure 6.16 : Bar graphs representing the apparent hydrodynamic diameters of pure LMPC 
micelles and protein!LMPC complexes, as presented in Table 6.3. 
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6.3.4 Mini-Band SP-A in LMPG Micelles 
The interaction between Mini-Box and SP-A was assessed next in anionic micelles 
composed of LMPG that mimic the lung lipid environment created by the surfactant 
phospholipids with PG headgroups. Again, in the lD 1H spectrum of Mini-Box/SP-A in 
LMPG, the signals from Mini-Box are buried under the intense signals of SP-A and the 
spectrum looks identical to SP-A in LMPG (Figure 6.17). The Mini-Box peaks in the 2D 
15N-1H HSQC spectra remain unchanged with the addition of SP-A (Figure 6.18), which is 
similar to Mini-Box/SP-A in SDS but different from Mini-Box/SP-A in DPC or LMPC. 
The translational diffusion measurements in LMPG, obtained using the 2D DOSY 
spectra, provide a similar result to that in LMPC (Figures 6.19 & 6.20 and Table 6.4). Each 
of the four signal attenuation curves constitutes a single linear fit and hence indicates a single 
particle size. Again, the apparent hydrodynamic diameter of the complexes in Mini-Box/ 
SP-A mixture, calculated using the observed translational diffusion coefficient, is - 9.1 run, 
which is smaller than SP-A/LMPG complexes(- 11.2 run) but larger than Mini-Box/LMPC 
complexes (- 7.2 run). As in LMPC, this may be caused by rearrangements of the protein/ 
lipid structures induced by the Mini-Box/SP-A interactions. 
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Figure 6.17: 10 1H spectraof(A) 0.25 mM Mini-Box (acquired using 160 scans), (B) 0.25 
mM SP-A (acquired using 160 scans) and (C) 0.125 mM Mini-Box + 0.125 mM SP-A 
(acquired using 320 scans) in 50 mM LMPG, in the presence of 4.5 mM Hepes at pH 6.9 and 
temperature 37 °C. The spectra were processed with 1 Hz line broadening. The 6-9 ppm 
regions of all spectra are enlarged and shown in the bottom panel (D). 
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Figure 6.18: 2D 15N- 1H HSQC spectra of(A) 0.25 mM Mini-Box (acquired using 160 scans) 
and (B) 0.125 mM Mini-Box+ 0.125 mM SP-A (acquired using 320 scans) in 50 mM LMPG, 
in the presence of 4.5 mM Hepes at pH 6.9 and temperature 37 °C. 
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Figure 6.19 : Translational diffusion measurements of Mini-Box and SP-A in LMPG. Top 
panels show the 2D DOSY spectra of 0.25 mM Mini-Box (A), 0.25 mM SP-A (B) and 0.125 
mM Mini-Box+ 0.125 mM SP-A (C) in 50 mM LMPG, in the presence of 4.5 mM Hepes at 
pH 6.9 and temperature 25 °C. The observed diffusion coefficients are determined from the 
slopes of the 1H signal attenuation curves using four LMPG peaks (at 0.87, 1.28, 1.60 and 
2.38 ppm). Only two sets of signal attenuation curves for pure micelle and protein/micelle 
complexes, obtained from the peaks at 0.87 ppm (D) and 1.28 ppm (E), are shown in the 
bottom panels. 
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Table 6.4 : Observed translational diffusion coefficients and the corresponding 
hydrodynamic diameters of pure LMPG micelles and protein!LMPG complexes. The 
diffusion coefficients are represented by the slopes of the 1H signal attenuation linear fits 
obtained from the 2D DOSY data. The hydrodynamic diameters are calculated using the 
Stokes-Einstein equation (Eq. 2.20). 
Micelle/Complex 
Diff. Coeff. x 10"1 1 (m%) from Peak at 
Composition 0.87 1.28 1.60 2.38 
ppm ppm ppm ppm 
Pure LMPG 5.907 5.909 5.861 5.891 
Micelle ± 0.004 ± 0.003 ± 0.003 ± 0.003 
Mini-Box/LMPG 6.841 6.849 6.744 6.85 1 
Complex ± 0.014 ± 0.009 ± 0.007 ± 0.013 
SP-A/LMPG 4.359 4.374 4.300 4.345 
Complex ± 0.005 ± 0.005 ± 0.008 ± 0.004 
Mini-Box/SP-A/ 5.441 5.367 5.274 5.390 
LMPG Complex ± 0.009 ± 0.006 ± 0.004 ± 0.006 
LMPG Micelle Mini-B/LMPG SP-AILMPG 
Hydro. Dia. (nm) from Peak at 
0.87 1.28 
ppm ppm 
8.29 8.29 
7.16 7.15 
11.23 11 .20 
9.00 9.12 
Mini-B/SP-AILMPG 
1.60 2.38 
ppm ppm 
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11.39 11.27 
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Figure 6.20 : Bar graphs representing the apparent hydrodynamic diameters of pure LMPG 
micelles and protein/LMPG complexes, as presented in Table 6.4. 
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6.3.5 Mini-Band SP-A in Mixed LMPC/LMPG Micelles 
Lastly for this chapter, the interaction between Mini-Box and SP-A was probed in a 
mixed LMPCILMPG micelle system. As usual, the l D 1H spectrum of Mini-Box/SP-A 
mixture looks almost identical to that of SP-A alone (Figure 6.21 ). Interestingly, the 
Mini-Box peaks in the 2D 15N-1H HSQC spectra remain unchanged with the addition of 
SP-A (Figure 6.22), which matches the result obtained in I 00% LMPG although only 15% 
LMPG is present in the mixed micelle system. 
The change in the size of the protein/micelle complexes in the mixed micelle system, 
as obtained from the 2D DOSY spectra, follows the same trend as that of individual LMPC 
and LMPG systems (Figures 6.23 & 6.24 and Table 6.5). The hydrodynamic diameter of the 
particles present in the Mini-Box/SP-A mixture, calculated using the observed translational 
diffusion coefficient, is ~ 9.0 nm, which 'is smaller than SP-AILMPC/LMPG complexes 
(~ 10.7 nm) but larger than Mini-BoxiLMPC/LMPC complexes (~ 6.5 nm). Again, the 
protein-protein interactions may be responsible for rearrangements of the protein/lipid 
structures. 
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Figure 6.21 : 1D 1H spectra of (A) 0.25 mM Mini-Box (acquired using 160 scans), (B) 0.25 
mM SP-A (acquired using 160 scans) and (C) 0.125 mM Mini-Box + 0.125 mM SP-A 
(acquired using 320 scans) in 42.5 LMPC + 7.5 mM LMPG, in the presence of 4.5 mM 
Hepes at pH 6.9 and temperature 37 °C. The spectra were processed with 1 Hz line 
broadening. The 6-9 ppm regions of all spectra are enlarged and shown in the bottom 
panel (D). 
156 
I A. Mini-Box 
in LMPC/LMPG 
$ 
i) 
(). 
"" 
-
.. 
0> 
.c 
.., 
8.5 8.0 7.5 1H (ppm) 
,--... 
a 
0.. ~ 8 
z 
~ 
N 
B. Mini-Box + SP-A 
in LMPCILMPG 
\0 
-
-
0 
N 
8.5 8.0 
,--... 
a 
0.. 
8 
z 
~ 
7.5 1H (ppm) 
N 
-
-
0 
N 
-
Figure 6.22: 2D 15N- 1H HSQC spectra of(A) 0.25 mM Mini-Box (acquired using 160 scans) 
and (B) 0.125 mM Mini-Box + 0.125 mM SP-A (acquired using 320 scans) in 42.5 mM 
LMPC + 7.5 mM LMPG, in the presence of 4.5 mM Hepes at pH 6.9 and temperature 37 °C. 
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Figure 6.23: Translational diffusion measurements of Mini-Box and SP-A in LMPC/LMPG. 
Top panels show the 20 DOSY spectra of 0.25 mM Mini-Box (A), 0.25 mM SP-A (B) and 
0.125 mM Mini-Box+ 0.125 mM SP-A (C) in 42.5 mM LMPC + 7.5 mM LMPG, in the 
presence of 4.5 mM Hepes at pH 6.9 and temperature 25 °C. The observed diffusion 
coefficients are determined from the slopes of the 1H signal attenuation curves using four 
LMPC/LMPG peaks (at 0.86, 1.28, 1.59 and 2.37 ppm). Only two sets of signal attenuation 
curves for pure micelle and protein/micelle complexes, obtained from the peaks at 0.86 ppm 
(D) and 1.28 ppm (E), are shown in the bottom panels. 
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Table 6.5 : Observed translational diffusion coefficients and the corresponding 
hydrodynamic diameters of pure LMPCILMPG micelles and protein/LMPCILMPG 
complexes. The diffusion coefficients are represented by the slopes of the 1H signal 
attenuation linear fits obtained from the 2D DOSY data. The hydrodynamic diameters are 
calculated using the Stokes-Einstein equation (Eq. 2.20). 
Micelle/Complex 
Composition 
Pure LMPC/ 
LMPG Micelle 
Mini-Box/LMPC/ 
LMPG Complex 
SP-AILMPC/ 
LMPG Complex 
Mini-Box/SP-A/ 
LMPC/LMPG 
12 
E' 10 
..s 
... 
., 
..u 8 
E 
OJ 
Ci 
u 6 
·e 
OJ 
~ 4 
"0 
0 
i 2 
I 
Diff. Coeff. X I o-J I (m2/s) from Peak at 
0.86 1.28 1.59 2.37 
ppm ppm ppm ppm 
5.910 5.866 5.706 5.854 
± 0.003 ± 0.002 ± 0.012 ± 0.004 
7.635 7.504 7.134 7.541 
± 0.003 ± 0.003 ± 0.01 2 ± 0.005 
4.564 4.571 4.387 4.563 
± 0.006 ± 0.003 ± 0.019 ± 0.009 
5.436 5.427 5.252 5.415 
± 0.007 ± 0.004 ± 0.013 ± 0.006 
Hydro. Dia. (nm) from Peak at 
0.86 1.28 
ppm ppm 
8.29 8.35 
6.41 6.53 
10.73 10.7 1 
9.01 9.02 
1.59 2.37 
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Figure 6.24 : Bar graphs representing the apparent hydrodynamic diameters of pure 
LMPCILMPG micelles and protein/LMPCILMPG complexes, as presented in Table 6.5 . 
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6.4 Discussion 
Protein-protein interactions play vital roles in many biological processes. For optimal 
function of surfactant materials in the lung, interactions between SP-B and SP-A may also 
play important roles. Although mechanistic descriptions of the events that take place at the 
molecular and submolecular levels in lung surfactant function are still unavailable, a few 
models have been proposed portraying the mechanisms of SP-B- and SP-A-induced 
rearrangement and stabilization of phospholipid structures on an individual basis [70, 17] as 
well as through their concerted actions [12, 23, 198]. Formation of tubular myelin [59-6 1 ], 
enhancement of lipid adsorption along the air-water interface [62, 63], fusion of lipid 
membranes [193 , 194] and inhibition of blood and plasma proteins [196] are well-established 
in vitro demonstrations of concerted actions between SP-A and SP-B. However, it is still 
unknown if the two proteins interact directly to accomplish these results or if these are 
achieved by their indirect interactions mediated through the lipids. Knowledge of the high-
resolution structure of Mini-B provides a tool to probe its interactions with SP-A, if any, in 
model surfactant lipids and thus enhances our understanding of the ramifications of SP-8/ 
SP-A interactions in the lung. 
The interactions between Mini-B and SP-A are investigated by assessing the changes 
m the features of NMR spectra when the two proteins are mixed at equal molar 
concentrations. Like the individual proteins, these investigations are carried out in an array of 
five micelle systems mimicking various lipid components found in lung surfactant. Two of 
the micelle systems are anionic, composed from the detergent SDS and the surfactant 
PG-analogue LMPG, two are zwitterionic, composed from the lipid DPC and the surfactant 
PC-analogue LMPC, and the remaining one is a mixed micelle system composed of 85% 
LMPC and 15% LMPG, in keeping with the physiological ratio of PC to PG in the lung. 
For all micelle systems, the ID 1H spectra of Mini-B + SP-A look almost identical to 
SP-A alone (Figures 6.1, 6.2, 6.7, 6.8, 6.13 , 6.17 and 6.21). The 10 1H spectra ofthe mixed 
sample is expected to be dominated by the signals from SP-A since an SP-A monomer (248 
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amino acids) has more than 7 times the number of amino acids as a Mini-B monomer (34 
amino acids). Thus the signals from Mini-B are completely buried under the many more 
intense signals of SP-A. However, lack of any observable differences between the ID 1H 
spectra of SP-A and Mini-B + SP-A gives a primary indication that, in all micelle systems, 
the overall conformation of SP-A does not change with the addition of Mini-B. This, 
however, does not rule out an interaction between Mini-B and SP-A because the proton 
signals of SP-A are already very broad and overlapped and thus the SP-A signal intensity 
may not change much even if the relatively smaller Mini-B and SP-A are bound within the 
same micelle complex. 
Since Mini-B consists of nine 15N-labeled amino acids, the 2D 15N- 1H HSQC spectra 
provide an opportunity to assess the SP-A effects on the Mini-B conformation as a result of 
any interactions between the two proteins. Interestingly, upon addition of SP-A, the intensity 
of Mini-Box HSQC peaks decreases drastically for zwitterionic DPC and LMPC micelles 
(Figures 6.9 and 6.14) but remains mostly unaffected for anionic SDS and LMPG and mixed 
LMPC/LMPG micelles (Figures 6.3, 6.18 and 6.22). The same results are also observed for 
Mini-BRED + SP-A in DPC and SDS m,icelles (Figures 6.10 and 6.4). Therefore, in 
zwitterionic micelles, a much larger subpopulation of Mini-Box and the entire population of 
Mini-BRED appear to be bound in complexes that are too large to yield the HSQC signals, 
presumably complexes of SP-A-bound micelles. Since there are enough DPC/LMPC present 
to provide at least 4 times as many micelles as Mini-B molecules, it seems that Mini-B has a 
strong preference to interact with SP-A-bound DPC/LMPC complexes over SP-A-free 
DPC/LMPC micelles. This interpretation is supported by the absence of any changes in the 
HSQC spectra when more DPC is added (Figure 6.9 D and E). For the anionic micelles, the 
scenario appears to be substantially different. The absence of any apparent change in the 
HSQC peak intensity indicates that Mini-B does not interact with the SP-A/micelle complex 
and remains bound to its own micelle. Surprisingly, in mixed LMPC/LMPG micelles, 
Mini-B behaves similarly to that in pure LMPG micelles although the mixed micelles 
comprise 85% LMPC. It is, however, possible that even in the anionic and mixed micelle 
systems, a much smaller subpopulation of Mini-B interacts with SP-A and that does not 
cause an observable reduction in the overall HSQC peak intensity. 
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Indeed, the 2D DOSY spectra indicate the presence of larger complexes in both DPC 
and SDS micelle systems although the overall results are different between DPC and SDS. In 
DPC, the Mini-Box/SP-A mixture contains two populations of different sizes as indicated by 
the two translational diffusion coefficients. The apparent hydrodynamic diameters are ~ 12.8 
and 20.4 nm as calculated from the attenuation of the protein HN signals. Both of these sizes 
are much larger than the apparent hydrodynamic diameters of the complexes containing the 
proteins individually, ~ 2.3 nm for Mini-B0 x/DPC and ~ 4.1 nm for SP-AIDPC. The 
approximate ratio ofthe small-to-large subpopulations ofMini-Box/SP-A/DPC is 62%: 38% 
as estimated from the y-axis (relative signal intensity) intercepts of the two linear fits 
representing the two diffusion coefficients (Figure 6.11 ). However, as both species of Mini-
Box+ SP-A in DPC are much larger than Mini-Box alone, the intensity of the HSQC peaks 
decreases markedly (Figure 6.9). On the other hand, the mixed Mini-Box/SP-A sample in 
SDS also contains two species but the apparent hydrodynamic diameters are ~ 6.8 and 19.4 
nm. The approximate ratio of small-to-large subpopulations of Mini-Box/SP-A/SDS is 85% : 
15%. Moreover, the size of the predominant smaller species in this case is not very different 
from the~ 5.6 nm apparent hydrodynamic diameter of SP-A/SDS alone. Therefore, only a 
smaller fraction of the total number of Mini-B molecules present in the SDS sample seems to 
be bound to SP-A. This likely explains why the HSQC peaks of Mini-Box + SP-A do not 
noticeably lose intensity when compared to Mini-Box alone (Figure 6.3). The apparent sizes 
of the DPC- and SDS-bound protein(s) mentioned here are estimated from the attenuation of 
the protein HN signals. Although the numbers are different when the estimation is done from 
the attenuation of the micelle peaks, the trend of the size-change remains the same between 
the mixed and individual protein samples. Therefore, almost the entire population of Mini-
Box presumably interacts with SP-A when in zwitterionic DPC micelles but only a 
subpopulation of Mini-Box interacts with SP-A when in anionic SDS micelles. 
In contrast to the results obtained for smaller DPC/SDS micelles, the 20 DOSY 
spectra of Mini-Box + SP-A in larger LMPC/LMPG micelles do not provide a clear 
indication about the formation of bigger complexes containing both proteins together. 
Surprisingly, the apparent sizes of the particles present in Mini-Box + SP-A samples, 
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calculated from the translational diffusion coefficients, consistently come in between the 
sizes of the particles present in individual protein samples (Figures 6.13, 6.16 and 6.19). For 
example, the apparent hydrodynamic diameter of Mini-Box/SP-A/LMPC is ~ 8.5 nm, 
whereas that of Mini-BoxiLMPC and SP-A/ LMPC are~ 6.7 and 10.3 nm, respectively. It 
should be mentioned that the apparent sizes of the protein/lipid complexes in these larger 
micelle systems are estimated from the lipid peaks only. As deuterated versions of LMPC 
and LPMG are not commercially available to date, the signals from the protonated lipids 
overwhelm the signals from the protein(s), as the lipid-protein ratio is 400 : 1, and hence the 
protein HN signals are too weak to produce meaningful signal attenuation curves. 
It is not clear why, in LMPC and LMPG samples, Mini-Box + SP-A diffuses more 
rapidly than SP-A alone (Figures 6.13, 6.16 and 6.19). However, my previous studies of 
Mini-Box alone show that Mini-Box induces either a size decrease, a shape change, or a 
faster exchange of free and micelle-bound amphiphiles for the larger micelles composed of 
LMPC or LMPG, which results in a faster diffusion of the Mini-Box/micelle complexes than 
pure micelles (Chapter 4). Perhaps something similar takes place even when SP-A is present. 
Also surprising is the observation that the excellent single fits of the signal attenuations 
curves for Mini-Box + SP-A in LMPC and LMPG indicate a single translational diffusion 
coefficient, and hence apparently one size, for each system. In comparison with SDS or DPC, 
large amphiphiles like LMPC and LMPG are much less used in the NMR studies of proteins. 
Many of the physical properties of these micelles, such as the shape and the size, are not well 
characterized to date. It is possible that the shape of pure LMPC and LMPG micelles is 
largely nonspherical and when bound to the protein(s) the shape may further deviate either 
way. This effect may be more prominent for a small amphipathic peptide like Mini-B and 
may result in an apparently unusual faster diffusion of the peptide/micelle complexes, even 
when the much larger SP-A is present. Another possibility is a Mini-Box induced further 
reduction of SP-A oligomeric states, e.g., from 2~3 trimers to single trimers or even smaller, 
in LMPC and LMPG systems causing the Mini-Box/SP-A/micelle complexes to diffuse more 
rapidly than the SP-A/micelle complexes. This may be a very interesting demonstration of 
Mini-Box-induced rearrangement of not only the lipid structures but also the SP-A structures. 
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How exactly Mini-B interacts with SP-A is a matter of discussion. Since, in all cases, 
the chemical shifts of the Mini-B HSQC peaks (or their much weaker traces) remain 
unchanged, most likely the interactions between the two proteins do not occur directly but 
are mediated through the micelles. It is plausible that the Mini-B/micelle complexes fuse 
with the SP-A/micelle complexes but the two proteins remain apart in the final assembly. 
However, it is also possible that Mini-B directly interacts with SP-A but the complexes 
representing the directly interacting subpopulation are so large that they are completely 
absent from the HSQC spectra and hence the corresponding chemical shift changes of the 
peaks can not be tracked. 
Electrostatic interaction between the positively charged Mini-B (net charge +7) and 
negatively charged SP-A (net charge -4) is most likely at the root of the fusion of the 
complexes containing the individual proteins. However, since both proteins are initially 
bound to their own micelles, the charges of lipid/detergent headgroups are expected to 
greatly influence the fusion process. Thus in the context of zwitterionic micelles, it is 
reasonable to think that electrostatic interaction between Mini-B and SP-A would be 
relatively strong, while in anionic micelles, the repulsion between micelles could 
substantially reduce the interaction between the two proteins. Moreover, as discussed in 
Chapter 4 (Page 90), Mini-B appears to be more compactly and deeply bound to anionic 
micelles than zwitterionic micelles. Therefore when within an anionic micelle, perhaps 
Mini-B does not experience a strong attraction toward SP-A which is bound to another 
anionic micelle. However, the Brownian motion and random collision in solution may bring 
instantaneous changes in the overall electrostatic profile of the individual protein complexes 
and thus a smaller subpopulation of the two proteins may become bound to the same anionic 
micelle complexes. In contrast, when bound to the zwitterionic micelles, whose own net 
charge is zero, the oppositely charged Mini-B and SP-A complexes likely experience a much 
stronger attraction and may easily fuse to form single Mini-B/SP-A/micelle complexes for 
the entire population, even if the two proteins do not directly bind each other. The apparent 
relatively superficial positioning of Mini-B in zwitterionic micelles may further enhance the 
complex formation process. 
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Comparison of the apparent particle sizes containing Mini-Box and SP-A jointly and 
individually indicates that, at least in DPC and SDS, the protein-protein complexes are not 
formed as just one Mini-Box plus one SP-A. Both subpopulations of Mini-Box/SP-A/DPC 
and the larger subpopulation of Mini-Box/SP-A/SDS are presumably formed by binding 
multiple subunits ofthe two proteins in a single complex. 
In summary, the degree of interaction between Mini-B and SP-A appears to be 
dependent on the type of detergent/lipid headgroup. For the model surfactant lipids used in 
this study, most likely the interaction is not a direct protein-protein interaction, but rather is 
mediated via the detergent/lipid micelles. While the atomistic understanding of Mini-B/SP-A 
interaction is not complete, a lipid-dependent interaction between native SP-B and SP-A may 
have important implications in lung surfactant function. 
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Chapter 7 
odifications · o SP-Bs-2s St uc ure 
and Lipid In eractio - s upon 
Tryp · ophan Oxidation 
Note : Peptides used in this study were synthesized and purified by Donna Jackman 
(Booth lab, Biochemistry, MUN) . CD data were acquired and analyzed with help of 
Prof David H. Heeley (Heeley lab, Biochemistry, MUN) and Dr. Michael Hayley 
(Booth lab, Biochemistry, MUN). 
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7.1 Overview 
Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) can arise 
from a variety of insults of the lung including oxidative stress caused by an increase in 
reactive oxygen species (ROS) [199-202]. ROS-induced modifications result in dysfunction 
of lung surfactant (LS) and can lead to its complete inactivation [202-205]. Several studies 
have examined the disruptive effects of ROS on both individual LS components, namely 
lipids and proteins, and overall alterations of surfactant biophysical activity [ 179, 205-21 0]. 
However, the most deleterious effects are observed for ROS-induced modifications of SP-B, 
which appear to make the most severe contributions to surfactant inactivation [202, 206, 21 0]. 
In vitro studies have shown that the oxidation of SP-B involves modification of a maximum 
of three amino acids; the two methionines and the only tryptophan [211]. Analysis of 
fusogenic, lytic and surface tension reducing activities of SP-B-based peptides demonstrates 
that Trp9 is critical for optimal interface affinity ofSP-B [107, 142]. It is therefore crucial to 
characterize the changes to the structure and lipid interactions of SP-B caused by the 
oxidative modification of Trp9 which potentially leads to the loss of protein function. 
Tryptophan is an amino acid that typically either contributes to the hydrophobic core 
of a globular protein or anchors a lipid-associated protein to a polar/apolar interface [212]. 
From the structure of Mini-B, determined in detergent micelles composed of SDS, the 
sidechain ofTrp9 (W2 in Mini-B) does not appear to contribute to the interhelix hydrophobic 
contacts and therefore its role is most likely in interacting with the lipids to help anchor 
Mini-Bat the lipid/water interface (Chapter 3 and [156]). 
In this part of my research, I have studied the conformations of Wild-Type and 
Trp-Oxidized SP-B8_25, an 18 amino acid peptide that consists of the N-terminal helical 
segment of SP-B (i.e., the N-terminal half of Mini-B). The objectives were to investigate if 
the oxidation of Trp9 destroys the helical structure or makes the peptide unable to anchor 
inside lipids only, or results in both. The structural differences between the two peptide 
versions were probed in lung lipid mimetic SDS and DPC micelles, in organic solvent HFIP, 
as well as in water alone, using solution NMR and circular dichroism (CD). 
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7.2 Materials and Methods 
7.2.1 Peptide Synthesis and Purification 
SP-Bs-25 consists of human SP-B amino acids 8 to 25. Two versions of the peptide 
were synthesized and purified by Donna Jackman (Booth lab, Biochemistry, MUN). The 
wild-type version [SP-Bs-25 (Wild-Type)] retained the native tryptophan at position 2, which 
corresponds to position 9 in the natural protein. In the oxidized version [SP-B8_25 (Trp9Kyn)], 
tryptophan was replaced by one of its oxidized forms, kynurenine [Figure 7.1]. The amino 
acid sequences are : 
SP-Bs-25 (Wild-Type) : Cys-Trp-Leu-Cys-Arg-Ala-Leu-IIe-Lys-Arg-Ile-Gln-Ala-Met-Ile-Pro-Lys-Giy 
SP-Bs-25 (Trp9Kyn) : Cys-Kyn-Leu-Cys-Arg-Ala-Leu-IIe-Lys-Arg-IIe-Gin-Aia-Met-Ile-Pro-Lys-Giy 
H 
.,..,.,.,N 
0 
Tryptophan 
(Trp) 
0 
NH2 Figure 7.1 : Chemical structures 
of tryptophan (Trp) and one of its 
oxidized forms kynurenine (Kyn). 
Kynurenine 
(Kyn) 
Both versions of SP-B8_25 were synthesized in a CS336X peptide synthesizer (C S Bio 
Co., Menlo Park, CA) following manufacturer's instructions. The peptides were produced by 
solid phase peptide synthesis method employing 0-fluorenylmethyloxycarbonyl (Fmoc) 
chemistry. All Fmoc amino acids and coupling agents were purchased from C S Bio Co. with 
the exception of Fmoc kynurenine that was purchased from Advanced ChemTech (Louisville, 
KY). Organic solvents and other reagents used for the synthesis and purification were high 
performance liquid chromatography (HPLC) grade or better and purchased from Fisher 
Scientific (Ottawa, ON) and Aldrich Chemical (St. Louis, MO). The peptides were 
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synthesized at a 0.2 mmol scale using a single coupling. A prederivatized Rink amide resin 
was used to assemble the peptides during synthesis. At completion, deprotection and 
cleavage of the peptides from the resin were carried out with a TF A/Water (95/5 by volume) 
cleavage cocktail followed by cold precipitation with tert-butyl ether. The crude products 
were then purified by preparative reverse-phase HPLC in a Vydac C-8 column by use of a 
water/acetonitrile linear gradient with 0.1% trifluoroacetic acid as the ion-pairing agent. The 
molecular weight of the peptides were confirmed by matrix-assisted laser desorption/ 
ionization - time of flight (MALDI-TOF) mass spectrometry performed at the CREAIT 
Network facility (MUN). Finally, the purified peptides were lyophilized and stored at 4 °C. 
7.2.2 Sample Preparation 
Four samples were prepared for each version of SP-88_25 . First a stock buffer solution 
was prepared in H20/D20 (90%110%) with 0.4 mM DSS and 0.2 mM NaN3. The final 
samples were then prepared by dissolving peptides and other contents in the buffer. For 
samples in water, 1 mM peptide was dissolved in the buffer. Samples in HFIP also contained 
1 mM peptide but the buffer was adjusted to have 40% HFIP (98% deuterated; Cambridge 
Isotope, Andover, MA) plus 50% H20 and 10% D20 . For samples in SDS or DPC, 1 mM 
peptide and 100 mM detergent (98% deuterated; Cambridge Isotope, Andover, MA) were 
dissolved in the buffer. One mM DTT was also added to all eight samples from a freshly 
prepared DTT stock solution. The pH of the samples was set to 7.0 by use ofNaOH and HCl, 
without taking the isotope effects into account. Only one sample of each composition was 
made and the same sample was used for both NMR and CD experiments. 
7.2.3 NMR Data Collection and Processing 
A set of 1D 1H, 2D 1H- 1H TOCSY, 2D 1H-1H NOESY and 2D DOSY experiments 
was performed for each SP-88_25 sample on a Bruker Avance II 14.1 Tesla (600 MHz) 
spectrometer (Billerica, MA) equipped with z-gradients and an inverse triple resonance TXI 
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probe. The NMR data were collected and processed using the Bruker Topspin 2.0 software. 
The pulse length (P 1) and the transmitter offset (0 1) were optimized for each sample before 
running the full set of NMR experiments. The 1D 1H, 2D 1H-1H TOCSY and 2D 1H- 1H 
NOESY spectra were acquired at temperature 37 octo match the physiological temperature. 
All these experiments used the water-gate water suppression technique [146]. In 1D 1H 
experiments, data were collected with 32 scans and processed using an exponential 
apodization function with 1 Hz line broadening. The 2D 1H- 1H TOCSY experiments used a 
60 ms mixing time and were run with 80 or 128 scans (indicated in the figure captions). A 
total of 2048/512 data points were collected in F2/F 1 dimensions and the processed spectra 
had 1024 points in both dimensions. The 2D 1H- 1H NOESY experiments used a 200 ms 
mixing time and were run with 128 scans. A total of 2048/512 data points were collected in 
F2/F1 dimensions and the processed spectra had 1024 points in both dimensions. All TOCSY 
and NOESY spectra were processed using the Qsine apodization function with a sine bell 
shift of 2. The 2D DOSY experiments were performed using PFG NMR [157]. The pulse 
sequence used a stimulated echo with bipolar gradient pulses and one spoil gradient [ 158], 
followed by a 3-9-19 pulse for water suppression [159]. The DOSY spectra were acquired for 
SDS samples at 37 °C. However, for DPC samples, the DOSY spectra were acquired at 
25 oc to minimize the effect of thermal convection. The diffusion time was kept constant at 
100 ms. The gradient pulse length was optimized for each sample and set between 4 and 6 ms. 
The maximum amplitude of the gradient strength was 35 G/cm and the 1H signals were 
attenuated in 32 steps. The translational diffusion coefficient was determined from the slope 
of the signal attenuation curve plotted using Eq. 2. 17. The hydrodynamic diameter was 
calculated using the Stokes-Einstein equation [Eq. 2.20]. The viscosity of pure water was 
used for the viscosity of solution in the calculation and the values were 8.91 x 10-4 kg/m.s at 
25 oc (298 K) and 6.92 x 10-4 kg/m.s at 37 oc (31 0 K). 
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7.2.4 CD Data Collection and Processing 
The CD spectra, in the far-ultraviolet (far-UV) region (from 260 to 190 nm), were 
recorded for all eight SP-B8•25 samples using a Jasco-81 0 spectrapolarimeter (Easton, MD). 
The CD data were acquired at 37 oc using a quartz cuvette with 0.1 mm path length. The 
NMR samples were transferred to the cuvette without making any changes in the sample 
conditions. The temperature was controlled by a CTC-345 circulating water bath. The 
scanning speed of the instrument was set at 100 run! min with normal sensitivity. Five 
accumulations were collected for each sample in 0.1 nm steps. The Molar ellipticity [8] was 
calculated using the equation suggested by Heeley et al. [213], 
[8] = 8obsl( 1 OLC), (7 .1 ) 
where Sobs is the observed ellipticity, L is the path length of the cell (0.0 1 em) and C is the 
number of amino acids multiplied by the molar concentration of the peptide (0.0 18 M). The 
secondary structural content was calculated from the molar ellipticity data using a computer 
program following the method of Yang et a/. [214]. Although the computer program 
calculated the structure percentages as a-helix, ~-sheet, ~-tum and random coil, SP-Bs-25 is 
unlikely to contain a ~-sheet which requires two or more strands hydrogen-bonded together. 
It is more plausible that the ~-sheet content indicated by the computer program actually 
represents an extended conformation and hence is reported as such in the CD results sections. 
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7.3 Results 
7.3.1 NMR Spectra of SP-B8_25 in SDS 
Figure 7.2 shows the lD 1H spectra of SP-Bs-25 (Wild-Type) and SP-Bs-25 (Trp9Kyn) 
in SDS micelles, a mimetic for the lung surfactant phospholipids with anionic headgroups. 
The signals seen for SP-Bs.25 (Wild-Type) in the enlarged 6-9 ppm region, corresponding to 
the backbone and sidechain amide protons (HNs), are broad and possibly overlapped in some 
cases but well dispersed. This level of line-broadening and overlap is not unexpected as the 
peptide is bound to a detergent micelle. The spectral dispersion and intensity of backbone 
HNs indicate SP-Bs-25 (Wild-Type) is structured in SDS. The 6-9 ppm region of SP-Bs-25 
(Trp9Kyn), on the other hand, looks substantially different. There are fewer signals present 
and the signals are less intense and less resolved, although the 7-7.5 ppm region has some 
peaks with greater intensity likely from sidechain HNs. Overall, the lD 1H spectrum of 
SP-Bs-25 (Trp9Kyn) is atypical for a structured peptide. 
Similarly, the HA-HN regions of 2D 1H- 1H TOCSY and 2D 1H-1H NOESY spectra 
(data not shown) show fewer cross peaks for SP-B8_25 (Trp9Kyn) than for SP-B8•25 (Wild-
Type). The overall appearance of these spectra is consistent with Wild-Type peptide being 
well structured and Trp9Kyn peptide exhibiting far less structure. This interpretation is 
further supported by the examination ofHN-HN regions of2D 1H- 1H NOESY spectra ofSP-
Bs.25 (Wild-Type) and SP-B8•25 (Trp9Kyn) in SDS (Figure 7.3). About 9 backbone HN-HN 
cross peaks and some sidechain HN-HN cross peaks are seen for SP-B8.25 (Wild-Type). The 
~ 9 intense backbone HN-HN correlations result from short HN-HN distances and indicate 
an a-helical folding of the peptide for about 10 amino acids (i.e., about 3 helical turns). 
However, for SP-B8.25 (Trp9Kyn), only ~ 2 backbone HN-HN cross peaks are seen. This 
indicates that SP-Bs-25 (Wild-Type) contains a helical region comprised of only about 3 
amino acids (i .e., approximately 1 helical tum). 
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Next, diffusion NMR spectroscopy is used to indicate differences in the 
peptide/micelle complex sizes. The 2D DOSY spectra of SP-Bs-25 (Wild-Type) and SP-Bs-25 
(Trp9Kyn) in SDS (Figure 7.4) display 1H signals resulted from translational diffusion. The 
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in SDS 
, . 0 (ppm] 
~ B. SP-Bs-25 {Trp9Kyn) 
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Figure 7.2 : 1D 1H spectra of (A) mM SP-B8_25 (Wild-Type) and (B) 1 mM SP-Bs-25 
(Trp9Kyn) in 100 mM SDS at pH 7.0 and temperature 37 °C, acquired using 32 scans. The 
6-9 ppm regions of both spectra are enlarged and shown in the bottom panel (C). 
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translational diffusion coefficients are represented by the slopes of the signal attenuation 
curves, obtained from the underlying 1D 1H experiments, for the two sharpest SDS peaks at 
0.80 ppm (corresponding to CH3) and 1.22 ppm (corresponding to (CH2)3_11), as well as the 
SP-Bs-25 HN regions (6-9 ppm). The observed diffusion coefficients, along with the 
hydrodynamic diameters calculated using the Stokes-Einstein equation, are reported in the 
table of Figure 7.4. The diameters are 2.82, 2.85 and 2.71 nm, respectively, for SP-Bs-25 
(Wild-Type)/SDS complex and 3.93, 3.77 and 3.45 nm, respectively, for SP-B8_25 
(Trp9Kyn)/SDS complex. Therefore, the micelle complex containing SP-Bs-25 (Trp9Kyn) 
appears substantially larger than the micelle complex containing SP-B8_25 (Wild-Type). 
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Figure 7.3: HN-HN regions of2D 1H-1H NOESY spectra of(A) 1 mM SP-B8_25 (Wild-Type) 
and (B) 1 mM SP-B8_25 (Trp9Kyn) in 100. mM SDS at pH 7.0 and temperature 37 °C, 
acquired using 128 scans and 200 ms mixing time. The base contour level, level increment 
and number of levels are the same for both spectra. 
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Figure 7.4 : SP-B8•25/SDS complex sizes as 
indicated by translational diffusion. Upper panels 
show the 2D DOSY spectra of (A) I mM SP-Bs-25 
(Wild-Type) and (B) 1 mM SP-Bs-25 (Trp9Kyn) in 
I 00 mM SDS at pH 7.0 and temperature 37 °C. 
Linear fits (C, D and E) show the attenuation of the 
peaks at 0.80, I .22 and 6-9 ppm obtained from the 
DOSY data. The observed diffusion coefficients, 
represented by the slopes of the curves, and the 
hydrodynamic diameters, calculated using the 
Stokes-Einstein equation (Eq. 2.20), are shown in 
the table (F). 
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7.3.2 CD Spectra of SP-B8_25 in SDS 
CD spectroscopy provides an alternate measure of the secondary structural content of 
both versions of the peptide to complement the NMR data. Figure 7.5 shows the CD spectra 
of SP-Bs-25 (Wild-Type) and SP-Bs-25 (Trp9Kyn) in SDS at pH 7.0 and temperature 37 °C. It 
is observed that more than half of SP-B8_25 (Wild-Type) is helical (- 52%), with the 
remainder in random coil (- 18%) and extended (- 30%) conformation. However, the 
features for SP-Bs-25 (Trp9Kyn) are substantially different, with reduction of helical content 
to about one-fourth (- 27%) and a considerable increase in random coil (36%) along with 
some increase in extended (- 3 7%) conformation. 
In SDS 
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Figure 7.5 : Far-UV CD spectra of 1 mM SP-B8_25 (Wild-Type) and 1 mM SP-Bs-25 
(Trp9Kyn) in 100 mM SDS at pH 7.0 and temperature 37 °C, acquired using 5 accumulations 
and a 0.1 mm light path. The molar ellipticity is calculated from the observed ellipiticity 
following the method described in Ref. [213]. The secondary structural contents are 
calculated from the molar ellipticities following the method described in Ref. [214] . 
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7.3.3 NMR Spectra of SP-B8_25 in DPC 
The results for both Wild-Type and Trp9Kyn versions of SP-B8_25 in DPC micelles, a 
mimetic for lung surfactant phospholipids with zwitterionic headgroups, were similar to 
those obtained in the anionic SDS micelles. Figure 7.6 shows the 1 D 1H spectra of SP-B8_25 
in DPC. For SP-Bs-25 (Wild-Type), well-dispersed signals from the backbone and sidechain 
amide protons (HNs) are seen in the enlarged 6-9 ppm region. The 6-9 ppm region of 
SP-Bs-25 (Trp9Kyn), on the other hand, looks substantially different. In spite of the signals in 
7.1-7.5 ppm region with greater intensity, likely from sidechain HNs, there are much fewer 
and less intense backbone HN signals present. Again, the dispersion and intensity of 
backbone HN signals indicate SP-Bs-25 (Wild-Type) is structured but that of SP-Bs-25 
(Trp9Kyn) are atypical for a structured peptide. 
This interpretation is supported further from the analysis of HN-HN regions of 2D 
1H- 1H NOESY spectra ofSP-Bs-25 (Wild-Type) and SP-Bs-25 (Trp9Kyn) in DPC (Figure 7.7). 
About eight backbone HN-HN cross peaks and some sidechain HN-HN cross peaks are seen 
for SP-B8_25 (Wild-Type). The intense backbone HN-HN correlations indicate an a-helical 
folding of the peptide for about 9 amino acids (i.e., 2.5 helical turns). However, for SP-Bs-25 
(Trp9Kyn), only two backbone HN-HN cross peaks are seen. This indicates that SP-B8_25 
(Wild-Type) contains a helical region ·comprised of only about 3 amino acids (i .e. 
approximately 1 helical turn). The HA-HN regions of 2D 1H- 1H TOCSY and 2D 1H- 1H 
NOESY spectra [data not shown] also indicate less structuring of SP-B8_25 (Trp9Kyn) when 
compared to SP-B8_25 (Wild-Type). 
Similarly to the study in SDS, differences in the complex sizes are also obtained for 
the peptides in DPC micelles using diffusion NMR spectroscopy (Figure 7.8). Again, three 
hydrodynamic diameters are calculated from the translational diffusion coefficients obtained 
for the signal attenuation of the two sharpest DPC peaks at 0. 79 ppm (corresponding to CH3) 
and 1.20 ppm (corresponding to (CH2)3_11 ) as well as the SP-B8_25 HN region (6-9 ppm). The 
diameters are 4.57, 4.51 and 4.19 nm, respectively, for SP-B8_25 (Wild-Type)/DPC complex 
and 3.83, 3.74 and 3.73 nm, respectively, for SP-B8_25 (Trp9Kyn)/DPC complex. The sizes of 
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the DPC micelle complexes, containing two different peptide versions, are not as dissimilar 
as for SDS complexes. Also, in contrast to SDS, the hydrodynamic diameter of the SP-B8•25 
(Trp9Kyn)/DPC complex is smaller than the SP-B8•25 (Wild-Type)/DPC complex. 
~ A. SP-Bs-25 (Wild-Type) 
inDPC 
0 (ppm) 
~ B. SP-Bs-25 (Trp9Kyn) 
in DPC 
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Figure 7.6 : 1D 1H spectra of (A) 1 mM SP-B8.25 (Wild-Type) and (B) 1 mM SP-Bs.25 
(Trp9Kyn) in 100 mM DPC at pH 7.0 and temperature 37 °C, acquired using 32 scans. The 
6-9 ppm regions of both spectra are enlarged and shown in the bottom panel (C). 
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Figure 7.7: HN-HN regions of(A) 2D 1H-1H NOESY spectra of 1 rnM SP-Bs-25 (Wild-Type) 
and (B) 1 mM SP-B8_25 (Trp9Kyn) in 100 mM DPC at pH 7.0 and temperature 37 °C, 
acquired using 128 scans and 200 ms mixing time. The base contour level, level increment 
and number of levels are the same for both spectra. 
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Figure 7.8 : SP-B8_25/DPC complex sizes as 
indicated by translational diffusion. Upper panels 
show the 2D DOSY spectra of (A) I mM SP-Bs-25 
(Wild-Type) and (B) 1 mM SP-Bs-25 (Trp9Kyn) in 
100 mM DPC at pH 7.0 and temperature 25 °C. 
Linear fits (C, D and E) show the attenuation of the 
peaks at 0.79, 1.20 and 6-9 ppm obtained from the 
DOSY data. The observed diffusion coefficients, 
represented by the slopes of the curves, and the 
hydrodynamic diameters, calculated using the 
Stokes-Einstein equation (Eq. 2.20), are shown in 
the table (F). 
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7.3.4 CD Spectra of SP-B8_25 in DPC 
To complement the NMR data and obtain an alternate measure of the secondary 
structural content, CD spectroscopy was also performed for both versions of SP-B8_25 in DPC 
at pH 7.0 and temperature 37 oc (Figure 7.9). The CD data indicate that about two-fifths of 
SP-Bs-25 (Wild-Type) is helical (~ 38%) with the remainder in random coil (~ 26%) and 
extended (~ 36%) conformation. However, the features for SP-B8_25 (Trp9Kyn) are 
substantially different, with the reduction of helical content to about one-fifth (~ 20%) and a 
considerable increase in random coil(~ 39%) along with some increase in extended(~ 4I%) 
conformation. Differences in the structures of the two peptide versions in DPC are similar to 
that observed in SDS. 
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Figure 7.9 : Far-UV CD spectra of I mM SP-Bs-25 (Wild-Type) and I mM SP-Bs-25 
(Trp9Kyn) in IOO mM DPC at pH 7.0 and temperature 37 °C, acquired using 5 
accumulations and a O.I mm light path. The molar ellipticity is calculated from the observed 
ellipiticity following the method described in Ref. [2I3]. The secondary structural contents 
are calculated from the molar ellipticities following the method described in Ref. [2I4]. 
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7.3.5 NMR Spectra of SP-B8_25 in HFIP (40°/o) 
In contrast to the micelle systems, 40% HFIP m aqueous solution provides a 
secondary structure-inducing environment, but without a polar/apolar interface, which can be 
important in inducing native-like folding of amphipathic helices. For SP-Bs-25 in 40% HFIP 
(plus 50% H20 and 10% D20), likewise in the SDS and DPC micelle systems, the 1 D 1H, 2D 
1H- 1H TOCSY and 2D 1H- 1H NOESY spectra indicate SP-Bs-25 (Wild-Type) is much more 
structured than SP-Bs-25 (Trp9Kyn) (Figures 7.10 and 7.11). The numbers of intense cross 
peaks in the HN-HN regions of 2D 1H-1H NOESY spectra indicate an a-helix at least 8 
amino acid long for Wild-Type peptide, but only 3 amino acid long for Trp9Kyn peptide. 
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Figure 7.10 : lD 1H spectra of (A) 1 mM SP-Bs-25 (Wild-Type) and (B) 1 mM SP-Bs-25 
(Trp9Kyn) in 40% HFIP (plus 50% H20 and 10% D20) at pH 7.0 and temperature 37 °C, 
acquired using 32 scans. The 6-9 ppm regions of both spectra are enlarged and shown in the 
bottom panel (C). 
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Figure 7.11 : HN-HN regions of (A) 20 1H-1H NOESY spectra of 1 mM SP-Bs-25 (Wild-
Type) and (B) 1 mM SP-B8_25 (Trp9Kyn) in 40% HFIP (plus 50% H20 and 10% 0 20) at pH 
7.0 and temperature 37 °C, acquired using · l28 scans and 200 ms mixing time. The base 
contour level, level increment and number of levels are the same for both spectra. 
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7.3.6 CD Spectra of SP-B8_25 in HFIP (40°/o) 
The interpretation of NMR spectra in 40% HFIP is further supported by the CD 
spectroscopy of SP-B8.25 performed at pH 7.0 and temperature 37 oc (Figure 7.12). The 
secondary structure calculation shows that about two-fifths of SP-B8•25 (Wild-Type) is helical 
(~ 41 %) with the remainder in random coil (~ 29%) and extended (~ 30%) conformation. 
However, for SP-Bs-25 (Trp9Kyn), the helical content is reduced to about one-fifth(~ 19%) 
and the random coil is increased substantially (~ 44%) along with some increase of the 
extended ( ~ 3 7%) conformation. These features are similar to that of the micelle-bound 
Wild-Type and Trp9Kyn peptides. 
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Figure 7.12 : Far-UV CD spectra of 1 mM SP-B8•25 (Wild-Type) and 1 mM SP-Bs-25 
(Trp9Kyn) in 40% HFIP (plus 50% H20 and 10% D20) at pH 7.0 and temperature 37 °C, 
acquired using 5 accumulations and a 0.1 mm light path. The molar ellipticity is calculated 
from the observed ellipiticity following the method described in Ref. [213]. The secondary 
structural contents are calculated from the molar ellipticities following the method 
described in Ref. [214]. 
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7.3.7 NMR Spectra of SP-B8_25 in Water 
Unlike in surfactant phospholipid mimetic SDS and DPC micelles, or in structure-
inducing organic solvent HFIP, the lD 1H, 2D 1H-1H TOCSY and 2D 1H- 1H NOESY spectra 
indicate both version of SP-Bs.25 to be largely unstructured in water alone (90% H20 plus 
10% D20) (Figures 7.13 and 7.14). There are no cross peaks seen representing backbone 
HN-HN correlations in the corresponding regions of 2D 1H-1H NOESY. The cross-peaks 
seen for the Wild-Type are likely from the sidechain HNs. Overall features of the spectra 
suggest either aggregation or absence of an a-helical structure for both SP-Bs-25 (Wild-Type) 
and SP-Bs.25 (Trp9Kyn) in water alone. 
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Figure 7.13 : lD 1H spectra of (A) 1 mM SP-B8.25 (Wild-Type) and (B) 1 mM SP-Bs-25 
(Trp9Kyn) in water (90% H20 and 10% D20) at pH 7.0 and temperature 37 °C, acquired 
using 32 scans. The 6-9 ppm regions of both spectra are enlarged and shown in the 
bottom panel (C). 
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Figure 7.14 : HN-HN regions of (A) 2D 1H- 1H NOESY spectra of 1 mM SP-Bs-25 (Wild-
Type) and (B) 1 mM SP-B8_25 (Trp9Kyn) in water (90% H20 and 10% D20) at pH 7.0 and 
temperature 3 7 oc, acquired using 128 scans ·and 200 ms mixing time. The base contour level, 
level increment and number of levels are the same for both spectra. 
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7.3.8 CD Spectra of SP-B8_25 in Water 
Complementing the NMR observation, the CD spectra of SP-Bs-25 in water at pH 7.0 
and temperature 37 oc indicates no considerable a-helical secondary structure for the Wild-
Type peptide (only ~ 8%) but some helical structure for the Trp9Kyn peptide (~ 33%) 
(Figure 7 .15). The remainders, representing the majority portions of both peptides, are in 
random coil and extended conformation. These features are substantially different from what 
are observed for SP-Bs-25 either in detergent micelles or in organic solvent. 
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Figure 7.15 : Far-UV CD spectra of 1 mM SP-Bs-25 (Wild-Type) and 1 mM SP-Bs-25 
(Trp9Kyn) in water (90% H20 and 10% D20) at pH 7.0 and temperature 37 °C, acquired 
using 5 accumulations and a 0.1 mm light path. The molar ellipticity is calculated from 
the observed ellipiticity following the method described in Ref. [213]. The secondary 
structural contents are calculated from the molar ellipticities following the method 
described in Ref. [214]. 
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7.4 Discussion 
Inactivation of lung surfactant occurs in potentially fatal respiratory disorders like 
ARDS [33]. There are multiple biophysical and biochemical alterations of lung surfactant 
associated with ARDS [215]. However, several studies have confirmed that patients with 
ARDS show clear evidence of increased oxidative damage to surfactant lipids as well as 
proteins [179, 205-21 0]. Oxidative modification of SP-B, an essential component of lung 
surfactant, appears to be a major contributor to surfactant inactivation [202, 206, 21 0]. The 
modifications likely occur through the changes in the chemical structures of the two 
methionines and the only tryptophan of SP-B [211]. While oxidation of both residues hamper 
surfactant biophysical activity [211 ], modification of Trp9 likely produces the most 
deleterious effect as this amino acid is vital for SP-B function [1 07, 142]. 
SP-88_25, an 18 amino acid fragment comprising the N-teminal helical region of SP-B, 
has been shown to exhibit in vitro surface activity [ 103, 1 07] as well as to retain partial 
biological function when included in artificial surfactants [ 101]. This peptide carries a net 
charge of+4 (Arg12, Lys16, Arg17 and Lys24) at neutral pH as compared to the net change 
of +7 for the full-length SP-B monomer. It also includes the only tryptophan (Trp9) present 
in the SP-B sequence. The function of SP-B is thought to relate to its positive charges and 
amphipathic helical structure [83, 1 06], and thus the retention of these structural features by 
the fragment SP-88_25 is presumably what makes this peptide partially functional. 
The structure of SP-8 11 _25 in methanol was studied by Kurtz et al. and found to be 
a-helical for amino acids 13 to 21 [76]. However, this fragment did not include the 
functionally important Trp9. In my previous structural studies of Mini-B (Chapter 3 and 
M.Sc. Thesis), a larger peptide comprised of SP-Bs-25 joined to SP-B63-7s was found to 
consist of two helices. The N-terminal helix comprises amino acids 10 to 21 in SDS [ 156] 
and 11 to 22 in HFIP [ 11 0]. The experiments performed for this chapter indicated that 
SP-88_25 (Wild-Type), which corresponds to theN-terminal half of Mini-B, also took on an 
a-helical conformation in SDS and DPC micelles, as well as in HFIP, as indicated by NMR 
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and CD spectra. It is therefore reasonable to consider the corresponding segment of Mini-B 
(i.e., amino acids 1-18) as a reference structure for SP-B8_25 (Wild-Type) (Figure 7.16). 
However, as the other half of Mini-B is missing and interhelix interactions between the two 
halves were observed for Mini-B in SDS, small differences in the helical structure of 
SP-Bs-25 (Wild-Type) would not be unexpected. 
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Mini-B SP-B8_25 
Figure 7.16 : Topology and structure 
of SP-Bs-25 (Wild-Type) based on the 
structure of Mini-B in SDS (PDB lD 
2DWF). The numbers with sjngle 
letter amino acid codes represent the 
position within the peptides (not the 
full-length protein). 
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The objective of this part of my research was to directly probe the changes in the 
structure of SP-Bs_25 due to the oxidation of Trp9. Therefore, conformational features of both 
Wild-Type and Trp-oxidized SP-Bs-25 were studied under four different conditions; in SDS 
micelles that contain anionic headgroups, in DPC micelles that contain zwitterionic 
headgroups, in organic solvent HFIP ( 40%), and in water alone. The choices of detergents 
were made based on the requirements for mimicking the natural lung surfactant lipid 
environments. SDS is a mimetic for PGs, the anionic surfactant phospholipids that SP-B is 
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thought to preferentially bind in surface monolayers of surfactant films [83, 84]. DPC, on the 
other hand, is a mimetic for DPPC, the most abundant zwitterionic phospholipid generally 
considered to be of paramount importance in attaining low surface tension in the alveolar air-
water interface [24]. HFIP is not a lung lipid mimetic but an organic solvent that induces the 
helical secondary structure of a peptide. Hence the features of SP-B8•25 in HFIP would reveal 
any generic changes in the helical structure due to tryptophan oxidation, even in the absence 
of an interfacial environment. Although the lipid-associated SP-B and its fragments are 
unlikely to be properly folded without any intervention of lipids or organic solvents, the 
features of SP-Bs.25 have still been studied in water alone to unveil any differences owing to 
the tryptophan oxidation under this condition. 
The NMR data reveal that SP-B8.25 (Wild-Type) adopts an a-helical conformation 
comprising 9 to 10 amino acids in both SDS and DPC micelles, as well as in HFIP. The rest 
of the peptide appears to be random and extended. These structural features are also well 
supported by the CD data. This structure of SP-B8.25 (Wild-Type) is not very different from 
the corresponding segment of Mini-B in SDS, in which the N-terminal helix comprises 12 
amino acids. However, the peptide seems to be unstructured and possibly aggregated in water 
alone. This is not unexpected since about half of SP-Bs.25 (Wild-Type) amino acids are 
hydrophobic and, therefore, the peptide is presumably insoluble in water. 
Assuming it takes on a similar structure alone to its structure within Mini-B, the 
SP-B8.25 (Wild-Type) helix is apparently strikingly amphipathic with three positively charged 
amino acids (Argl2, Lys16 and Argl7) clustering in one face and four non-polar amino acids 
(Leu1 0, Leu14, Ile15 and Ile18) grouping at the opposite face. Also, in light of the Mini-B 
structure, Trp9 is unlikely to be a part of the helix, rather it is located in between the charged 
and hydrophobic faces. This positioning is very suitable for its sidechain to interact with 
lipids and anchor the peptide at the lipid/water interface. It is conceivable that the 
amphipathic helical structure, along with the tryptophan anchor, provide the basis for the 
partial biological activity of SP-B8•25 (Wild-Type). Any disruption in the helix could alter the 
amphipathic nature of the peptide and thus potentially lead to its inactivation. 
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Indeed, the helical structure of SP-Bs_25 (Wild-Type) is drastically disrupted when 
tryptophan is replaced by one of its oxidized forms, kynurenine. The helical stretch of two 
and a half turns (or more) is reduced to less than one turn in both SDS and DPC micelles, as 
well as in HFIP. This confirms that the oxidative modification of tryptophan makes the 
SP-Bs-25 helix largely unstructured regardless of whether it is within a micelle environment 
or in an organic solvent. It is likely that the N-terrninus of the helix nearby Trp9 is the most 
affected part and the oxidation leads to an unwinding of the helix at this end. However, 
besides this disruption of the helix, there may be additional modifications to the SP-B8_25 
structure due to the replacement of tryptophan by kynurenine. 
Trp9 is likely involved in anchoring SP-B8_25 to the micelles. The oxidation reduces 
the hydrophobicity of its sidechain and presumably leads to a failure in the anchoring. As a 
result, the hydrophobic face of the helix near Trp9 may get more exposed to the surrounding 
water molecules which possibly triggers the partial unfolding. It is reasonable to consider the 
mechanism of partial unfolding of the SP-B8_25 (Trp9Kyn) helix to be similar in both SDS 
and DPC micelles. However, in organic solvent condition too, in the absence of any micelles, 
the folded SP-B8_25 (Wild-Type) exhibits similar disruption of the helix owing to the 
tryptophan replacement by kynurenine. This clearly indicates that tryptophan, not only plays 
an anchoring role inside the lipids but also contributes to the integrity of the peptide structure, 
and its oxidation brings about a generic change in the helical structure of SP-Bs-25. It appears 
likely that the oxidation causes substantial changes to the quadruple moment and/or the ring 
current of tryptophan sidechain thus triggering the peptide unstructuring. 
The DOSY data correlate with the surface area of the peptide/micelle complex and 
indicate that SP-Bs-25 (Trp9Kyn)/SDS complex is substantially larger than SP-Bs-25 (Wild-
Type)/SDS complex (hydrodynamic diameters are - 3.7 and - 2.8 nm, respectively). The 
structure of SP-B8_25 (Wild-Type), with an intact amphipathic helix, is suitable to strongly 
interact with both negatively charged headgroups and hydrophobic acyl chains of the SDS 
micelle. These interactions apparently lead to a compact complex of the peptide and the 
micelle. Within the complex, SP-B8_25 (Wild-Type) is likely positioned with its helix parallel 
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to the surface of the micelle, with its hydrophobic face in contact with the acyl chains of SDS 
and its positively charged face in contact with the negatively charged headgroups of SDS and 
surrounding water molecules. When the tryptophan is replaced by kynurenine, a large portion 
of the helix appears to be unstructured. This likely disrupts the clustering of the positive 
charges and makes them spread over the peptide surface. The drastic reduction caused 
thereby to the peptide' s amphipathicity would substantially affect the interactions between 
the peptide and the micelle. Therefore, presumably SP-B8_25 (Trp9Kyn) is not as compactly 
bound to the SDS micelle as SP-B8_25 (Wild-Type) would be. The SDS micelle may be 
stretched to accommodate the partially unstructured SP-B8_25 (Trp9Kyn) within it, which 
would explain the increased size of the complex when tryptophan is replaced by kynurenine. 
The DOSY data of SP-Bs-25 in zwitterionic DPC micelles represent a somewhat 
different scenario. The sizes of the complexes with two versions of the peptide are not as 
different as in SDS. Also, the difference is opposite to the SDS results, i.e. , the SP-Bs-25 
(Trp9Kyn)/DPC complex is smaller than the SP-B8_25 (Wild-Type)/DPC complex 
(hydrodynamic diameters are - 3.7 and - 4.5 run, respectively). There are three plausible 
explanations for this. First, as DPC headgroups contain both positive and negative charges, 
the electrostatic component of the peptide/micelle interactions may not be as strong as it is in 
SDS. As a result, SP-B8_25 (Wild-Type) is probably not as compactly bound to the DPC 
micelle as it is with the SDS micelle. When tryptophan is replaced by kynurenine, the helix is 
disrupted but the overall electrostatic and hydrophobic interactions between the peptide and 
the DPC micelle do not change much and hence the sizes of the complexes may not be 
drastically different. Second, the position of the SP-Bs-25 (Wild-Type) in the DPC micelle 
may not be as deep inside the micelle as it is in the SDS micelle, again owing to the 
difference in the electrostatic part of the peptide/micelle interactions. Therefore, the 
disruption in the helix of SP-B8_25 (Trp9Kyn) may not bring a substantial change in the 
surface area of the DPC micelle within which the peptide positioning is relatively shallow. 
This hypothesis is favorably supported by the observation that SP-B63_78, the C-terminal half 
of Mini-B with a similar degree of amphipathicity (due to 3 clustered positive charges), takes 
a deeper position inside anionic phospholipids-containing bilayers (mimicked by SDS in this 
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study) than purely zwitterionic bilayers (mimicked by DPC in this study) [162]. 
Third, because of the loss of amphiphilicity, SP-B8.25 (Trp9Kyn) may not be able to bind as 
many DPC molecules in the complex as SP-B8.25 (Wild-Type) can. Hence, the size of the 
micelle complex containing the Trp-oxidized peptide is smaller than the complex containing 
the Wild-Type peptide. 
In water alone, contrary to the observations in micelles and organic solvent, the 
helical content of SP-Bs.25 is increased from 8% to 33% with the replacement of tryptophan 
by kynurenine as revealed by the CD spectra. However, this is not surprising since 
kynurenine is less hydrophobic than tryptophan because of the broken indole ring and 
exposed 0 and NH2 groups. Hence the oxidation of tryptophan may partially reduce the 
insolubility of the peptide in water and induce some helical folding in SP-Bs-25 (Trp9Kyn). 
However, SP-Bs-25 (Trp9Kyn) is still not so soluble that the backbone HA-HN correlations in 
the TOCSY or HN-HN correlations in the NOESY can be observed. Thus the partial helical 
folding does not change much the likely aggregation of the peptide in water alone. 
In summary, the findings from this part of my work reveal a substantial disruption in 
the helical structure of SP-Bs.25 induced by the oxidative modification of tryptophan. This 
disruption is generic and likely perturbs the amphipathic profile of the peptide. Therefore, 
tryptophan plays a crucial role in the proper helical folding and lipid interactions of SP-Bs-25 
and presumably ofthe full-length SP-B. 
The oxidative modification of tryptophan is a major source of lung surfactant 
dysfunction as it inactivates an essential component SP-B [202, 206, 21 0]. This is likely a 
leading factor in conditions like ARDS. This study indicates, in addition to preventing the 
protein from anchoring properly to the phospholipids, the oxidation causes a loss of helical 
structure and amphipathicity of the N-terminus of SP-B. These changes likely drastically 
affect the interactions between the native protein and surfactant phospholipids thus 
contributing to the lung surfactant dysfunction. 
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Chapter 8 
Conforma io o ~ ax" -BcT, 
t · ~ e C-T rminal Half of SP-B 
Note : Maxi-Bcr was synthesized and purified by Prof Alan J Waring and his group 
(Waring Lab, Medicine, UCLA). CD data were acquired and analyzed with help of 
Prof David H. Heeley (Heeley Lab, Biochemistry, MUN) and Dr. Michael Hayley 
(Booth Lab, Biochemistry, MUN). 
, I ~ 
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8.1 Overview 
Despite many efforts, to my knowledge, no lab has yet succeeded in producing 
recombinant SP-B in the amounts needed for structural studies. Thus, our collaborator Prof. 
Alan Waring (Medicine, UCLA) has undertaken the challenging task of producing a near-
complete version of SP-B, termed Maxi-B, by chemical synthesis. Maxi-B is based on SP-B 
amino acids 8 to 78. It contains all the helical regions of the SP-B predicted from the 
sequence alignment with known Saposin proteins and retains the three native-like disulfide 
bonds (Figure 8.1 ). Therefore, Maxi-B would be expected to provide significant structural 
information on full-length SP-B. However, initial attempts to synthesize Maxi-B did not 
succeed. A new synthesis strategy was planned afterwards which involves first synthesizing 
the N- and C-terminal halves of Maxi-B separately. Each of these fragments contains two 
predicted helices (one full and the other near-full) of SP-B. The attempt to synthesize the 
C-terminal peptide, Maxi-BeT, in the Waring lab was indeed successful. 
N 
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SP-8 
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Maxi-8 
c 
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Figure 8.1 : Topology of SP-B, Maxi-B, truncated Maxi-B (Maxi-BTR) and Maxi-BeT, based 
on known Saposin protein structures. Maxi-B is a proposed synthetic protein based on amino 
acids 8 to 78 of full-length SP-B. The predicted helical regions are shown as cylinders. The 
disulfide bonds are shown as dashed lines. 
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As a step towards the determination of the structure of fu ll-length SP-B, the 
conformational features of Maxi-BeT in organic solvent HFIP and in SDS micelles were 
studied by solution NMR and CD. 
8.2 Materials and Methods 
8.2.1 Peptide Synthesis and Purification 
Maxi-BeT is a 33 amino acid synthetic peptide based on human SP-B amino acids 46 
to 78 with two mutations C48S and E51A (numbers refer to SP-B sequence positions). The 
two mutations were originally planned for full Maxi-B and have been retained in Maxi-BeT· 
The mutation C48S was proposed to avoid the intermolecular disulfide bond that makes the 
native SP-B a homodimer. The other mutation E51A was proposed in order to prevent the 
formation of any intermolecular salt bridge. The primary structure of Maxi-BeT is shown 
below with gray shading on the mutated amino acids : 
Cys-Gln-Ser-Leu-Ala-Ala-Arg-Tyr-Ser-Val-Ile-Leu-Leu-Asp-Thr-Leu-Leu-
Gly-Arg-Met-Leu-Pro-Gln-Leu-Val-Cys-Arg-Leu-Val-Leu-Arg-Cys-Ser 
The peptide was produced by the Waring lab using solid-phase chemical synthesis via 
0-fluorenylmethyloxycarbonyl (Fmoc) chemistry. Fmoc amino acids and coupling agents 
were purchased from AnaSpec (Fremont, CA). Organic solvents and other reagents used for 
the synthesis and purification were HPLC grade or better and purchased from Fisher 
Scientific (Ottawa, ON) and Aldrich Chemical (St. Louis, MO). The peptide was synthesized 
at a 0.25 mmol scale in an ABI 431A peptide synthesizer configured for FastMoc double-
coupling cycles of all residues to optimize yield [143]. A prederivatized N-Fmoc-0-tert-
butylserine HMP resin (AnaSpec) was used to assemble the peptide during synthesis. 
Deprotection and cleavage of the peptide from the resin were carried out using a 
TFA/thioanisole/EDT A/phenol/water mixture (1 0/0.5/0.25/0.5/0.5 by volume) followed by 
cold precipitation with tert-butylether. The sidechains of the two cysteines in the sequence, 
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C71 and C77, were kept protected by tert-butyl groups to prevent any formation of 
inter/intra-molecular disulfide bonds. The crude product was purified by preparative reverse-
phase HPLC in a Vydac C-18 column using a water/acetonitrile linear gradient with 0.1% 
trifluoroacetic acid as the ion-pairing agent. The molecular weight of the peptide was 
confirmed by fast atom bombardment or MALDI-TOF mass spectrometry. The purity of the 
final product was determined by analytical HPLC and found to be > 95%. The purified 
peptide was lyophilized and stored at 4 °C. 
8.2.2 Sample Preparation 
First, a stock buffer solution was prepared in H20 /D20 (90%/10%) with 0.4 mM DSS 
and 0.2 mM NaN3. The final samples were then prepared by dissolving peptide and other 
contents in the buffer. The sample of Maxi-BeT in HFIP contained 1 mM peptide in a buffer 
adjusted to have 40% HFIP (98% deuterated; Cambridge Isotope, Andover, MA) plus 50% 
H20 and 10% D20. For the sample of Maxi-BeT in SDS, 1 mM peptide and 100 mM 
detergent (98% deuterated; Cambridge Isotope, Andover, MA) were dissolved in the buffer. 
The pH of the samples was set to 5.0 by use of NaOH and HCl without taking the isotope 
effects into account. This pH was chosen in order to obtain the NMR spectra in a region 
where the amide proton/deuteron exchange rate is relatively slow. Only one sample of each 
composition was prepared and the same sample was used for both NMR and CD experiments. 
8.2.3 NMR Data Collection and Processing 
A set of 10 1H, 2D 1H- 1H TOCSY, 2D 1H- 1H NOESY experiments was performed 
for each Maxi-BeT sample on a Bruker Avance II 14.1 Tesla (600 MHz) spectrometer 
(Billerica, MA) equipped with z-gradients and an inverse triple resonance TXI probe. The 
NMR data were collected and processed using the Bruker Topspin 2.0 software. The pulse 
length (P 1) and the transmitter offset (0 1) were optimized for each sample before running 
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the full set of experiments. All NMR experiments were performed at 3 7 oc using the water-
gate water suppression technique [146]. In 1D 1H experiments, data were collected with 32 
scans and processed using an exponential apodization function with 1 Hz line broadening. 
The 2D 1H-1H TOCSY experiments used a 60 ms mixing time and were run with 160 scans. 
A total of 2048/512 data points were collected in F2/F 1 dimensions and the processed spectra 
had 1024 points in both dimensions. The 20 1H- 1H NOESY experiments used a 200 ms 
mixing time and were run with 160 scans. A total of 2048/512 data points were collected in 
F2/F 1 dimensions and the processed spectra had 1024 points in both dimensions. All 
TOCSY and NOESY spectra were processed using the Qsine apodization function with a 
sine bell shift of 2. 
8.2.4 CD Data Collection and Processing 
The CD spectra, in the far-ultraviolet (far-UV) region (from 260 to 190 nm), were 
recorded for both Maxi-Bcr samples using a Jasco-81 0 spectrapolarimeter (Easton, MD). The 
CD data were acquired at 37 oc using a quartz cuvette with 0.1 mm path length. The NMR 
samples were transferred to the cuvette without making any changes in the sample conditions. 
The temperature was controlled by a CTC-345 circulating water bath. The scanning speed of 
the instrument was set at 100 nm/min with normal sensitivity. Five accumulations were 
collected for each sample in 0.1 run steps. The Molar ellipticity [8] was calculated using the 
equation suggested by Heeley et a/. [213 ], 
[8] = OobsiC 1 OLC), (8.1) 
where Sobs is the observed ellipticity, L is the path length of the cell (0.01 em) and C is the 
number of amino acids multiplied by the molar concentration of the peptide (0.0 18 M). The 
secondary structural content was calculated from the molar ellipticity data using a computer 
program following the method of Yang et al. [214]. 
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8.3 Results 
8.3.1 NMR Spectra of Maxi-BeT in HFIP (40°/o) 
Panel A in Figures 8.2 - 8.4 present the structure characterization of Maxi-BeT by 
NMR and CD. The spectra of Mini-B in 40% HFIP (from My M.Sc. work, Booth lab) 
provide convenient reference spectra due to the similarity in size and an a -helical content 
compared to Maxi-BeT and thus are presented in panel B of the figures. Unfortunately, that 
the Mini-B spectra were acquired at a lower temperature (15 °C) than Maxi-BeT (3 7 °C) sets 
a limitation on how much information can be gleaned from comparing the two sets of spectra. 
However, it is still valuable to compare Maxi-BeT data to data from a construct whose atomic 
resolution structure has been determined and for which the exact secondary structure is thus 
known. 
Figure 8.2 shows the 1D 1H spectra of Maxi-BeT acquired on a 600 MHz 
spectrometer at 37 oc and Mini-Bin HFIP acquired on a 700 MHz spectrometer 15 °C. The 
signals seen in the enlarged 6-9 ppm region of Maxi-BeT, corresponding to the backbone and 
sidechain amide protons (HNs), are more overlapped and less dispersed when compared to 
Mini-B, even when taking the difference in spectrometer field into consideration. The 
dispersion of backbone HN signals of Maxi-BeT appears to be intermediate between what are 
typically observed for a random coil and a folded peptide. 
The 2D 1H- 1H TOCSY spectra provides more insight into the structural features of 
Maxi-BeT. The TOCSY peaks in Figure 8.3 mostly correspond to the HA-HN correlations 
that result from the through-bond magnetization transfer between alpha and amide protons of 
the amino acid spin systems. There are 33 amino acids in Maxi-BeT, but more than 33 HA-
HN crosspeaks are seen including some weak peaks in the panel A of Figure 8.3. The total 
count of 33-plus peaks and presence of weak peaks suggest some degree of conformational 
heterogeneity for Maxi-BeT· Also, the peaks are mostly grouped in two regions with one 
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region exhibiting a downfield shift (i.e., higher ppm) in the F2 (HN) dimension. The number 
of HA-HN crosspeaks present in the down-shifted region is higher when compared to the 
peaks from the same region of Mini-B shown in the panel B. This comparison of the general 
appearance of HA-HN crosspeaks likely indicates a decreased a-helical structure of 
Maxi-BeT in organic solvent environment. 
This interpretation is further supported by the examination of HN-HN region of 2D 
1H-1H NOESY (Figure 8.4). The downfield shifts of at least 3 backbone HN signals of Maxi-
BeT are evident when compared to Mini-B. Besides, there are only about 15 intense 
backbone HN-HN crosspeaks present for Maxi-BeT while more than 21 such crosspeaks are 
observed for Mini-B. These correlations result from short HN-HN distances and indicate an 
a-helical folding for about half of Maxi-BeT as compared to at least two-thirds of Mini-B. 
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Figure 8.2 : 1 D 1H spectra of 
(A) 1 mM Maxi-BeT in 40% 
HFIP (plus 90% H20 and 
10% D20) at pH 5.0 and 
temperature 3 7 °C, acquired 
using Bruker 600 MHz 
spectrometer with 32 scans; 
and for comparison, (B) 1.5 
mM Mini-BREo in 40% HFIP 
(plus 90% H20 and 10% 
D20) at pH 5.0 and 
1H (ppm) temperature 15 oc, acquired 
usmg Bruker 700 MHz 
spectrometer with 16 scans. 
Maxi-BeT spectrum was 
collected using the water-gate 
water suppression technique 
and processed by Topspin. 
Mini-B spectrum was 
collected using 3-9-19 water 
suppression technique and 
processed by NMR.Pipe. The 
signal intensities are also 
not normalized between the 
two spectra. 
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Figure 8.3 : HA-HN regions of 2D 1H-1H TOCSY spectra of (A) 1 mM Maxi-BeT in 40% 
HFIP, acquired using Bruker 600 MHz spectrometer and processed by Topspin; and for 
comparison, (B) 1.5 mM Mini-BRED in 40% HFIP, acquired using Bruker 700 MHz 
spectrometer and processed by NMRPipe. Note, the peptide concentrations, temperatures, 
numbers of scans, mixing times and base levels are different for the two spectra. 
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Figure 8.4 : HN-HN regions of 2D 1H-1H NOESY spectra of (A) 1 mM Maxi-BeT in 40% 
HFIP, acquired using Bruker 600 MHz spectrometer and processed by Topspin; and for 
comparison, (B) 1.5 mM Mini-BRED in 40% HFIP, acquired using Bruker 700 MHz 
spectrometer and processed by NMRPipe. Both spectra were acquired using 200 ms mixing 
time. However, the peptide concentrations, temperatures and numbers of scans are different. 
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8.3.2 NMR Spectra of Maxi-BeT in SDS 
As for the HFIP studies described in the previous section, the 10 1H, HA-HN region 
of 2D 1H- 1H TOCSY, and HN-HN region of 2D 1H- 1H NOESY spectra of Maxi-BeT are 
compared to Mini-B in anionic lung lipid mimetic SDS micelles. However, unlike the 
version of Mini-B used in the HFIP studies, the version of Mini-B used in the SDS micelle 
studies was oxidized, i.e., it retained the two native-like disulfide bonds. It is known from my 
previous structural studies (Chapter 3 and [156]) that this version of Mini-B also adopts a 
well-defined a-helical conformation in SDS micelles. Comparing the spectra, despite the 
differences in spectrometer field and temperature at which data were acquired, should 
therefore provide insight on the extent of the Maxi-BeT structuring in lipid mimetic micelle 
environment. 
Figure 8.5 shows the lD 1H spectra of Maxi-BeT and Mini-B in SDS micelles. The 
signals seen from the backbone and sidechain amide protons (HNs) in the enlarged 6-9 ppm 
region are broad and/or overlapped for both peptides but dispersed. This level of line-
broadening and overlapping is not unexpected as the peptides are bound to detergent micelles. 
However, the backbone HNs of Maxi-BeT exhibit decreased dispersion, which indicates, in 
SDS, Maxi-BeT is not as structured as Mini-B. 
The 2D 1H-1H TOCSY spectra demonstrate more differences in the folding patterns 
of Maxi-BeT in SDS when compared to Mini-B (Figure 8.6). More prominently than in HFIP, 
a larger group of Maxi-BeT HA-HN crosspeaks exhibits a downfield shift (i.e., higher ppm) 
in the F2 (HN) dimension as shown in the panel A. The number of peaks present in the 
down-shifted region is also significantly higher when compared to the same region of Mini-B 
shown in the panel B. Therefore, in SDS micelles, Maxi-BeT likely consists of a decreased 
a-helical structure than Mini-B. Furthermore, as in HFIP, the apparent count of 33-plus 
HA-HN crosspeaks and the presence of weak peaks suggest some degree of conformational 
heterogeneity of Maxi-BeT in the micelle environment too. 
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The examination of backbone HN-HN crosspeaks in the 2D 1H- 1H NOESY spectra 
further suggests that Maxi-BeT is less structured than Mini-B in SDS micelles (Figure 8.7). 
While there are many backbone HN-HN correlations present for Maxi-BeT, in contrast to 
Mini-B, they are relatively weak and largely obscured by the strong diagonal signals and thus 
hard to count. However, the downfield shifts for some HN signals are still evident. 
Furthermore, although it is difficult to draw an inference about the number of Maxi-BeT 
amino acids that belong to the a-helical structure in SDS micelles, overall the peptide seems 
to be less structured in the anionic detergent environment when compared to the organic 
solvent environment. 
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Figure 8.5 : 10 1H spectra of 
(A) 1 mM Maxi-BeT in 100 
mM SDS at pH 5.0 and 
temperature 37 °C, acquired 
using Bruker 600 MHz 
spectrometer with 32 scans; 
and for comparison, (B) 1.5 
mM Mini-Box in 150 mM 
SDS at pH 5.0 and 
temperature 45 °C, acquired 
using Bruker 500 MHz 
spectrometer with 8 scans. 
Maxi-BeT spectrum was 
collected using the water-gate 
water suppression technique 
and processed by Topspin. 
Mini-B spectrum was 
collected using pre-saturation 
water suppression technique 
and processed by NMRPipe. 
The signal intensities are also 
not normalized between the 
two spectra. 
.-----------------------------~ ~ 
Maxi-Bcr (1 mM) in SDS (100 mM) a 
0.. pH: 5.0, Temp: 37 oc 5 
No. of scans: 160, Mixing time: 60 ms :C: 
Base level : 70000 
; 
• J 
8.5 8.0 
A 
7.5 7.0 1H (ppm) 
0 
M 
~--------------------------~ ~ 
Mini-B (1.5 mM) in SDS (150 mM) a 
0.. pH : 5.0, Temp : 45 oc 5 
No. of scans: 128, Mixing time: 80 ms :C: 
Base level :4000000 
0 
8.5 
' . ' I 
II' 
8.0 7.5 7.0 H (ppm) 
0 
M 
Figure 8.6 : HA-HN regions of 2D 1H-1H TOCSY spectra of (A) 1 mM Maxi-Bcr in 100 
mM SDS, acquired using Bruker 600 MHz spectrometer and processed by Topspin; and for 
comparison, (B) 1.5 mM Mini-Box in 150 mM SDS, acquired using Bruker 500 MHz 
spectrometer and processed by NMRPipe. Note, the peptide concentrations, temperatures, 
numbers of scans, mixing times and base levels are different for the two spectra. 
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Figure 8.7 : HN-HN regions of 2D 1H- 1H NOESY spectra of (A) 1 mM Maxi-Bcr in 100 
mM SDS, acquired using Bruker 600 MHz spectrometer and processed by Topspin; and for 
comparison, (B) 1.5 mM Mini-Box in 150 mM SDS, acquired using Bruker 500 MHz 
spectrometer and processed by NMRPipe. Both spectra were acquired using 200 ms mixing 
time. However, the peptide/detergent concentrations, temperatures, numbers of scans and 
base levels are different. 
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8.3.3 CD Spectra of Maxi-BeT in HFIP (40°/o) and SDS 
To complement the NMR data and obtain an alternate measure of the secondary 
structural content, circular dichroism spectra were acquired for Maxi-BeT in both HFIP and 
SDS at pH 5.0 and temperature 37 oc (Figure 8.8). Although the computer program used for 
the secondary structure calculation (following the method described in Ref. [214]) calculated 
the structure percentages as a-helix, P-sheet, P-turn and random coil, Maxi-BeT is unlikely to 
contain a P-sheet which requires two or more strands hydrogen-bonded together. It is more 
plausible that the P-sheet content calculated by the computer program actually represents an 
extended conformation and hence is reported as such in the table of Figure 8.8. Thus the CD 
data indicate, in HFIP, about half of Maxi-BeT is a-helical (~ 49%), with the remainder 
taking extended(~ 18%) and random coil (~ 33%) conformation. However, the features for 
Maxi-BeT in SDS are substantially different, with reduction of a-helical content to about one-
third (~ 35%) and a considerable increase in extended (~ 38%) along with some decrease in 
random coil(~ 27%) conformation. 
50000~----------------------------~ 
~ 25000 
-In HFIP 
·--·In SDS 
-25000+----.---.----.---.----.---.--~ 
190 200 210 220 230 240 250 260 
Wavelength (nm) 
Seconda Structure % 
Pe tide I Extended I Random I 
Maxi-BeT in HFIP 49 I 18 I 33 I 
Maxi-BeT in SDS 35 I 38 I 27 I 
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Figure 8.8 Far-UV CD 
spectra of 1 mM Maxi-BeT in 
40% HFIP and in 1 00 mM SDS 
at pH 5.0 and temperature 37 
°C, acquired using 5 
accumulations and a 0.1 mm 
light path. The molar ellipticity 
is calculated from the observed 
ellipiticity following the method 
described in Ref. [213]. The 
secondary structural contents, 
shown in the table, are 
calculated from the molar 
ellipticities following the 
method described in Ref. [214]. 
8.4 Discussion 
Knowledge of the high-resolution three-dimensional structure of a protein IS an 
important step in understanding its functional mechanism. The structure of SP-B, an 
indispensable protein for air-breathing vertebrates, is not known yet which limits our 
understanding of its crucial contribution(s) to lung surfactant function. Determination of the 
high-resolution structure of SP-B is one major research goal of the Booth lab (Biochemistry, 
Memorial University of Newfoundland). However, this is very challenging and attempts to 
achieve recombinant expression of high levels of 13C/15N-labeled protein, required for 
solution NMR studies have not succeeded yet. As an alternative, the chemical synthesis of a 
protein based on SP-B amino acids 8 to 78, termed Maxi-B, was proposed by the Waring 
group (Medicine, UCLA). This synthetic Maxi-B is expected to provide significant structural 
information on full-length SP-B. However, difficulties were encountered in initial attempts to 
synthesize Maxi-B in a single step. This was not unexpected, as synthesis of a protein which 
contains 71 amino acids and 3 internal disulfide bonds is indeed very challenging. An 
alternate plan was devised, in which the N- and C-terminal halves of Maxi-B would be 
synthesized separately, and then connected by the three disulfide bonds (termed as truncated 
Maxi-B (Maxi-BrR) in Figure 8.1). The C-terminal fragment, Maxi-Bcr, was attempted first 
and successfully synthesized by the Waring group. This part of my work was conducted to 
obtain the first structural characterization of Maxi-Bcr in organic solvent and detergent 
micelles and lay down a foundation for future studies ofMaxi-B and/or Full-length SP-B. 
Maxi-B would contain all the predicted helical regions of full-length SP-B and retain 
the three native-like disulfide bonds between C8-C77, Cll-C71 and C35-C46. Two 
mutations, C48S and E51 A, were proposed to avoid the intermolecular disulfide bond and 
salt bridge, respectively. The first seven N-terminal amino acids of SP-B were clipped off in 
Maxi-B to eliminate the possibility of self-association. The C-terminal amino acid of SP-B, 
M79, was removed from Maxi-B sequence as it does not belong to the predicted C-terminal 
helix. Hydrophobic amino acid contents of the two proteins are similar, 52% in SP-B and 
54% in Maxi-B. The net charges carried by the proteins at neutral pH are also similar, +8 for 
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Maxi-Band +7 for SP-B, with the difference resulting from the mutation E51A. All these 
features render Maxi-B an interesting protein to learn about the structure, properties, 
lipid/protein interactions and functional mechanism of full-length SP-B. 
Maxi-BeT, a 33 residue peptide, is based on amino acids 46 to 78 from the C-terminal 
region of SP-B. Sequence homology with known Saposin proteins predicts this fragment to 
contain two a-helical segments, i.e., the C-terminal helix of SP-B, as well as the helix next to 
it. To obtain the first structural characterization of Maxi-BeT, I performed solution NMR and 
CD studies in organic solvent HFIP and anionic surfactant lipid mimetic SDS micelles. The 
NMR data are also compared to that of Mini-B, a 34 residue peptide comprised of SP-B 
amino acids 8 to 25 and 63 to 78. It is known from my previous structural studies (Sarker, M. , 
M.Sc. Thesis and Chapter 3 of this Ph.D. Thesis, Booth lab) that Mini-B adopts a 
well-defined conformation with two a-helices in both HFIP and SDS micelles. Thus, the 
NMR spectra of Mini-B were ideal to compare the extent of Maxi-BeT structuring in the 
same environments. 
The NMR data indicate approximately half of Maxi-BeT to be a-helical in organic 
solvent condition. The helical content of the peptide is reduced in detergent micelles. The 
NMR data also indicate that the peptide consists of some non-helical content, likely some 
extended conformation, in HFIP, and an even increased non-helical conformation in SDS 
micelles. These findings are well supported by the CD data of Maxi-BeT that show the 
structure in HFIP to be 49% helical with 18% extended and 33% random coil, while in SDS, 
it is 35% helical with 38% extended and . ·33% random coil. Overall, the peptide is Jess 
structured (i.e., Jess helical) in detergent micelles than in organic solvent. 
The relatively decreased helical structuring of Maxi-BeT in SDS micelles, when 
compared to the structuring in HFIP, is likely influenced by the physiochemical properties of 
the peptide. Maxi-BeT consists of four positively changed amino acids and one negatively 
charged amino acid. Three of the four positively charged amino acids (R64, R72 and R76) 
are localized in the C-terminal region of the peptide, which correspond to the C-terminal half 
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of Mini-B (amino acids 63 to 78) that contain an amphipathic a-helix. The other positively 
charged amino acid (R52) and the only negatively changed amino acid (059) make the N-
terminal region of Maxi-BeT neutral. It is therefore possible that the electrostatic interactions 
between the positively charged C-terminal region of Maxi-BeT and the negatively charged 
SDS micelle induce an amphipathic helical conformation for this part of the peptide which 
may be similar to the C-terminal half of Mini-B. However, theN-terminal region of Maxi-
BeT, because of the lack of a charge bias, may not interact strongly with the SDS micelle and 
hence may not adopt a well defined helical conformation. These electrostatic interactions, on 
the other hand, may not be required in inducing the secondary structure of Maxi-BeT in HFIP, 
and thus the peptide presumably adopts a more helical conformation in the organic solvent 
environment. 
Determination of the high-resolution structure of Maxi-BeT is not attempted in this 
study as the main goal is to check the amenability of the peptide to NMR studies and prepare 
a foundation for study of full Maxi-B. It is not possible to draw a clear inference about 
whether the peptide consists of a single helical stretch or two distinct helical segments in 
either of the environments without performing spectral assignments and a high-resolution 
structure calculation. However, considering the presence of a glycine (G63) and a proline 
(P67) in the middle region, it seems unlikely that Maxi-BeT consists of a single helix 
spanning this middle region. In light of the NMR data, well supplemented by the CD data, it 
is possible that, in HFIP, Maxi-BeT consists of two helices but in SDS, Maxi-BeT has a 
helical folding mainly at the C-terminus. 
Maxi-BeT is Jess helical in both HFIP and SDS micelles when compared to Mini-B. 
While Mini-B possesses two a-helices comprising two-thirds of the peptide in both 
conditions, only half of Maxi-BeT is helical in HFIP which reduces to just one-third in SDS 
micelles. The distribution of seven positively charged amino acids in the two regions, 
presence of two native-like disulfide bonds and inter-helix interactions likely play crucial 
roles in the overall helical folding of Mini-B. In contrast, Maxi-BeT has no disulfide bonds 
and has a far less net charge of + 3 that is localized in one region only. These properties, 
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therefore, are apparently essential for the physiologically relevant helical folding of SP-B 
based peptides. 
Although this study finds that Maxi-BeT exhibits decreased helical structuring, 
especially in SDS micelles, the inclusion of Maxi-BNT, the other Maxi-B fragment consisting 
of amino acids 8 to 35 of SP-B, would possibly bring a significant improvement m 
structuring and induce a more native-like conformation of Maxi-B or Maxi-BTR· 
In this study, the high resolution structure of Maxi-BeT was not attempted, as the 
main objectives were to gain an insight into the overall conformational features and check the 
amenability of the proposed Maxi-B/Maxi-BTR to future NMR studies. The NMR spectra of 
Maxi-BeT indicate that Maxi-B (or Maxi-BTR), if available with sufficient 13C/15N labels, 
would likely be suitable for a high-resolution structural characterization by solution NMR. 
The observations from Maxi-BeT would also aid in the future investigations of the near-
complete or the full-length SP-B. 
213 
214 
Chapter 9 
Concl sion 
9.1 Summary and Remarks 
Lung surfactant is a complex mixture of lipids and proteins that enables normal 
breathing by reducing the surface tension created at the alveolar air-water interface and 
additionally provides the first line of defense against inhaled microbes in the lungs . SP-B, a 
protein component which accounts for not more than "' 1.5% of the total surfactant weight, is 
absolutely essential for the survival of mammals f37 , 38, 216]. Biophysical studies suggest 
that SP-B facilitates large-scale rearrangements of lipids and stabilizes complex structures 
required for interfacial adsorption , surfactant film stability and respreading capacity of 
surfactant materials [821. To understand the mechanistic basis for this ability and the 
physiological ramifications of lipid rearrangements , it is important to know the high-
resolution structure of SP-B. Unfortunately , the 30 structure of SP-B has not yet been 
determined since, as is generally the case for membrane and other lipid-associated 
hydrophobic proteins, the production of an SP-B sample for structural studies has been very 
challenging and unsuccessful to date . Interestingly , synthetic fragments of SP-B retain 
substantial biological activity when compared to the full -length protein [109]. Oxidized 
Mini-B (Mini-B0 x) tops this list and it likely encompasses the key functional regions of the 
full -length protein [109]. This Ph.D. research has applied solution NMR methods to Mini-B 
and two other SP-B-based peptides to reveal at least some of the critical structural features 
and lipid/protein interactions that presumably underlie the functional mechanisms of SP-B in 
physiological conditions. 
I have determined the high-resolution structure of Mini-B in the presence of micelles 
composed of the anionic detergent SDS, which provides a reasonable mimetic of SP-B ' s 
physiological environment in the lung (Chapter 3). Mini-B consists of two a-helices 
connected by an unstructured loop. The helices are packed tightly together and interhelical 
interactions are stabilized by the two disulfide bonds as well as by several hydrophobic 
contacts. Mini-B possesses a strikingly amphipathic surface with a large positively charged 
patch on one face of the peptide and a large hydrophobic patch on the opposite face. The 
tryptophan side chain extends outward from the peptide in a position to interact with lipids 
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and anchor Mini-B at the lipid-water interface. Amino acids of Mini-B in theN-terminus and 
the loop regions appear to exhibit a certain degree of plasticity. All of these distinctive 
structural features likely contribute to the mechanism by which Mini-B, and presumably 
SP-B, functions. 
The structure of Mini-B in SDS, with its strikingly amphipathic surface and 
projecting tryptophan anchor, appears very well suited for making strong interactions with 
surfactant phospholipid analogues. Indeed, Mini-B binds both anionic and zwitterionic 
micelles composed of SDS, DPC, LMPC, LMPG and mixed LMPC/LMPG and induces 
substantial rearrangements of the micelle structures (Chapter 4). However, interesting 
differences are noticed in the overall conformation and dynamics of Mini-B in zwitterionic 
versus anionic environments. Despite the similarity in structuring of Mini-B in DPC to 
LMPC and SDS to LMPG, intriguing differences are found in how Mini-B interacts with the 
smaller SDS/DPC micelles compared to the larger LMPC/LMPG micelles. Thus, subtle 
differences in the lipid structure can substantially impact Mini-B/Iipid interactions. 
Presumably, in the native lung conditions, SP-B also adopts diverse conformations and forms 
different types of lipid-associations at various stages of the breathing cycle. 
To prepare a foundation for directly probing the interaction between Mini-B and 
SP-A, I have investigated the conformation and lipid interactions of SP-A in the presence of 
micelles composed from the same model surfactant lipids (Chapter 5). SP-A's biological 
roles, in relation to either anti-microbial activities or surfactant biophysical activities, are 
almost always attributed to its octadecameric structure and preferential interactions with 
DPPC (17, 53, 56]. However, my investigations unveil that SP-A binds not only to 
zwitterionic micelles but also to anionic micelles and that the micelle-bound SP-A exists 
predominantly as smaller oligomers, in sharp contrast to the octadecamers observed when in 
an aqueous environment, and the form in which SP-A has long been presumed to function. 
These findings demonstrate the necessity of developing new models to portray how the 
protein may function as smaller oligomers and interact with different lipid types in the 
native lung conditions. 
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Several biophysical studies have indicated an in vitro interaction, either direct or 
indirect, between SP-B and SP-A that may be important in lung surfactant function [59, 62, 
170, 171]. I have attempted to directly probe the interaction between Mini-B and SP-A, if 
any, in the presence of micelles composed of model surfactant lipids LMPC, LMPG and 
mixed LMPCILMPG, alongside SDS and DPC (Chapter 6). Mini-B appears to interact with 
SP-A in all micelle systems, although the degree of the interaction is dependent on the 
detergent/lipid headgroup. The entire population of Mini-B appears to interact with SP-A 
when in zwitterionic micelles (at least in DPC) but only a subpopulation of Mini-B interacts 
with SP-A when in anionic micelles (at least in SDS). Interestingly, in larger LMPC and 
LMPG micelles, there may occur a Mini-B-induced reduction of the SP-A oligomeric states. 
In all of these model surfactant lipids, however, the interactions between Mini-B and SP-A 
are most likely not direct protein-protein interactions but mediated via the micelles. 
Next, I have investigated the modifications to SP-B's structure and lipid interactions 
brought about by tryptophan oxidation using the N-terminal fragment SP-B8_25 (Chapter 7). 
Oxidative modification of SP-B, considered to be a major factor in conditions like ARDS, 
most deleteriously affects the biophysical activity of lung surfactant and can lead to its 
complete inactivation [202, 206, 21 OJ. Trp9, the only tryptophan present in SP-B sequence, is 
essential for optimal interface affinity of the protein [140] and is a prime site for oxidative 
damage [211]. Replacement of tryptophan by one of its oxidized forms, kynurenine, 
substantially disrupts the helical structure of SP-B8_25 . This likely perturbs the amphipathic 
profile of the peptide as well and thereby affects its interactions with the micelles. Thus, in 
the lung, tryptophan oxidation perhaps causes a loss of the helical structure of native SP-B 
and interrupts its interactions with surfactant phospholipids, which lead to lung surfactant 
dysfunction. 
Lastly, as a step towards the determination of the structure of full-length SP-B, the 
overall conformation of Maxi-BeT, the C-terminal half of Maxi-B (or SP-B), has been 
investigated in organic solvent HFIP and SDS micelles (Chapter 8). Although Maxi-BeT (33 
amino acids) exhibits a decreased helical structuring when compared to Mini-B (34 amino 
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acids), especially in SDS micelles, the inclusion ofMaxi-BNT, theN-terminal halfofMaxi-B, 
would possibly bring a significant improvement in the overall structure and induce a more 
native-like conformation of Maxi-B. The results obtained for Maxi-BeT indicate that the 
synthetic Maxi-B (or the recombinant full-length SP-B), if produced containing an 
appropriate number of 13C/ 1~ labels, would likely be suitable for high-resolution structural 
characterization by solution NMR. 
SP-B is indispensable for life, but the molecular basis for its activity IS not yet 
understood. The findings of my Ph.D. research contribute to the ongoing endeavor in 
characterizing SP-B's structure-function relationships and its mechanisms of lipid/protein 
interactions that are crucial for lung surfactant function. This work also provides a strong 
foundation for future studies on the conformations and interactions of near-complete or 
full-length SP-B. 
9.2 Future Work 
What role SP-B exactly plays in lung surfactant function is still a puzzle. A great tool 
to resolve this puzzle would be the high-resolution structure of full -length SP-B, or at least a 
near-full SP-B variant (e.g. Maxi-B), in a lipid-bound state . Knowledge of the high-
resolution structure of SP-B will facilitate unveiling the mechanisms of its function in the 
lung and directly probing its interactions with surfactant lipids and other proteins. Production 
of a synthetic/recombinant sample to conduct the structural studies is the greatest hurdle to 
overcome in this regard. There are at least three labs currently working on this and hopefully 
the endeavor will be successful in the near future. In the mean time, further progress can still 
be achieved by characterizing biologically active fragments of SP-B that are now available . 
Mini-B has enormous potential from a therapeutic perspective. In my Ph.D. work , the 
high-resolution structure of Mini-B has been determined and its interactions with model 
surfactant lipids and SP-A have been probed. One interesting future study will be to 
218 
investigate if tubular myelin can be formed by adding Mini-B. instead of full -length SP-B, 
with mixtures of DPPC, PG and SP-A in the presence of Ca2+ . 
Recently an extended version of Mini-B, called Super Mini-B, has been synthesized 
by the Waring group (Medicine, UCLA) which includes theN-terminal seven amino acids of 
native SP-B that are not part of Mini-B. Super Mini-B shows excellent surfactant activity , 
even better than Mini-Box• in ventilated rats with ARDS induced by in vivo lavage [217J . The 
first structural characterization using Attenuated Total Reflectance-Fourier Transform 
Infrared (ATR-FTIR) spectroscopy shows a similar degree of a-helical conformation of 
Super Mini-B when compared to Mini-B f217J. This is not unexpected since the first seven 
amino acids of SP-B represent a putative lipid insertion region of the protein 11421 and are 
unlikely to extend the span of its N-terminal helix. Nevertheless, it may be informative to 
determine the high resolution structure of Super Mini-B and investigate if it exhibits stronger 
interactions with model surfactant lipids than Mini-B. 
Chemical synthesis of Maxi-B (a near-complete versiOn of SP-B), first in the 
truncated form as Maxi-BTR (Figure 8.1, Page 197), will be attempted soon by the Waring 
group (Medicine, UCLA). Since it is not feasible to synthesize Maxi-B incorporating 15N/13C 
labels uniformly, I have developed a selective labeling scheme to incorporate an appropriate 
number of 15N backbone amide labels at strategic locations along the polypeptide chain of 
Maxi-B. If successfully synthesized, the first structural characterization of Maxi-BTR will be 
obtained in organic solvent HFIP by the Booth group using solution NMR. Although the 
absence of some of the native amino acids and the organic solvent environment will limit the 
structure's ability to explain SP-B ' s function in physiological conditions, helpful 
information, such as the span of the helices, distribution of hydrophobic and hydrophilic 
amino acids along the structure and extent of the positively charged patches on the surface, 
will be unveiled by this study. Identification of the resonance frequencies of proton spin 
systems from the HFIP data will also guide future NMR studies of Maxi-B/SP-B in a more 
physiologically relevant environment such as detergent/lipid micelles or oriented 
phospholipid bilayers. 
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Because the synthetic Maxi-B (or Maxi-BTR) will carry only a limited number of 
15N-labels, an attempt to determine its high-resolution structure in the presence of 
detergent/lipid micelles using solution NMR is unlikely to be successful. However, the 
internal dynamics of different Maxi-B regions and its interactions with model surfactant 
lipids/proteins can still be probed using solution NMR. In addition, with selected site-
specific isotope ( 13C/15N/19F) labels, solid-state NMR studies can lead to some inferences on 
the overall tertiary conformation of Maxi-B in lipid environments. One possible option will 
be to use oriented samples and determine the orientations of the helices in phospholipid 
bilayers. Another option will be to directly investigate if Maxi-B folds with its two predicted 
pairs of helices tightly packed as in the closed-type Saposins or further apart as in the 
open-type Saposins. 
Recombinant expression of full-length SP-B in bacteria is currently underway in the 
Booth Lab. Protocols are being explored to resolve the problems that other labs have 
encountered in SP-8 production. However, given the difficulties in expressing and then 
purifying a properly folded protein that contains over 50% hydrophobic amino acids and 
three intrachain and one interchain disulfide bonds , this project still demands formidable 
efforts to get accomplished. Nevertheless, if successful, it will allow an incorporation of 
uniform 13C/15N labels in SP-B which will make the protein acquiescent to the structural 
studies in the presence of detergent/lipid micelles by solution NMR. The high-resolution 
three-dimensional structure of full-length SP-B will likely revolutionize the ongoing lung 
surfactant-related research and contribute significantly in developing a more accurate model 
for lung surfactant function. 
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